
<html lang="en"     class="pb-page"  data-request-id="431a81e1-c1e5-41c8-b55b-31067d773624"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-23;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm5012808;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, Ivacaftor), a Potent and Orally Bioavailable CFTR Potentiator" /></meta><meta name="dc.Creator" content="Sabine  Hadida" /></meta><meta name="dc.Creator" content="Fredrick  Van Goor" /></meta><meta name="dc.Creator" content="Jinglan  Zhou" /></meta><meta name="dc.Creator" content="Vijayalaksmi  Arumugam" /></meta><meta name="dc.Creator" content="Jason  McCartney" /></meta><meta name="dc.Creator" content="Anna  Hazlewood" /></meta><meta name="dc.Creator" content="Caroline  Decker" /></meta><meta name="dc.Creator" content="Paul  Negulescu" /></meta><meta name="dc.Creator" content="Peter D. J.  Grootenhuis" /></meta><meta name="dc.Description" content="Quinolinone-3-carboxamide 1, a novel CFTR potentiator, was discovered using high-throughput screening in NIH-3T3 cells expressing the F508del-CFTR mutation. Extensive medicinal chemistry and iterat..." /></meta><meta name="Description" content="Quinolinone-3-carboxamide 1, a novel CFTR potentiator, was discovered using high-throughput screening in NIH-3T3 cells expressing the F508del-CFTR mutation. Extensive medicinal chemistry and iterat..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 2, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5012808" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5012808" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5012808" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5012808" /></link>
        
    
    

<title>Discovery of N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, Ivacaftor), a Potent and Orally Bioavailable CFTR Potentiator | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5012808" /></meta><meta property="og:title" content="Discovery of N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, Ivacaftor), a Potent and Orally Bioavailable CFTR Potentiator" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0023.jpeg" /></meta><meta property="og:description" content="Quinolinone-3-carboxamide 1, a novel CFTR potentiator, was discovered using high-throughput screening in NIH-3T3 cells expressing the F508del-CFTR mutation. Extensive medicinal chemistry and iterative structure–activity relationship (SAR) studies to evaluate potency, selectivity, and pharmacokinetic properties resulted in the identification of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, 48, ivacaftor), an investigational drug candidate approved by the FDA for the treatment of CF patients 6 years of age and older carrying the G551D mutation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5012808"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5012808">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5012808&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5012808&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5012808&amp;href=/doi/10.1021/jm5012808" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 9776-9795</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm5016928" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Featured Article</span><a href="/doi/10.1021/jm501266w" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of <i>N</i>-(2,4-Di-<i>tert</i>-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, Ivacaftor), a Potent and Orally Bioavailable CFTR Potentiator</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sabine++Hadida">Sabine Hadida</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fredrick++Van+Goor">Fredrick Van Goor</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jinglan++Zhou">Jinglan Zhou</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vijayalaksmi++Arumugam">Vijayalaksmi Arumugam</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason++McCartney">Jason McCartney</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Hazlewood">Anna Hazlewood</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caroline++Decker">Caroline Decker</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Negulescu">Paul Negulescu</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+D.+J.++Grootenhuis">Peter D. J. Grootenhuis</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Vertex Pharmaceuticals Incorporated, 11010 Torreyana Road, San Diego, California 92121, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 1-858-404-6676. E-mail: <a href="/cdn-cgi/l/email-protection#94e4f1e0f1e6cbf3e6fbfbe0f1fafce1fde7d4e2e6e0ecbaf7fbf9"><span class="__cf_email__" data-cfemail="83f3e6f7e6f1dce4f1ececf7e6edebf6eaf0c3f5f1f7fbade0ecee">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5012808&amp;href=/doi/10.1021%2Fjm5012808" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 9776–9795</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 4, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 August 2014</li><li><span class="item_label"><b>Published</b> online</span>2 December 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 December 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5012808" title="DOI URL">https://doi.org/10.1021/jm5012808</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ec-1612971054143.svg" alt="ACS Editors’ Choice" /></img><span>ACS Editors’ Choice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5012808"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">9488</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">54</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5012808" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, Ivacaftor), a Potent and Orally Bioavailable CFTR Potentiator&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sabine&quot;,&quot;last_name&quot;:&quot;Hadida&quot;},{&quot;first_name&quot;:&quot;Fredrick&quot;,&quot;last_name&quot;:&quot;Van Goor&quot;},{&quot;first_name&quot;:&quot;Jinglan&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Vijayalaksmi&quot;,&quot;last_name&quot;:&quot;Arumugam&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;McCartney&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Hazlewood&quot;},{&quot;first_name&quot;:&quot;Caroline&quot;,&quot;last_name&quot;:&quot;Decker&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Negulescu&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;D. J. Grootenhuis&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;9776-9795&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5012808&quot;},&quot;abstract&quot;:&quot;Quinolinone-3-carboxamide 1, a novel CFTR potentiator, was discovered using high-throughput screening in NIH-3T3 cells expressing the F508del-CFTR mutation. Extensive medicinal chemistry and iterative structure–activity relationship (SAR) studies to evaluate potency, selectivity, and pharmacokinetic properties resulted in the identification of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, 48, ivacaftor), an investigational drug candidate approved by the FDA for the treatment of CF patients 6 years of age and older carrying the G551D mutation.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5012808&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5012808" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5012808&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5012808" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5012808&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5012808" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5012808&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5012808&amp;href=/doi/10.1021/jm5012808" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5012808" /></input><a href="/doi/pdf/10.1021/jm5012808" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5012808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5012808%26sid%3Dliteratum%253Aachs%26pmid%3D25441013%26genre%3Darticle%26aulast%3DHadida%26date%3D2014%26atitle%3DDiscovery%2Bof%2BN-%25282%252C4-Di-tert-butyl-5-hydroxyphenyl%2529-4-oxo-1%252C4-dihydroquinoline-3-carboxamide%2B%2528VX-770%252C%2BIvacaftor%2529%252C%2Ba%2BPotent%2Band%2BOrally%2BBioavailable%2BCFTR%2BPotentiator%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D23%26spage%3D9776%26epage%3D9795%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jmcmar.2014.57.issue-23/20141211/jmcmar.2014.57.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Quinolinone-3-carboxamide <b>1</b>, a novel CFTR potentiator, was discovered using high-throughput screening in NIH-3T3 cells expressing the F508del-CFTR mutation. Extensive medicinal chemistry and iterative structure–activity relationship (SAR) studies to evaluate potency, selectivity, and pharmacokinetic properties resulted in the identification of <i>N</i>-(2,4-di-<i>tert</i>-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, <b>48</b>, ivacaftor), an investigational drug candidate approved by the FDA for the treatment of CF patients 6 years of age and older carrying the G551D mutation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cystic fibrosis (CF) is a lethal genetic disease that affects approximately 70 000 patients worldwide.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> CF is caused by defective or deficient cystic fibrosis transmembrane conductance regulator (CFTR) protein resulting from mutations on both alleles of the CFTR gene. The CFTR protein is a PKA-regulated anion channel that is critical for the transport of chloride and bicarbonate ions in epithelial cells from multiple organs including the lung, pancreas, intestine, reproductive tract, and sweat duct. Over 1900 different mutations in the CFTR gene have been identified. Mutations of the CFTR gene can result in reduced amounts of CFTR at the cell surface, a decrease in the ability of CFTR to transport ions, or both.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The most common mutation is F508del, a deletion of phenylalanine at position 508, which is found in at least one allele in about 90% of CF patients and interferes with CFTR folding, trafficking, membrane stability, and channel gating. The resulting decrease of CFTR-dependent chloride secretion into the airway leads to an increase in fluid absorption across the surface epithelia causing the mucus to have abnormal composition and increased viscosity. This leads to airway obstruction and prevents clearance of harmful bacteria. There is still a large unmet medical need for CF patients, as the majority of the treatments such as antibiotics and mucus-clearing agents are only symptomatic.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Our strategy was to discover small molecules that target the underlying mechanism of CF by restoring the function of the mutant CFTR channel. Assays were developed to monitor the activity of compounds that affect the function of CFTR by two complementary mechanisms, CFTR potentiation and CFTR correction. Correctors are agents that improve the cellular processing and delivery of F508del-CFTR to the cell surface to increase CFTR-mediated Cl<sup>–</sup> secretion.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> CFTR potentiators act on CFTR to increase the flow of ions through CFTR channels that are present at the cell surface, usually by increasing their open probability (<i>P</i><sub>o</sub>).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Initial in vitro data suggested that CFTR potentiators are therapeutically useful in CF patients who have CFTR at the cell surface, including patients with gating mutations such as G551D. Additionally, potentiators might augment the effect of other agents, such as correctors, that increase CFTR presence at the cell surface. Thus, a potentiator that acts on different mutations, including F508del and G551D-CFTR, would be desirable.</div><div class="NLM_p">Several classes of CFTR potentiators have been reported<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) such as flavones (genistein), chromen-4-ones (UC<sub>CF</sub>-29), sulfonamides (SF-01), phenylglycines (PG-01), and our previously described pyrazoles (VRT-532).<a onclick="showRef(event, 'ref4 ref8'); return false;" href="javascript:void(0);" class="ref ref4 ref8">(4, 8)</a> It is speculated that these molecules interact directly with the nucleotide binding domain region of CFTR.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> However, many of these compounds display low potency, limited selectivity, and poor pharmacokinetic properties in preclinical species, making them unsuitable for development as human therapeutics.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Herein, we describe the discovery and subsequent evaluation of a novel class of CFTR potentiators, the quinolinone-3-carboxamides. Extensive structure–activity relationship around compound <b>1</b>, the starting point of our medicinal chemistry program, led to the identification of compounds that potentiated a number of mutant CFTR forms in vitro, including F508del-CFTR, G551D-CFTR, and others, culminating in the discovery of VX-770 (<b>48</b>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> VX-770 (also known by its generic name ivacaftor and now marketed under the name Kalydeco) was subsequently evaluated in randomized, placebo-controlled clinical trials<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> and was approved by the FDA on January 31, 2012 for the treatment of CF in patients aged 6 years or older who have the G551D mutation.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Ivacaftor exhibits excellent activity and pharmacokinetic properties, providing the opportunity to treat the underlying cause of CF either as monotherapy or in combination with CFTR correctors, depending on the CFTR mutation.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0001.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of CFTR potentiators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">High throughput screening in NIH-3T3 cells expressing the F508del-CFTR mutation was developed using a fluorescence-based assay that measured changes in membrane potential due to CFTR-mediated chloride efflux in response to stimulation by forskolin, an adenylcyclase activator. To correct the defective processing and trafficking of F508del-CFTR to the cell surface, the cells were incubated at 27 °C for 16 h prior to monitoring compounds’ activity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Compound <b>1</b> displayed an EC<sub>50</sub> of 2.1 ± 1.4 μM in this assay, a 4-fold improvement over genistein (EC<sub>50</sub> = 8.0 ± 2.0 μM). The response to <b>1</b> was observed only after forskolin addition, indicating that <b>1</b> was a potentiator and not an activator of CFTR function. To confirm the activity of <b>1</b>, human bronchial epithelial cells (HBE) isolated from bronchi of CF subjects carrying the F508del mutation on both alleles were used. When cultured as monolayers, these cells show impaired salt and fluid transport, defective cilia beating, and the formation of a thick mucus layer characteristic of CF airway epithelia in vivo.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> CFTR potentiation was measured as an increase in transepithelial current in the presence of forskolin, and the EC<sub>50</sub> in F508del/F508del-HBE for <b>1</b> was 1.5 μM. In addition, compound <b>1</b> increased the chloride secretion in G551D/F508del-HBE cells with an EC<sub>50</sub> of 12.2 μM, showing the potential for potentiation of multiple CFTR mutations. These findings, in combination with a relatively low molecular weight of 368 and cLogP of 2.9,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> made <b>1</b> an attractive, validated starting point for the CFTR potentiator project. In the remainder of this study, unless noted otherwise, all potentiator EC<sub>50</sub> data were obtained in the fluorescence-based assay in NIH-3T3 cells expressing the F508del-CFTR mutation. Key compounds were also profiled in F508del-HBE and G551D/F508del-HBE cells where we observed no more than 10-fold potency differences between NIH-3T3, F508del-HBE, and G551D/F508del-HBE cells.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33558" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33558" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To begin the investigation, information around compound <b>1</b> was generated by using the central amide bond to synthesize analogs and probe independently the role of both the quinolinone and the amine moieties. To simplify the structure–activity (SAR) interpretation in this work, we hypothesized that the molecular target is a single protein, most likely F508del-CFTR. A range of distinct analogs were synthesized to examine the requirements for the quinolinone moiety which could exist in the keto or enol form, either of which could be differentially replicated using different isosteric replacements. Removal of the quinolinone 4-oxo group as shown in compound <b>2</b>, truncation of the fused phenyl with pyridone <b>3</b>, alkylation of the quinolinone nitrogen <b>4</b>, or replacement of the quinolinone ring with pyridopyrimidone <b>5</b> all led to reduced potencies, whereas quinolinone replacement with naphthol derivative <b>6</b> retained activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Unexpectedly, the data in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> suggested that the quinolinone ring has two chemical features important for retaining activity. These are the hydrophobic phenyl ring and the quinolinol tautomer which is stabilized by intramolecular hydrogen bonding with the lone pair of electrons on the carbonyl oxygen of the amide (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of Quinolinone Modifications on Potentiator Activity in NIH-3T3 Cells Expressing F508del-CFTR<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a><sup>,</sup><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0014.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0015.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Footnotes: *Mean and standard deviation EC<sub>50</sub> values from at least three determinations are reported. <sup>#</sup>% activity of VRT-532 at the specified concentration.</p></div></div><div></div></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0002.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed active tautomer of compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine if changes in the amine portion of the molecule would lead to increased potency, a diverse set of ∼70 amines including primary, secondary, aliphatic, aromatic, and heterocyclic amines were selected for synthesis. As a result, 6-indolyl derivative <b>16</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) was identified, with an EC<sub>50</sub> of 0.1 μM, a 20-fold improvement in potency over compound <b>1</b>.</div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> shows several examples prepared as part of the amine exploration. Aniline <b>7</b>, 2,6-diethylaniline <b>10</b>, 4-ethylaniline <b>12</b>, and naphthyl derivative <b>14</b> appeared equipotent with <b>1</b>. Five- to ten-fold potency improvements were observed with the introduction of linear or branched aliphatic substituents to the ortho position of aniline <b>7</b> (e.g., <b>8</b>, <b>11</b>) or branched aliphatic groups at the aniline para position (<b>13</b>). Comparing the activity of <b>16</b> with 5-indolyl analog <b>15</b> and 1-methyl-6-indolyl derivative <b>18</b> suggested that the indole NH in <b>16</b> formed an important interaction, possibly a hydrogen bond, that improved the activity by 60-fold, and therefore, this position was left unsubstituted for the remainder of our studies. Reduction of indole <b>16</b> to indoline <b>17</b> retained activity. Further attempts to increase the polarity of the molecule by replacing the indole ring with other heterocycles while retaining the orientation of the NH (azaindole <b>19</b>, indazole <b>20</b>, benzimidazole <b>21</b>, and oxyindole <b>22</b>) or interchanging alkyl groups with polar moieties (<b>9</b>) resulted in reduction of potency.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effect of Amine Modifications on Potentiator Activity in NIH-3T3 Cells Expressing F508del-CFTR<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0016.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0017.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Footnotes: *Mean and standard deviation EC<sub>50</sub> values from at least three determinations are reported. <sup>#</sup>% activity of VRT-532 at the specified concentration.</p></div></div><div></div></div><div class="NLM_p">After the identification of lead compound <b>16</b>, it was profiled more broadly. Compound <b>16</b> had good selectivity against a panel of over 60 different targets, part of the Ricerca lead profiling screen, only hitting the GABA<sub>A</sub> benzodiazepine receptor, a ligand-gated chloride channel, with an IC<sub>50</sub> of ∼0.1 μM.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> It was found that <b>16</b> had low solubility (aqueous and organic)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> despite its low molecular weight of 303 and cLog P of 1.6, due to its planarity and hydrogen bonding that results in a tightly packed crystal lattice. In addition, indole <b>16</b> displayed low oral bioavailability in rats (11%) and a short iv half-life in dogs (0.9 h), mostly due to moderate to high clearance (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Parameters of Indole <b>16</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">ND = not determined.</p></div></div></div><div class="NLM_p">It was proposed that the formation of an intramolecular hydrogen bond between the amide hydrogen and the lone pair of electrons on the carbonyl oxygen of the quinolinone imposed a planar conformation to the whole structure that exposed the indole NH to form a key hydrogen bond interaction. Molecular mechanics calculations revealed that the most favorable conformation was one with an intramolecular hydrogen bond and that a rotational barrier for the amidequinolinone dihedral exceeded 10 kcal/mol.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Single crystal X-ray crystallography of <b>16</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) confirmed that, in the solid state, <b>16</b> adopted essentially a planar overall conformation, with the quinolinone moiety displaying the keto tautomeric form engaged in an intramolecular hydrogen bond with the amide hydrogen.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0003.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray structure of compound <b>16</b>. Anisotropic atomic displacement ellipsoids for the non-hydrogen atoms are shown at the 50% probability level. Hydrogen atoms are displayed with an arbitrarily small radius.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to disrupt the planarity of compound <b>16</b> and improve solubility, changes to the amide linker were investigated with the intent to modify the formation of the intramolecular hydrogen bond while recognizing that this may negatively affect activity. Representative examples of this approach are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Effect of Linker Modification in the Activity of <b>16</b> in NIH-3T3 Cells Expressing F508del-CFTR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0018.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">linker</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">-CONH-</td><td class="colsep0 rowsep0" align="left">0.1 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">-CO<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">19% at 30 μM<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">-SO<sub>2</sub>NH-</td><td class="colsep0 rowsep0" align="left">1% at 30 μM<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>NH-</td><td class="colsep0 rowsep0" align="left">1% at 30 μM<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">-NHCO-</td><td class="colsep0 rowsep0" align="left">8% at 30 μM<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Mean and standard deviation EC<sub>50</sub> values from at least three determinations are reported.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">% activity of VRT-532 at the specified concentration.</p></div></div></div><div class="NLM_p">Ester <b>23</b>, sulfonamide <b>24</b>,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> reduced analog <b>25</b>, and reverse amide <b>26</b> displayed lower potencies. These results highlighted the importance of the planar conformation for potentiator activity, and therefore, the quinolinone amide portion of <b>16</b> was kept unchanged. Subsequent efforts targeted further modifications to the aniline portion with the purpose of increasing potentiator potency by 10-fold, reducing GABA<sub>A</sub> activity, and adding three-dimensionality to the molecule to improve organic solubility. To that extent, a two-prong approach was undertaken. On one side, following up on our initial observations, substituents were introduced at positions 3 and 5 of indole derivative <b>16</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). On the other side encouraged by the activity of indoline <b>17</b>, several ring opened analogs were prepared (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Consistent with our initial observations, potency enhancements over <b>16</b> were observed with 5-ethyl analog <b>29</b> (5-fold), 3-<i>tert</i>-butyl derivative <b>28</b>, and 5-<i>tert</i>-butylindole <b>30</b> (10-fold) whereas 3-ethyl analog <b>27</b> remained equipotent with <b>16</b>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Potentiator Activity in NIH-3T3 Cells Expressing F508del-CFTR of Indole Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0019.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.1 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left"><sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.009 ± 0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">0.020 ± 0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">0.011 ± 0.002</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Mean and standard deviation EC<sub>50</sub> values from at least three determinations are reported.</p></div></div></div><div class="NLM_p">The second approach focused on the preparation of analogs of indoline <b>17</b>. Ring opened aniline <b>31</b> was prepared and showed 15-fold reduction in activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Introduction of alkyl groups of varying size and volume at the 4-position (compounds <b>32</b>–<b>36</b>) resulted in improved potency with increasing size (<b>32</b> vs <b>35</b>) and branching (<b>33</b> vs <b>36</b>) and culminated with compound <b>36</b>, which is equipotent with indole derivative <b>16</b>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro Potentiator Activity in NIH-3T3 Cells Expressing F508del-CFTR of 4-Substituted Aniline Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0020.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">6.9 ± 1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">6.0 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left"><i><sup>i</sup></i>Pr</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">0.3 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">0.4 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left"><sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">0.1 ± 0.05</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Mean and standard deviation EC<sub>50</sub> values from at least three determinations are reported.</p></div></div></div><div class="NLM_p">The next step in the evaluation targeted the replacement of the 1,3-dianiline motif of compound <b>36</b>. In an effort to understand the role of the aniline moiety at the 3 position, it was removed and replaced with hydrogen bond donating groups and aniline bioisosteres (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Whereas the removal of the amine group (<b>43</b>) retained activity, both amine acylation (<b>37</b>) and carbamate derivatization (<b>38</b>) had a detrimental effect on activity. Similarly, substitution of the aniline moiety with a benzylamine (<b>39</b>), a carboxylic acid (<b>41</b>), or a sulfonamide group (<b>42</b>) significantly reduced activities. Substitution of the aniline with a hydroxymethyl group (<b>40</b>) or a fluorine atom (<b>44</b>) was tolerated, while replacement with a phenolic group (<b>45</b>) increased the activity by 40-fold. Although the concept of indole–phenol bioisosterism was reported by Asselin et al. in the context of the dopamine receptor,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> the improved activity of phenol <b>45</b> was unexpected. We speculated that it was due to the combination of the flat conformation induced by the intramolecular hydrogen bond, the hydrophobic interaction created by the 4-<i>tert-</i>butyl group, and the 3-phenol moiety acting as a hydrogen-bond donor. As phenol <b>45</b> potentiated CFTR in F508del-CFTR HBE with a potency of 5 nM, a 300-fold increase over the starting point <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>), 2-fluoro (<b>46</b>), 2-trifluoromethyl (<b>47</b>), and 2-<i>tert</i>-butyl (<b>48</b>) derivatives were then selected for synthesis with the purpose of introducing a substituent of a varying molecular volume and lipophilic character at the para position of phenol <b>45</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). From an activity point of view, all three compounds appeared equipotent with <b>45</b> in the optical assay. Further profiling of compounds <b>28</b>, <b>30</b>, and <b>45</b>–<b>48</b> in F508del-HBEs and rat iv pharmacokinetic parameters is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. In Vitro Potentiator Activity in NIH-3T3 Cells Expressing F508del-CFTR of Aniline Replacements</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0021.gif" alt="" id="fx8" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">NHCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">24% at 30 μM<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">NHCO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3.5 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">20% at 30 μM<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">0.1 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">13% at 30 μM<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">5.1 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.1 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">0.1 ± 0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">0.003 ± 0.002</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Mean and standard deviation EC<sub>50</sub> values from at least three determinations are reported.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">% activity of VRT-532 at the specified concentration.</p></div></div></div><div class="NLM_p">Although compounds <b>28</b>, <b>30</b>, <b>45</b>–<b>48</b> retained excellent potencies in the F508del-CFTR HBE assay, phenol <b>48</b> displayed the best rat iv pharmacokinetic profile with low clearance and long half-life. Further profiling of <b>48</b> revealed that it had an improved organic solubility<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and no major CYP<sub>450</sub> activity (1A2, 2C9, 2C19, 2E1, 3A4, and 2D6 IC<sub>50</sub> > 20 μM) and did not inhibit the cardiac potassium channel hERG (IC<sub>50</sub> >10 μM). In the Ricerca spectrum screen, <b>48</b> showed no significant activity against 160 targets tested including the GABA<sub>A</sub> benzodiazepine receptor. The ability of compound <b>48</b> to increase the gating activity of G551D-CFTR was evaluated in HBE (F508del/G551D) epithelia using Ussing chambers recording techniques. Compound <b>48</b> increased the chloride secretion with an EC<sub>50</sub> of 0.236 ± 0.200 μM, a 10-fold shift in potency compared to the F508del HBEs. Further, the maximum Cl<sup>–</sup> secretion in F508del/G551D HBE reached levels close to 50% of the levels observed in HBE from individuals without CF, suggesting an excellent potential for clinical efficacy. These data also highlighted that the compound was able to potentiate two different CFTR mutations. More recently it was shown that <b>48</b> potentiates multiple mutant CFTR forms with defects in CFTR gating (including G551D), suggesting that <b>48</b> is not mutation-specific but may improve the underlying molecular cause of gating defects caused by several mutations.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. In Vitro Potency of Phenol Derivatives <b>45</b>–<b>48</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0022.gif" alt="" id="fx9" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">2 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left"><sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">3 ± 1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Mean and standard deviation EC<sub>50</sub> values from at least three determinations are reported.</p></div></div></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. In Vitro Potency and Rat iv Pharmacokinetic Parameters of Indole Analogs <b>28</b> and <b>30</b> and Phenol Derivatives <b>45</b>–<b>48</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM),<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a> F508del-HBE</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0–∞</sub> (μg·h/mL)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="char" char=".">2.45</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td><td class="colsep0 rowsep0" align="char" char=".">60.7</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">97 ± 63</td><td class="colsep0 rowsep0" align="char" char=".">2.49</td><td class="colsep0 rowsep0" align="char" char=".">2.64</td><td class="colsep0 rowsep0" align="char" char=".">15.8</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">5 ± 2</td><td class="colsep0 rowsep0" align="char" char=".">1.29</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">85.6</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">45 ± 61</td><td class="colsep0 rowsep0" align="char" char=".">1.57</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td><td class="colsep0 rowsep0" align="char" char=".">62.9</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">22 ± 14</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="char" char=".">17.7</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">22 ± 10</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">3.04</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">9.5</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Mean and standard deviation EC<sub>50</sub> values from at least three determinations are reported.</p></div></div></div><div class="NLM_p">Further characterization in male mice, beagle dogs, and cynomolgus monkeys indicated that compound <b>48</b> had prolonged half-lives, moderate to low clearance values, and good oral bioavailability in rat and dog (Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>).</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Mouse, Rat, Dog, and Cynomolgus Monkey Pharmacokinetic Parameters of <b>48</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">iv</th><th class="rowsep1 colsep0" colspan="3" align="center">po</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–∞</sub> (μg·h/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">20.0</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" colspan="3" align="center">not determined</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">9.5</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">55</td><td class="colsep0 rowsep0" align="left">4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="left">13.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">7.4</td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" colspan="3" align="center">not determined</td></tr></tbody></table></div></div><div class="NLM_p">In a rat dose proportionality study, the AUC and <i>C</i><sub>max</sub> were increased linearly after oral administration of <b>48</b> in a suspension vehicle at doses from 1 to 200 mg/kg (3, 10, 30, and 100 were the intermediate doses). A similar trend was observed in beagle dogs increasing the oral dose from 3 to 80 mg/kg (10, 30, and 60 were the intermediate doses), confirming high levels of oral absorption.</div><div class="NLM_p last">The predicted human hepatic clearance of <b>48</b> using allometric scaling from four species was 4.7 mL min<sup>–1</sup> kg<sup>–1</sup>, which is approximately 23% of hepatic blood flow. On the basis of its potency, selectivity, and favorable pharmacokinetic profile, compound <b>48</b> (VX-770, ivacaftor) was selected for further (pre)clinical evaluation and eventually was approved by the FDA for the treatment of CF patients 6 years and older carrying the G551D mutation.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusion and Perspective</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44582" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44582" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The quinolinone-3-carboxamides were discovered as a new class of CFTR potentiators with activity in NIH-3T3 cells expressing the F508del-CFTR mutation and in human bronchial epithelial cells isolated from CF subjects with F508del/F508del and G551D/F508del-CFTR. This article summarized the efforts toward the evaluation of screening hit dibenzylamide <b>1</b>. This work demonstrated that the quinolinone-3-carboxamide moiety played an important role satisfying the requirements of planar conformation for potentiator activity through intramolecular hydrogen-bonding. Variation of the amine moiety indicated that 6-indolinyl and 6-indolyl derivatives improved activity by 5- to 20-fold. Ring opening to 3-anilino-4-alkyl derivatives followed by replacement of the aniline with a phenol group resulted in an additional 40-fold improvement in potentiator activity. Introduction of an alkyl group at the 4-position to the aniline had a surprising and dramatic improvement in organic solubility (while retaining poor aqueous solubility). Incorporation of a substituent at the 2-position that varied molecular volume and lipophilicity culminated with the identification of <i>N</i>-(2,4-di-<i>tert</i>-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>48</b>). This compound potentiates more than one CFTR mutation in human bronchial epithelial cells with greater potency than genistein (70-fold in G551D/F508del, 200-fold in F508del/F508del), has favorable pharmacokinetic properties in rodents and non-rodents, and was selected for clinical evaluation for the treatment of cystic fibrosis.</div><div class="NLM_p last">The discovery of VX-770 (<b>48</b>) is an example of a personalized medicine drug discovery effort.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The excellent in vitro activity of <b>48</b> for the G551D mutation (see above) guided us to first study the compound in CF patients with this particular mutation. Thus, the efficacy and safety of <b>48</b> in CF patients carrying the G551D mutation in the <i>CFTR</i> gene was demonstrated in two randomized, double-blind, placebo-controlled trials.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Significant improvements in lung function as measured by FEV<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> were observed in the CF patients who received VX-770 (<b>48</b>), compared to the patients who received placebo. In addition the VX-770 (<b>48</b>)-treated patients generally showed improved body weight parameters and reduced frequency of pulmonary exacerbations. VX-770 (<b>48</b>) was generally well tolerated. VX-770 (<b>48</b>) was first approved for the treatment of CF patients aged 6 years and older who carry the G551D mutation in their <i>CFTR</i> gene. Subsequently, VX-770 (<b>48</b>) has been approved in the U.S. for the treatment of eight additional CFTR mutations. Additional clinical studies are underway or planned to assess the clinical benefit of VX-770 (<b>48</b>) in other groups of CF patients carrying different CFTR mutations. In retrospect, it took over 22 years from the discovery of the CFTR gene in 1989<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> until approval of the first drug that targets the defective CFTR mutant protein, which is the underlying cause of cystic fibrosis. Looking forward, it is likely that additional CFTR modulators will eventually be approved to treat other mutations, either alone or in combination with VX-770 (<b>48</b>).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65374" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65374" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">4-Oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>) was synthesized from aniline and diethyl 2-(ethoxymethylene)malonate following a reported procedure.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Sulfonamide <b>24</b> was prepared in two synthetic steps from quinolin-4-one (<b>50</b>) following a procedure previously described by Davis et al.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Briefly, electrophilic addition of chlorosulfonic acid to <b>50</b> afforded 3-sulfonyl chloride intermediate <b>51</b> that was reacted under standard conditions to yield desired product <b>24</b>.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Quinolinone-4-oxo-3-sulfonamide <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ClSO<sub>3</sub>H, 125 °C, 100%; (b) 6-indolylamine, pyridine, DCE, Δ<i>T</i>, 3%.</p></p></figure><div class="NLM_p">Compound <b>26</b> was prepared in modest yield by coupling of 3-aminoquinoline-4-one (<b>56</b>) and commercially available indole-6-carboxylic acid (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Amine <b>56</b> was synthesized in four steps and 39% overall yield following a modified route reported by Reich et al.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Condensation of nitromethane (<b>52</b>) yielded acetaldehyde oxime <b>53</b> that was trapped with antranilic acid to afford benzoic acid <b>54</b>. Cyclization promoted by acetic anhydride and sodium acetate followed by reduction yielded <b>56</b>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Reverse Amide <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaOH, H<sub>2</sub>O, rt to 45 °C; (b) anthranilic acid, HCl, H<sub>2</sub>O, 96% over two steps; (c) AcONa anhydrous, Ac<sub>2</sub>O, 120 °C, 41%; (d) ammonium formate, Pd/C, THF, 70 °C, 99%; (e) 6-indolylcarboxylic acid, HATU, DIEA, DMF, rt, 21%.</p></p></figure><div class="NLM_p">4-<i>tert</i>-Butyl-3-amino derivative <b>36</b> was prepared following the three synthetic steps shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Starting with the corresponding <i>tert</i>-butylbenzene <b>57</b>, nitration with fuming HNO<sub>3</sub>/H<sub>2</sub>SO<sub>4</sub> yielded the 1,3-dinitrophenyl derivative <b>58</b> that was reduced to afford the dianiline intermediate <b>59</b>. Coupling with 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>) yielded a mixture of regioisomers in moderate yields that were separated by chromatography. It was noted that as the size of the alkyl group at the 4 position increased, the coupling favored the desired and less sterically hindered amine isomer.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Compound <b>36</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a><sup>,</sup><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) fuming HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4,</sub> 0 °C to rt, 95% ; (b) H<sub>2</sub>, Pd/C, MeOH, 51%; (c) HATU, DIEA, DMF, 62%.</p></p></figure><div class="NLM_p">Compounds <b>39</b>–<b>41</b> were prepared from common intermediate <b>62</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) obtained from bromination<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> of commercially available <b>60</b> followed by palladium mediated cyanation.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Selective reduction of the cyano group with BH<sub>3</sub>·THF yielded benzylamine <b>63</b> in moderate yield. Protection and reduction of the nitro group followed by amide coupling and deprotection under acidic conditions afforded compound <b>39</b>.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of <b>49</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ag<sub>2</sub>SO<sub>4</sub>, Br<sub>2</sub>, 90% H<sub>2</sub>SO<sub>4</sub>, 98%; (b) Pd(PPh<sub>3</sub>)<sub>4</sub>, Zn(CN)<sub>2</sub>, DMF, 200 °C, 80%; (c) BH<sub>3</sub>, THF, 70 °C, 43%; (d) Boc<sub>2</sub>O, THF, 70 °C, 78%; (e) H<sub>2</sub>, Pd/C, AcOH, MeOH, 92%; (f) (i) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), DMF, TEA, HBTU; (ii) CH<sub>2</sub>Cl<sub>2</sub>, TFA, 53% over two steps.</p></p></figure><div class="NLM_p">Acidic hydrolysis of cyano intermediate <b>62</b> proceeded smoothly under microwave irradiation to afford the corresponding carboxylic acid <b>66</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Esterification of <b>66</b> by treatment with methyl iodide and K<sub>2</sub>CO<sub>3</sub> followed by reduction of the nitro group afforded ester <b>67</b> that was reduced with LAH to yield benzyl alcohol <b>68</b>. Coupling with 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>) under standard conditions yielded <b>40</b>. Coupling ester <b>67</b> with 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>) under standard conditions followed by ester hydrolysis afforded carboxylic acid <b>41</b> in moderate yield.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of <b>40</b> and <b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 75% H<sub>2</sub>SO<sub>4</sub>, microwave, 200 °C, 90%; (b) (i) K<sub>2</sub>CO<sub>3</sub>, MeI, DMF, 71%; (ii) Pd/C, HCO<sub>2</sub>H, EtOH, 95%; (c) LAH, THF, 70 °C, 20%; (d) (i) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), HATU, Et<sub>3</sub>N, DMF, 60 °C, 80%; (ii) LiOH, MeOH, THF, microwave 140 °C, 66%; (e) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), HBTU, Et<sub>3</sub>N, DMF, 5%.</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a> outlines the preparation of sulfonamide <b>42</b> and phenol <b>45</b> from common intermediate <b>70</b> prepared by nitration of commercially available 2-<i>tert</i>-butylaniline <b>69</b>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Diazotization followed by quenching with water<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and nitro reduction yielded the anilinophenol intermediate <b>71</b> that was coupled with 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>) to afford <b>45</b> in moderate yields. Diazotization of <b>70</b> followed by sulfonylation<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> with Na<sub>2</sub>SO<sub>3</sub> and CuSO<sub>4</sub>, sulfonamide formation, and nitro reduction afforded aniline intermediate <b>72</b> that was coupled with quinoline-4-oxo-3-carboxylic acid (<b>49</b>) to afford desired sulfonamide <b>42</b>.</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of <b>42</b> and <b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, 64%; (b) (i) NaNO<sub>2</sub>, H<sub>2</sub>SO<sub>4</sub>–H<sub>2</sub>O, 62%; (ii) NH<sub>4</sub>CO<sub>2</sub>H, Pd–C, 87%; (c) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), HBTU, Et<sub>3</sub>N, DMF, 47% (<b>45</b>), 33% (<b>42</b>); (d) (i) NaNO<sub>2</sub>, HCl, Na<sub>2</sub>SO<sub>3</sub>, CuSO<sub>4</sub>, H<sub>2</sub>O, 17%; (ii) NH<sub>4</sub>OH, diethyl ether, 34% ; (iii) SnCl<sub>2</sub>, EtOH, 100%.</p></p></figure><div class="NLM_p">Diazotization of <b>70</b> followed by fluorination<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(36)</a> afforded nitro intermediate <b>73</b> that was reduced and coupled with 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>) to afford <b>44</b> (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>).</div><figure id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Preparation of <b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaNO<sub>2</sub>, HPF<sub>6,</sub> 12%; (b) NaBH<sub>4,</sub> NiCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 75%; (c) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), HATU, Et<sub>3</sub>N, THF, 21%.</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a> outlines the preparation of fluoro derivative <b>46</b> from 4-fluorophenol (<b>75</b>). Regioselective incorporation of the <i>tert</i>-butyl group was achieved by Friedel–Crafts alkylation in the presence of AlCl<sub>3</sub> as reported by Charpentier et al.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(37)</a> Phenol intermediate <b>76</b> was protected as a carbonate (<b>77</b>) and subjected to nitration conditions<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(38)</a> to afford <b>78</b>. Deprotection proceeded smoothly at 25 °C using piperidine to yield phenol <b>79</b> that was reduced to aniline <b>80</b> and coupled with 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>) to achieve desired compound <b>46</b> in moderate yields.</div><figure id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Preparation of <b>46</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <sup><i>t</i></sup>BuOH, H<sub>2</sub>SO<sub>4</sub>, AlCl<sub>3,</sub> 42%; (b) CH<sub>3</sub>CO<sub>2</sub>Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2,</sub> 59%; (c) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4,</sub> 55%; (d) piperidine, CH<sub>2</sub>Cl<sub>2,</sub> 62%; (e) ammonium formate, Pd/C, EtOH, 83%; (f) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), HBTU, Et<sub>3</sub>N, DMF, 23%.</p></p></figure><div class="NLM_p">Trifluoromethyl derivative <b>47</b> was prepared in eight steps as shown in Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>. Selective bromination of commercially available <i>tert</i>-butylphenol <b>81</b> with freshly crystallized NBS in acetonitrile afforded 4-bromophenol intermediate <b>82</b>. Protection of the phenol group as a carbamate, nitration, and deprotection afforded phenol intermediate <b>85</b> that was reprotected as benzyl derivative <b>86</b>. Trifluoromethylation to yield key intermediate <b>87</b> was achieved in moderate yield by treatment with ClCF<sub>2</sub>CO<sub>2</sub>Me, KF, KBr, CuI in DMF following the procedure reported by Su et al.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(39)</a> Finally, phenol deprotection and coupling with 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>) afforded compound <b>47</b> in poor yield.</div><figure id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Preparation of <b>47</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, CH<sub>3</sub>CN, 68%; (b) CH<sub>3</sub>CO<sub>2</sub>Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 72%; (c) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4,</sub> 83%; (d) KOH, MeOH, 96%; (e) BnBr, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 94%; (f) ClCF<sub>2</sub>CO<sub>2</sub>Me, KF, KBr, CuI, DMF, 67%; (g) ammonium formate, Pd/C, EtOH, 52%; (h) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), HBTU, Et<sub>3</sub>N, DMF, 8%.</p></p></figure><div class="NLM_p">Compound <b>48</b> was prepared in five synthetic steps from commercially available 2,4-di-<i>tert</i>-butylphenol (<b>89</b>) as shown in Scheme <a class="ref internalNav" href="#sch10" aria-label="10">10</a>. Phenol protection as a carbonate followed by nitration with nitric acid and sulfuric acid afforded an 8:1 mixture of nitro intermediates <b>91</b> and <b>92</b> that were separated by column chromatography. Deprotection under basic conditions afforded the desired nitrophenol <b>93</b> in 30% yield. Reduction followed by coupling with 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>) afforded compound <b>48</b> in moderate yield.</div><figure id="sch10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0013.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Preparation of <b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>3</sub>CO<sub>2</sub>Cl, Et<sub>3</sub>N, DMAP, CH<sub>2</sub>Cl<sub>2,</sub> quant; (b) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>; (c) KOH, MeOH, 29% over two steps for the preparation of <b>91</b>; (d) ammonium formate, Pd/C, EtOH, quant; (e) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), HBTU, Et<sub>3</sub>N, DMF, 71%.</p></p></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88207" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88207" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 4-Oxo-1,4-dihydroquinoline-3-carboxylic Acid Dibenzylamide (<b>1</b>)</h3><div class="NLM_p">To a solution of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>, 0.62 g, 3.0 mmol) and triethylamine (0.8 mL, 6.0 mmol) in dichloromethane (15 mL) was added thionyl chloride (0.5 mL, 6.0 mmol). The reaction mixture was heated at reflux for 1 h and concentrated to give the corresponding acid chloride.</div><div class="NLM_p last">A mixture of the acid chloride, triethylamine (0.8 mL, 6.0 mmol), and dibenzylamine (1.2 g, 6.0 mmol) was stirred at 25 °C in dichloromethane (15 mL) for 16 h. The crude reaction mixture was washed with 1 N HCl (10 mL), a saturated aqueous solution of NaHCO<sub>3</sub> (10 mL), and brine (10 mL). The organics were dried over MgSO<sub>4</sub> and evaporated under reduced pressure. The crude material was purified by silica gel chromatography (ethyl acetate–hexane, 50–100%) to give <b>1</b> (0.93 g, 84%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.20 (s, 1H), 8.26 (s, 1H), 8.20 (dd, <i>J</i> = 8.1, 1.2 Hz, 1H), 7.70 (ddd, <i>J</i> = 8.4, 7.0, 1.5 Hz, 1H), 7.59 (d, <i>J</i> = 8.1 Hz, 1H), 7.51–7.43 (m, 2H), 7.43–7.33 (m, 3H), 7.33–7.21 (m, 4H), 7.21–7.13 (m, 2H), 4.59 (s, 2H), 4.42 (s, 2H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>, 369.1603; found, 369.1592.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Quinoline-3-carboxylic Acid Dibenzylamide (<b>2</b>)</h3><div class="NLM_p last">A mixture of quinoline-3-carboxylic acid (17 mg, 0.1 mmol), dibenzylamine (30 mg, 0.15 mmol), triethylamine (0.03 mL, 0.2 mmol), and HATU (38 mg, 0.1 mmol) in DMF (1 mL) was stirred for 3 h. The reaction mixture was filtered and purified by reverse-phase HPLC to give <b>2</b> (10 mg, 28%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.95 (d, <i>J</i> = 2.1 Hz, 1H), 8.55 (d, <i>J</i> = 1.9 Hz, 1H), 8.03 (t, <i>J</i> = 8.1 Hz, 2H), 7.87–7.78 (m, 1H), 7.67 (t, <i>J</i> = 7.5 Hz, 1H), 7.49–7.23 (m, 8H), 7.23–7.07 (m, 2H), 4.69 (s, 2H), 4.53 (s, 2H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>20</sub>N<sub>2</sub>O, 353.1654; found, 3353.1652.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>,<i>N</i>-Dibenzyl-4-hydroxynicotinamide (<b>3</b>)</h3><div class="NLM_p last">Compound <b>3</b> was prepared from 4-hydroxynicotinic acid (40 mg, 0.3 mmol) in a similar manner as described for compound <b>2</b>. Yield: 66 mg, 69%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.03 (s, 1H), 7.80 (d, <i>J</i> = 5.3 Hz, 1H), 7.43–7.21 (m, 9H), 7.17 (d, <i>J</i> = 6.7 Hz, 2H), 6.36 (d, <i>J</i> = 7.2 Hz, 1H), 4.54 (s, 2H), 4.34 (s, 2H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>, 319.1446; found, 319.1431.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-Methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Dibenzylamide (<b>4</b>)</h3><div class="NLM_p last">Compound <b>1</b> (74 mg, 0.2 mmol) and triethylamine (0.06 mL, 0.4 mmol) were dissolved in a mixture of toluene (0.5 mL) and methanol (0.5 mL). A 2 M solution of TMS-diazomethane (0.3 mL, 0.6 mmol) was added, and the reaction mixture was stirred at 25 °C for 16 h. The reaction mixture was evaporated to dryness, and the residue was purified by reverse-phase HPLC. Yield: 14 mg, 18%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42 (s, 1H), 8.30 (d, <i>J</i> = 7.3 Hz, 1H), 7.80 (m, 1H), 7.72 (d, <i>J</i> = 8.5 Hz, 1H), 7.47 (m, 3H), 7.37 (t, <i>J</i> = 7.5 Hz, 2H), 7.28 (m, 4H), 7.17 (d, <i>J</i> = 7.1 Hz, 2H), 4.57 (s, 2H), 4.43 (s, 2H), 3.89 (s, 3H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>22</sub>N<sub>2</sub>O<sub>2</sub>, 383.1759; found, 383.1758.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4-Oxo-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-3-carboxylic Acid Dibenzylamide (<b>5</b>)</h3><div class="NLM_p last">Compound <b>5</b> was prepared from 4-oxo-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidine-3-carboxylic acid (38 mg, 0.2 mmol) in a similar manner as described for compound <b>2</b>. Yield: 58 mg, 78%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.21 (d, <i>J</i> = 7.0 Hz, 1H), 8.63 (s, 1H), 7.89 (td, <i>J</i> = 7.8, 1.3 Hz, 1H), 7.78 (d, <i>J</i> = 8.8 Hz, 1H), 7.30 (m, 9H), 7.16 (d, <i>J</i> = 7.1 Hz, 2H), 4.76 (s, 2H), 4.48 (s, 2H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub>, 370.1555; found, 370.1552.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 1-Hydroxynaphthalene-2-carboxylic Acid Dibenzylamide (<b>6</b>)</h3><div class="NLM_p last">Compound <b>6</b> was prepared from 1-hydroxy-2-naphthoic acid (50 mg, 0.3 mmol) in a similar manner as described for compound <b>2</b>. Yield: 26 mg, 24%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.27 (s, 1H), 8.37–8.24 (m, 1H), 7.92–7.81 (m, 1H), 7.57–7.50 (m, 2H), 7.46 (d, <i>J</i> = 8.4 Hz, 1H), 7.41–7.18 (m, 11H), 4.52 (s, 4H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>21</sub>NO<sub>2</sub>, 368.1650; found, 368.1638.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-Oxo-1,4-dihydroquinoline-3-carboxylic Acid Phenylamide (<b>7</b>)</h3><div class="NLM_p last">Compound <b>7</b> was prepared from aniline (19 mg, 0.2 mmol) in a similar manner as described for compound <b>1</b>. Yield: 17 mg, 32%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.97 (s, 1H), 12.50 (s, 1H), 8.89 (s, 1H), 8.34 (dd, <i>J</i> = 8.1, 1.1 Hz, 1H), 7.83 (t, <i>J</i> = 8.3 Hz, 1H), 7.75 (m, 3H), 7.55 (t, <i>J</i> = 8.1 Hz, 1H), 7.37 (t, <i>J</i> = 7.9 Hz, 2H), 7.10 (t, <i>J</i> = 6.8 Hz, 1H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>12</sub>N<sub>2</sub>O<sub>2</sub>, 265.0977; found, 265.0976.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(2-Ethylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>8</b>)</h3><div class="NLM_p last">Compound <b>8</b> was prepared from 2-ethylaniline (60.6 mg, 0.5 mmol) in a similar manner as described for compound <b>1</b>. Yield: 16 mg, 11%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.93 (s, 1H), 12.37 (s, 1H), 8.90 (s, 1H), 8.36 (dd, <i>J</i> = 8.1, 1.4 Hz, 1H), 8.32 (dd, <i>J</i> = 8.1, 1.3 Hz, 1H), 7.86–7.79 (m, 1H), 7.76 (dd, <i>J</i> = 8.4, 1.1 Hz, 1H), 7.65–7.43 (m, 1H), 7.27 (dd, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.25–7.18 (m, 1H), 7.15–6.98 (m, 1H), 2.80 (q, <i>J</i> = 7.5 Hz, 2H), 1.27 (t, <i>J</i> = 7.5 Hz, 3H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>, 293.1285; found, 293.1296.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(2-(Cyanomethyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>9</b>)</h3><div class="NLM_p last">Compound <b>9</b> was prepared from 2-ethylaniline (152.7 mg, 0.5 mmol) in a similar manner as described for compound <b>1</b>. Yield: 9.8 mg, 6%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.00 (s, 1H), 12.44 (s, 1H), 8.91 (s, 1H), 8.37 (dd, <i>J</i> = 8.2, 1.4 Hz, 1H), 8.16 (dd, <i>J</i> = 8.2, 1.3 Hz, 1H), 7.87–7.81 (m, 1H), 7.78 (dd, <i>J</i> = 8.3, 1.2 Hz, 1H), 7.60–7.52 (m, 1H), 7.49 (dd, <i>J</i> = 7.7, 1.5 Hz, 1H), 7.45–7.34 (m, 1H), 7.25–7.18 (m, 1H), 4.11 (s, 2H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>, 304.1081; found, 304.1087.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-(2,6-Diethylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>10</b>)</h3><div class="NLM_p last">Compound <b>10</b> was prepared from 2,6-diethylaniline (74.6 mg, 0.5 mmol) in a similar manner as described for compound <b>1</b>. Yield: 14.4 mg, 9%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.87 (s, 1H), 11.64 (s, 1H), 8.86 (s, 1H), 8.34 (dd, <i>J</i> = 8.1, 1.4 Hz, 1H), 7.87–7.79 (m, 1H), 7.76 (dd, <i>J</i> = 8.4, 1.2 Hz, 1H), 7.64–7.46 (m, 1H), 7.25–7.19 (m, 1H), 7.19–7.11 (m, 2H), 2.57 (q, <i>J</i> = 7.6 Hz, 4H), 1.12 (t, <i>J</i> = 7.5 Hz, 6H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>, 321.1598; found, 321.1609.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-(2-Isopropylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>11</b>)</h3><div class="NLM_p last">Compound <b>11</b> was prepared from 2-isopropylaniline (67.6 mg, 0.5 mmol) in a similar manner as described for compound <b>1</b>. Yield: 16.6 mg, 11%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.92 (s, 1H), 12.35 (s, 1H), 8.90 (s, 1H), 8.36 (dd, <i>J</i> = 8.1, 1.4 Hz, 1H), 8.20 (dd, <i>J</i> = 8.1, 1.4 Hz, 1H), 7.85–7.79 (m, 1H), 7.76 (d, <i>J</i> = 8.1 Hz, 1H), 7.61–7.46 (m, 1H), 7.35 (dd, <i>J</i> = 7.7, 1.6 Hz, 1H), 7.28–7.18 (m, 1H), 7.18–7.06 (m, 1H), 3.40–3.33 (m, 1H), 1.29 (d, <i>J</i> = 6.7 Hz, 6H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>, 307.1441; found, 307.1454.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-(4-Ethylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>12</b>)</h3><div class="NLM_p last">Compound <b>12</b> was prepared from 4-ethylaniline (60.6 mg, 0.5 mmol) in a similar manner as described for compound <b>1</b>. Yield: 5.6 mg, 4%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 8.83 (s, 1H), 8.29 (d, <i>J</i> = 7.8 Hz, 1H), 7.78–7.70 (m, 2H), 7.61 (d, <i>J</i> = 7.8 Hz, 2H), 7.51 (t, 1H), 7.17 (d, <i>J</i> = 8.1 Hz, 2H), 2.57 (q, <i>J</i> = 7.5 Hz, 2H), 1.17 (t, <i>J</i> = 7.5 Hz,1H), 0.92 (t, <i>J</i> = 7.8 Hz, 3H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>, 293.1285; found, 293.1292.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-(4-Isopropylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>13</b>)</h3><div class="NLM_p last">Compound <b>13</b> was prepared from 4-isopropylaniline (67.6 mg, 0.5 mmol) in a similar manner as described for compound <b>1</b>. Yield: 5.5 mg, 3%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 8.84 (s, 1H), 8.29 (d, <i>J</i> = 8.1 Hz, 1H), 7.78–7.70 (m, 2H), 7.61 (d, <i>J</i> = 8.4 Hz, 2H), 7.50 (t, <i>J</i> = 7.8 Hz, 1H), 7.20 (d, <i>J</i> = 8.7 Hz, 2H), 2.85 (h, <i>J</i> = 6.9 Hz, 1H), 1.19 (d, <i>J</i> = 6.9 Hz, 6H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>, 307.1441; found, 307.1439.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 4-Oxo-1,4-dihydroquinoline-3-carboxylic Acid Naphthalen-2-ylamide (<b>14</b>)</h3><div class="NLM_p last">Compound <b>14</b> was prepared from 2-naphthylamine (28 mg, 0.2 mmol) in a similar manner as described for compound <b>1</b>. Yield: 20 mg, 32%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.74 (s, 1H), 8.92 (s, 1H), 8.45 (d, <i>J</i> = 1.7 Hz, 1H), 8.37 (dd, <i>J</i> = 8.1, 1.0 Hz, 1H), 7.93 (d, <i>J</i> = 8.8 Hz, 1H), 7.90–7.80 (m, 3H), 7.80–7.72 (m, 2H), 7.60–7.53 (m, 1H), 7.53–7.46 (m, 1H), 7.46–7.39 (m, 1H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>, 315.1133; found, 315.1141.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 4-Oxo-1,4-dihydroquinoline-3-carboxylic Acid (1<i>H</i>-Indol-5-yl)amide (<b>15</b>)</h3><div class="NLM_p last">Compound <b>15</b> was prepared from 5-aminoindole (26 mg, 0.2 mmol) in a similar manner as described for compound <b>1</b>. Yield: 31 mg, 50%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.89 (s, 1H), 12.34 (s, 1H), 11.05 (s, 1H), 8.88 (s, 1H), 8.35 (d, <i>J</i> = 7.1 Hz, 1H), 8.08 (s, 1H), 7.81 (dd, <i>J</i> = 11.7, 4.8 Hz, 1H), 7.75 (d, <i>J</i> = 8.1 Hz, 1H), 7.54 (t, <i>J</i> = 7.5 Hz, 1H), 7.37 (d, <i>J</i> = 8.6 Hz, 1H), 7.34 (t, <i>J</i> = 2.7 Hz, 1H), 7.29 (dd, <i>J</i> = 8.6, 1.9 Hz, 1H), 6.41 (s, 1H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>, 304.1086; found, 304.1086.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 4-Oxo-1,4-dihydroquinoline-3-carboxylic Acid (1<i>H</i>-Indol-6-yl)amide (<b>16</b>)</h3><div class="NLM_p last">Compound <b>16</b> was prepared from 6-aminoindole (45 mg, 0.34 mmol) in a similar manner as described for compound <b>1</b>. Yield: 54 mg, 52%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.92 (s, 1H), 12.47 (s, 1H), 11.08 (s, 1H), 8.90 (s, 1H), 8.35 (dd, <i>J</i> = 8.1, 1.1 Hz, 1H), 8.20 (t, <i>J</i> = 0.8 Hz, 1H), 7.83 (t, <i>J</i> = 8.3 Hz, 1H), 7.76 (d, <i>J</i> = 7.7 Hz, 1H), 7.55 (t, <i>J</i> = 8.1 Hz, 1H), 7.50 (d, <i>J</i> = 8.4 Hz, 1H), 7.30 (t, <i>J</i> = 2.7 Hz, 1H), 7.06 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 6.39 (m, 1H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>, 304.1086; found, 304.1078.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-Oxo-1,4-dihydroquinoline-3-carboxylic Acid (2,3-Dihydro-1<i>H</i>-indol-6-yl)amide (<b>17</b>)</h3><div class="NLM_p"><i>Step 1.</i> 4-Oxo-1,4-dihydroquinoline-3-carboxylic acid (1-acetyl-2,3-dihydro-1<i>H</i>-indol-6-yl)amide was prepared from 1-(6-amino-2,3-dihydroindol-1-yl)ethanone (70 mg, 0.4 mmol) in a similar manner as described for compound <b>1</b>. Yield: 43 mg, 30%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.75 (d, <i>J</i> = 13.6 Hz, 1H), 8.87 (s, 1H), 8.32–8.28 (m, 2H), 7.76–7.70 (m, 2H), 7.60 (d, <i>J</i> = 7.8 Hz, 1H), 7.49–7.45 (m, 1H), 7.18 (d, <i>J</i> = 8.4 Hz, 1H), 4.11 (t, <i>J</i> = 8.3 Hz, 2H), 3.10 (t, <i>J</i> = 7.7 Hz, 2H), 2.18 (s, 3H).</div><div class="NLM_p last"><i>Step 2.</i> 4-Oxo-1,4-dihydroquinoline-3-carboxylic acid (1-acetyl-2,3-dihydro-1<i>H</i>-indol-6-yl)amide (43 mg, 0.12 mmol) was heated at reflux in a mixture of ethanol (0.5 mL) and 1 N NaOH (0.5 mL) for 48 h. The reaction mixture was evaporated under reduced pressure, and the residue was purified by reverse-phase HPLC. Yield: 10 mg, 27%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.27 (d, <i>J</i> = 6.6 Hz, 1H), 12.73 (s, 1H), 11.36 (s, 1H), 8.87 (d, <i>J</i> = 6.7 Hz, 1H), 8.33 (d, <i>J</i> = 8.1 Hz, 1H), 8.15 (s, 1H), 7.83 (q, <i>J</i> = 8.1 Hz, 2H), 7.65–7.29 (m, 3H), 3.75 (t, <i>J</i> = 7.7 Hz, 2H), 3.18 (t, <i>J</i> = 7.7 Hz, 2H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>15</sub>N<sub>3</sub>O<sub>2</sub>, 306.1242; found, 306.1237.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-Oxo-1,4-dihydroquinoline-3-carboxylic Acid (1-Methyl-1<i>H</i>-indol-6-yl)amide (<b>18</b>)</h3><div class="NLM_p last">Compound <b>18</b> was prepared from 1-methyl-1<i>H</i>-indol-6-ylamine (55 mg, 0.3 mmol) in a similar manner as described for compound <b>1</b>. Yield: 30 mg, 32%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.94 (d, <i>J</i> = 5.3 Hz, 1H), 12.51 (s, 1H), 8.89 (d, <i>J</i> = 6.3 Hz, 1H), 8.36 (dd, <i>J</i> = 8.1, 1.1 Hz, 1H), 8.06 (t, <i>J</i> = 0.7 Hz, 1H), 7.85–7.75 (m, 2H), 7.57–7.51 (m, 2H), 7.28 (d, <i>J</i> = 3.1 Hz, 1H), 7.24 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 6.39 (dd, <i>J</i> = 3.1, 0.8 Hz, 1H), 3.78 (s, 3H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>15</sub>N<sub>3</sub>O<sub>2</sub>, 318.1242; found, 318.1231.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-Oxo-1,4-dihydroquinoline-3-carboxylic Acid (1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridin-6-yl)amide (<b>19</b>)</h3><div class="NLM_p last">Compound <b>19</b> was prepared from 1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-6-ylamine (53 mg, 0.4 mmol) in a similar manner as described for compound <b>1</b>. Yield: 18 mg, 15%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.79 (s, 1H), 12.02 (s, 1H), 10.46 (s, 1H), 9.00 (s, 1H), 8.48 (d, <i>J</i> = 8.4 Hz, 1H), 8.29 (d, <i>J</i> = 8.1 Hz, 1H), 7.97 (d, <i>J</i> = 8.7 Hz, 1H), 7.82 (m, 2H), 1H), 7.37 (s, 1H), 6.46 (s, 1H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>12</sub>N<sub>4</sub>O<sub>2</sub>, 305.1038; found, 305.1039.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-(1<i>H</i>-Indazol-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>20</b>)</h3><div class="NLM_p last">Compound <b>20</b> was prepared from 1<i>H</i>-indazol-6-amine (26 mg, 0.2 mmol) in a similar manner as described for compound <b>1</b>. Yield: 27 mg, 44%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.95 (s, 1H), 12.78 (s, 1H), 8.91 (s, 1H), 8.40–8.31 (m, 2H), 7.99 (s, 1H), 7.84–7.69 (m, 3H), 7.53 (t, <i>J</i> = 7.4 Hz, 1H), 7.09 (dd, <i>J</i> = 8.6, 1.6 Hz, 1H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>12</sub>N<sub>4</sub>O<sub>2</sub>, 305.1038; found, 305.1031.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-(1<i>H</i>-Benzo[<i>d</i>]imidazol-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>21</b>)</h3><div class="NLM_p last">Compound <b>21</b> was prepared from 1<i>H</i>-benzo[<i>d</i>]imidazol-6-amine (27 mg, 0.2 mmol) in a similar manner as described for compound <b>1</b>. Yield: 28 mg, 46%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.05 (d, <i>J</i> = 6.4 Hz, 1H), 12.77 (s, 1H), 9.09 (s, 1H), 8.92 (d, <i>J</i> = 6.7 Hz, 1H), 8.52 (d, <i>J</i> = 1.6 Hz, 1H), 8.35 (d, <i>J</i> = 7.4 Hz, 1H), 7.87–7.81 (m, 1H), 7.77 (dd, <i>J</i> = 8.3, 6.1 Hz, 2H), 7.60–7.49 (m, 2H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>12</sub>N<sub>4</sub>O<sub>2</sub>, 305.1038; found, 305.1043.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 4-Oxo-<i>N</i>-(2-oxoindolin-6-yl)-1,4-dihydroquinoline-3-carboxamide (<b>22</b>)</h3><div class="NLM_p last">Compound <b>22</b> was prepared from 6-aminoindolin-2-one (60 mg, 0.4 mmol) in a similar manner as described for compound <b>1</b>. Yield: 4 mg, 3%. <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.95 (s, 1H), 12.51 (s, 1H), 10.43 (s, 1H), 8.86 (s, 1H), 8.33 (d, <i>J</i> = 8.1 Hz, 1H), 7.82 (t, <i>J</i> = 7.6 Hz, 1H), 7.76 (d, <i>J</i> = 8.2 Hz, 1H), 7.58–7.50 (m, 2H), 7.17 (d, <i>J</i> = 8.0 Hz, 1H), 7.06 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 3.44 (s, 2H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>13</sub>N<sub>3</sub>O<sub>3</sub>, 320.1035; found, 320.1041.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1<i>H</i>-Indol-6-yl 4-oxo-1,4-dihydroquinoline 3-Carboxylate (<b>23</b>)</h3><div class="NLM_p last">In a round-bottom flask 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>, 57 mg, 0.3 mmol), benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphate (133 mg, 0.3 mmol), 1<i>H</i>-indol-6-ol (40 mg, 0.3 mmol), DMF (1.0 mL), and DIEA (116.3 mg, 0.16 mL, 0.9 mmol) were added and the mixture was stirred at 25 °C for 18 h. The solvent was evaporated under reduced pressure. The crude material was dissolved in DMSO, filtered, and purified by reverse-phase HPLC to provide compound <b>23</b>. Yield: 27 mg, 30%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 12.58 (s, 1H), 11.17 (s, 1H), 8.83 (d, <i>J</i> = 3.5 Hz, 1H), 8.21 (dd, <i>J</i> = 8.1, 1.0 Hz, 1H), 7.79–7.72 (m, 1H), 7.69 (d, <i>J</i> = 7.8 Hz, 1H), 7.55 (d, <i>J</i> = 8.5 Hz, 1H), 7.49–7.43 (m, 1H), 7.39–7.34 (m, 1H), 7.22 (d, <i>J</i> = 1.7 Hz, 1H), 6.83 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 6.49–6.42 (m, 1H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>12</sub>N<sub>2</sub>O<sub>3</sub>, 305.0926; found, 305.0921.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 4-Oxo-1,4-dihydroquinoline-3-sulfonyl Chloride (<b>51</b>)</h3><div class="NLM_p last">In a round-bottom flask, 4-hydroxyquinoline (<b>50</b>, 1.13 g, 7.78 mmol) was treated with chlorosulfonic acid (3.1 mL, 47 mmol), and the mixture was heated at 125 °C for 3 h. The brownish clear solution was then poured into ice–water, and a yellow precipitate was formed. The solid was collected by filtration and washed with cold water (5 × 50 mL). The solid was lyophilized to provide compound <b>51</b> (1.9 g, 100%) as a beige solid. <sup>1</sup>H NMR (300 MH, DMSO-<i>d</i><sub>6</sub>,) δ 9.20 (s, 1H), 8.36 (d, <i>J</i> = 8.4 Hz, 1H), 8.12–8.04 (m, 2H), 7.81 (t, <i>J</i> = 6.9 Hz, 1H).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>N</i>-(1<i>H</i>-Indol-6-yl)-4-oxo-1,4-dihydroquinoline-3-sulfonamide (<b>24</b>)</h3><div class="NLM_p last">To a solution of <b>51</b> (85 mg, 0.34 mmol) in pyridine (0.06 mL, 0.69 mmol) was added 1<i>H</i>-indol-6-amine (59 mg, 0.45 mmol) and the solution was heated at reflux for 3 h. The solvent was evaporated under reduced pressure and the crude residue was purified by reverse-phase HPLC to provide <b>24</b> (3.5 mg, 3% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.43 (d, <i>J</i> = 6.6 Hz, 1H), 10.92 (s, 1H), 9.42 (s, 1H), 8.36 (d, <i>J</i> = 6.6 Hz, 1H), 8.19 (d, <i>J</i> = 8.1 Hz, 1H), 7.72 (t, <i>J</i> = 7.7 Hz, 1H), 7.58 (d, <i>J</i> = 8.2 Hz, 1H), 7.45 (t, <i>J</i> = 7.6 Hz, 1H), 7.29 (d, <i>J</i> = 8.5 Hz, 1H), 7.24–7.10 (m, 2H), 6.81 (dd, <i>J</i> = 8.5, 1.6 Hz, 1H), 6.25 (s, 1H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>13</sub>N<sub>3</sub>O<sub>3</sub>S, 340.0756; found, 340.0742.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 3-((1<i>H</i>-Indol-6-ylamino)methyl)quinolin-4(1<i>H</i>)-one (<b>25</b>)</h3><div class="NLM_p last">A mixture of 4-hydroxyquinoline-3-carbaldehyde (10 mg, 0.06 mmol), 6-aminoindole (8 mg, 0.06 mmol), and sodium borohydride (4 mg, 0.07 mmol) was heated in toluene for 16 h at 100 °C. The reaction mixture was evaporated to dryness, and the residue was purified by reverse-phase HPLC. Yield: 7 mg, 40%. <sup>1</sup>H NMR (400 MHz, DMSO) δ 11.73 (s, 1H), 10.46 (s, 1H), 8.16 (d, <i>J</i> = 7.9 Hz, 1H), 7.80 (s, 1H), 7.63 (t, <i>J</i> = 7.5 Hz, 1H), 7.50 (d, <i>J</i> = 8.3 Hz, 1H), 7.32 (t, <i>J</i> = 7.5 Hz, 1H), 7.22 (d, <i>J</i> = 8.4 Hz, 1H), 6.98–6.90 (m, 1H), 6.49 (d, <i>J</i> = 8.5 Hz, 1H), 6.44 (s, 1H), 6.17 (s, 1H), 5.66 (t, <i>J</i> = 5.1 Hz, 1H), 4.15 (d, <i>J</i> = 5.0 Hz, 2H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>15</sub>N<sub>3</sub>O, 290.1293; found, 290.1288.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>E</i>)-2-(2-Nitrovinylamino)benzoic Acid (<b>54</b>)</h3><div class="NLM_p last">In a round-bottom flask, a solution of NaOH (6.9 g in 15 mL of water) was cooled and stirred while nitromethane (6 mL, 112 mmol) was added dropwise maintaining the internal temperature at 30 °C. The mixture was allowed to warm to 40 °C and then cooled again while nitromethane (6 mL) was added slowly. The mixture was warmed to 45 °C until the solid dissolved and then to 50–55 °C for 5 min. The mixture was cooled to 30 °C, poured over ice (30 g), and acidified with concentrated HCl (30 mL). The resulting solution of (<i>E</i>)-2-nitroacetaldehyde oxime (<b>53</b>) was immediately added to a filtered solution of anthranilic acid (7 g, 51 mmol) and 4.6 mL of concentrated HCl in 102 mL of water. After a few minutes a yellow precipitate formed and the mixture was allowed to stand at 25 °C for 12 h. The solid was collected by filtration and washed with cold water (6 × 60 mL). The residue was lyophilized to give compound <b>54</b> as a yellow solid (10.2 g, 96% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 8.06 (d, <i>J</i> = 6.6 Hz, 1H), 8.02 (m, 1H), 7.73 (d, <i>J</i> = 8.1 Hz, 1H), 7.65 (td, <i>J</i> = 8.2 Hz, 1H), 7.21 (td, <i>J</i> = 8.1 Hz, 1H), 6.74 (d, <i>J</i> = 6.0 Hz, 1H).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 3-Nitroquinolin-4-ol (<b>55</b>)</h3><div class="NLM_p last">To compound <b>54</b> (1 g, 4.8 mmol) acetic anhydride (5 mL, 4.8 mmol) was added, and the mixture was heated for 1 h at 100 °C. The heating was then withdrawn, and sodium acetate (0.4 g, 4.95 mmol), which was dried in an oven at 120 °C for 14 h, was added. The mixture was heated at reflux for 15 min, and a second equivalent of sodium acetate (0.4 g, 4.95 mmol) was added. The mixture was heated for an additional 1 h. The mixture was cooled to 25 °C and filtered. The beige precipitate was collected, washed with acetic acid (60 mL), water (2 × 20 mL), and dried under vacuum. Compound <b>55</b> was obtained as a beige solid (0.37 g, 41% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.17 (s, 1H), 8.23 (m, 1H), 7.82–7.69 (m, 2H), 7.50 (td, <i>J</i> = 7.2 Hz, 1H).</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 3-Aminoquinolin-4-ol (<b>56</b>)</h3><div class="NLM_p last">To a solution of compound <b>55</b> (0.74 g, 3.9 mmol) in THF (10 mL) was added ammonium formate (0.49 g, 7.8 mmol) followed by 10% Pd/C (cat.). After heating at reflux for 4 h, an additional equivalent of ammonium formate (0.49 g, 7.8 mmol) and Pd/C were added. After heating for an additional 2.5 h, the mixture was filtered through a bed of Celite, which was washed with THF (10 mL) and MeOH (10 mL). The combined filtrate was concentrated under reduced pressure, and the residue was dried under vacuum to provide <b>56</b> (0.62 g, 99% yield) as a yellow foam that was used in the next step without further purification. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.06 (d, <i>J</i> = 8.7 Hz, 1H), 7.51 (s, 1H), 7.45–7.43 (m, 2H), 7.15 (m, 1H), 4.36 (br s, 2H).</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>-(4-Hydroxyquinolin-3-yl)-1<i>H</i>-indole-6-carboxamide (<b>26</b>)</h3><div class="NLM_p last">A mixture of compound <b>56</b> (65 mg, 0.40 mmol), 1<i>H</i>-indole-6-carboxylic acid (68 mg, 0.4 mmol), HATU (0.23 g, 0.61 mmol), and DIEA (0.14 mL, 0.8 mmol) in DMF (0.8 mL) was stirred for 6 h at 25 °C. At this point, PS-trisamine (0.1 g, 4.1 mmol/g, Argonaut Technologies) was added and the mixture was heated at 70 °C for 2 h. The resin was filtered and the filtrate concentrated under reduced pressure. The residue was purified by reverse-phase HPLC to provide compound <b>26</b> (25.5 mg, 21% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.06 (d, <i>J</i> = 6.1, 1H), 11.48 (s, 1H), 9.33 (s, 1H), 9.10 (d, <i>J</i> = 6.2, 1H), 8.23 (d, <i>J</i> = 7.6, 1H), 8.07 (s, 1H), 7.72–7.55 (m, 5H), 7.37 (t, <i>J</i> = 7.4, 1H), 6.62–6.46 (m, 1H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>, 304.1086; found, 304.1071.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>-(3-(Ethyl)-1<i>H</i>-indol-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>27</b>)</h3><div class="NLM_p last">Compound <b>27</b> was prepared from 3-ethyl-1<i>H</i>-indol-6-ylamine (112.2 mg, 0.7 mmol) in a similar manner as described for compound <b>28</b> (vide infra). Yield: 5 mg, 2%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.91 (s, 1H), 12.46 (s, 1H), 10.73 (s, 1H), 8.89 (d, <i>J</i> = 6.7 Hz, 1H), 8.35 (d, <i>J</i> = 6.9 Hz, 1H), 7.83 (t, <i>J</i> = 8.3 Hz, 1H), 7.76 (d, <i>J</i> = 7.7 Hz, 1H), 7.55 (t, <i>J</i> = 8.1 Hz, 1H), 7.47 (d, <i>J</i> = 8.4 Hz, 1H), 7.05 (m, 2H), 2.70 (q, <i>J</i> = 7.6 Hz, 2H), 1.27 (t, <i>J</i> = 7.6 Hz, 3H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>, 332.1394; found, 332.1385.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>N</i>-(3-(<i>tert</i>-Butyl)-1<i>H</i>-indol-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>28</b>)</h3><div class="NLM_p"><i>Step 1: 3-tert-Butyl-6-nitro-1H-indole.</i> To a mixture of 6-nitroindole (1.0 g, 6.2 mmol), zinc triflate (2.1 g, 5.7 mmol), and tetrabutylamonium iodide (1.7 g, 5.16 mmol) in anhydrous toluene (11.0 mL) was added diisopropylethylamine (1.47 g, 11.4 mmol) at room temperature under nitrogen. The reaction mixture was stirred for 10 min at 120 °C, followed by addition of <i>tert</i>-butyl bromide (0.71 g, 5.16 mmol). The resulting mixture was stirred for 45 min at 120 °C. The solid was filtered off and the filtrate was concentrated to dryness and purified by column chromatography on silica gel using a mixture of petroleum ether and ethyl acetate (20:1) to give 3-<i>tert</i>-butyl-6-nitro-1<i>H</i>-indole as a yellow solid (0.25 g, 19%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.32 (d, <i>J</i> = 2.1 Hz, 1H), 8.00 (dd, <i>J</i> = 2.1, 14.4 Hz, 1H), 7.85 (d, <i>J</i> = 8.7 Hz, 1H), 7.25 (s, 1H), 1.46 (s, 9H).</div><div class="NLM_p"><i>Step 2: 3-tert-Butyl-1H-indol-6-ylamine.</i> A suspension of 3-<i>tert</i>-butyl-6-nitro-1<i>H</i>-indole (3.0 g, 13.7 mmol) and Raney Ni (0.5 g) in ethanol was stirred at room temperature under H<sub>2</sub> (1 atm) for 3 h. The catalyst was filtered off, and the filtrate was concentrated to dryness. The residue was purified by column chromatography on silica gel using a mixture of petroleum ether and ethyl acetate (4:1) to give 3-<i>tert</i>-butyl-1<i>H</i>-indol-6-ylamine (2.0 g, 77%) as a gray solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.58 (m, 2H), 6.73 (d, <i>J</i> = 1.2 Hz, 1H), 6.66 (s, 1H), 6.57(dd, <i>J</i> = 8.6, 0.8 Hz, 1H), 3.60 (br s, 2H), 1.42 (s, 9H).</div><div class="NLM_p last"><i>Step 3: N-(3-(<i>tert</i>-Butyl)-1H-indol-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>28</b>).</i> To 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (135.0 mg, 0.7 mmol) and HBTU (270 mg, 0.7 mmol) in DMF (1.2 mL) was added triethylamine (298 μL, 2.1 mmol), and the mixture was stirred at room temperature for 5 min. A solution of 3-<i>tert</i>-butyl-1<i>H</i>-indol-6-ylamine (131.7 mg, 0.7 mmol) in DMF (0.7 mL) was added to the mixture, and the mixture was heated in the microwave instrument at 150 °C for 20 min. The mixture was cooled to room temperature, filtered, and purified by reverse phase HPLC to yield <b>28</b> (42.0 mg, 16%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.91 (br s, 1H), 12.45 (s, 1H), 10.73 (d, <i>J</i> = 1.8 Hz, 1H), 8.89 (s, 1H), 8.35 (dd, <i>J</i> = 8.2, 1.0 Hz, 1H), 8.13 (d, <i>J</i> = 1.7 Hz, 1H), 7.82 (t, <i>J</i> = 8.3 Hz, 1H), 7.76 (d, <i>J</i> = 7.7 Hz, 1H), 7.66 (d, <i>J</i> = 8.6 Hz, 1H), 7.54 (t, <i>J</i> = 8.1 Hz, 1H), 7.04 (dd, <i>J</i> = 8.6, 1.9 Hz, 1H), 6.98 (d, <i>J</i> = 2.4 Hz, 1H), 1.40 (s, 9H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>, 360.1707; found, 360.1700.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>N</i>-(5-Ethyl-1<i>H</i>-indol-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>29</b>)</h3><div class="NLM_p">To a mixture of DMAP (1.5 g, 12.3 mmol), benzenesulfonyl chloride (24.0 g, 136 mmol), and 2,3-dihydro-1<i>H</i>-indole (14.7 g, 124 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (200.0 mL) in ice–water bath was added dropwise Et<sub>3</sub>N (19 g, 186 mmol). After addition, the mixture was stirred at room temperature overnight. The organic layer was washed with water twice, then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to dryness under reduced pressure to obtain 1-benzenesulfonyl-2, 3-dihydro-1<i>H</i>-indole (30.9 g, 96%) that was used in the next step without further purification.</div><div class="NLM_p">To a magnetically stirred suspension of AlCl<sub>3</sub> (144.0 g, 1.08 mol) in CH<sub>2</sub>Cl<sub>2</sub> (1070 mL) was added acetic anhydride (54 mL, 0.57 mol), and the mixture was stirred for 15 min. A solution of 1-benzenesulfonyl-2, 3-dihydro-1<i>H</i>-indole (46.9 g, 0.18 mol) in CH<sub>2</sub>Cl<sub>2</sub> (1070 mL) was then added dropwise. The mixture was stirred for 5 h and quenched by slow addition of crushed ice to the reaction. The organic layer was separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> two additional times. The combined organic layer was washed with saturated aqueous NaHCO<sub>3</sub> and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuum to obtain 1-(1-benzenesulfonyl-2, 3-dihydro-1<i>H</i>-indol-5-yl)ethanone (42.6 g) that was taken into the next step without further purification.</div><div class="NLM_p">To magnetically stirred TFA (1600 mL) at 0 °C was added sodium borohydride (64 g, 1.69 mol) over 1 h. To this mixture was added dropwise a solution of 1-(1-benzenesulfonyl-2,3-dihydro-1<i>H</i>-indol-5-yl)ethanone (40.0 g, 0.13 mol) in TFA (700 mL) over a period of 1 h. The mixture was then stirred overnight at 25 °C. After dilution with H<sub>2</sub>O (1600 mL), the mixture was made basic by the addition of sodium hydroxide pellets at 0 °C. The organic layer was separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by silica column using a gradient of ethyl acetate in hexanes (1–99%) to give 1-benzenesulfonyl-5-ethyl-2,3-dihydro-1<i>H</i>-indole (16.2 g, 47% over two steps).</div><div class="NLM_p">A mixture of 1-benzenesulfonyl-5-ethyl-2,3-dihydro-1<i>H</i>-indole (15 g, 0.05 mol) in HBr (48%, 162 mL) was heated at reflux for 6 h. The mixture was basified to pH ≈ 9 with saturated NaOH, and then it was extracted with ethyl acetate. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to give a residue that was purified by silica column using a gradient of ethyl acetate in hexanes (1–99%) to give 5-ethyl-2,3-dihydro-1<i>H</i>-indole (2.5 g, 32%).</div><div class="NLM_p">To a solution of 5-ethyl-2,3-dihydro-1<i>H</i>-indole (2.5 g, 17 mmol) in H<sub>2</sub>SO<sub>4</sub> (98%, 20 mL) was slowly added KNO<sub>3</sub> (1.7 g, 17 mmol) at 0 °C. After addition, the mixture was stirred at 0–10 °C for 10 min. The mixture was then carefully poured into ice, basified with NaOH solution to pH ≈ 9, and extracted with ethyl acetate. The combined extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to dryness. The residue was purified by silica column using a gradient of ethyl acetate in hexanes (1–99%) to give 5-ethyl-6-nitro-2,3-dihydro-1<i>H</i>-indole (1.9 g, 58%).</div><div class="NLM_p">To a solution of 5-ethyl-6-nitro-2,3-dihydro-1<i>H</i>-indole (1.9 g, 9.9 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) was added MnO<sub>2</sub> (4 g, 46 mmol). After addition, the mixture was stirred at 25 °C for 8 h. The solid was filtered off, and the filtrate was concentrated to dryness to give crude 5-ethyl-6-nitro-1<i>H</i>-indole (1.9 g). A suspension of 5-ethyl-6-nitro-1<i>H</i>-indole (1.9 g, 10 mmol) and Ni (1 g) in methanol (10 mL) was hydrogenated under H<sub>2</sub> (1 atm) at room temperature for 2 h. The catalyst was filtered off, and the filtrate was concentrated to dryness. The residue was purified by silica gel column using a gradient of ethyl acetate in hexanes (1–99%) to give 5-ethyl-1<i>H</i>-indol-6-amine (760 mg, 48% over two steps). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.90 (br s, 1H), 7.41 (s, 1H), 7.00 (s, 1H), 6.78 (s, 2H), 6.39 (s, 1H), 3.39 (br s, 2H), 2.63 (q, <i>J</i> = 7.2 Hz, 2H), 1.29 (t, <i>J</i> = 6.9 Hz, 3H). MS (ESI) <i>m</i>/<i>e</i> (M + H<sup>+</sup>): 161.05.</div><div class="NLM_p last">To a mixture of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (95.0 mg, 0.5 mmol) and 5-ethyl-1<i>H</i>-indol-6-amine (84 mg, 0.52 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added HBTU (227 mg, 0.6 mmol) followed by triethylamine (167 μL, 1.2 mmol). The mixture was heated at 60 °C for 24 h and cooled to 25 °C. The solid was collected via filtration and washed with CH<sub>2</sub>Cl<sub>2</sub> to provide <b>29</b> (58.0 mg, 35%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.92 (s, 1H), 12.34 (s, 1H), 10.96 (s, 1H), 8.91 (s, 1H), 8.48 (s, 1H), 8.37 (d, <i>J</i> = 8.1 Hz, 1H), 7.84–7.76 (m, 2H), 7.53 (t, <i>J</i> = 7.4 Hz, 1H), 7.39 (s, 1H), 7.26 (t, <i>J</i> = 2.6 Hz, 1H), 6.34 (s, 1H), 2.89–2.84 (m, 2H), 1.29 (t, <i>J</i> = 7.4 Hz, 3H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>, 332.1394; found, 332.1384.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>N</i>-(5-(<i>tert</i>-Butyl)-1<i>H</i>-indol-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>30</b>)</h3><div class="NLM_p">To a suspension of NaH (60% in mineral oil, 8.4 g, 0.21 mol) in THF (200 mL) was added dropwise a solution of 2-<i>tert</i>-butyl-4-methylphenol (32.8 g, 0.2 mol) in THF (100 mL) at 0 °C. The mixture was stirred at 0 °C for 15 min, and then phosphorochloridic acid diethyl ester (37.2 g, 0.21 mol) was added dropwise at 0 °C. After addition, the mixture was stirred at 25 °C for 30 min. The reaction was quenched with sat. NH<sub>4</sub>Cl (300 mL) and then extracted with Et<sub>2</sub>O (350 mL × 2). The combined organic layer was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and then evaporated under vacuum to give crude compound as a colorless oil (60 g, 100%), which was used directly in the next step.</div><div class="NLM_p">To NH<sub>3</sub> (liquid, 1000 mL) was added a solution of phosphoric acid 2-<i>tert</i>-butyl-4-methylphenyl ester diethyl ester (60 g, crude from last step, ∼0.2 mol) in Et<sub>2</sub>O (anhydrous, 500 mL) at −78 °C under N<sub>2</sub> atmosphere. Lithium metal was added to the solution in small chunks until the blue color persisted. The reaction mixture was stirred at −78 °C for 15 min and then quenched with a saturated solution of NH<sub>4</sub>Cl until the mixture turned to colorless. The liquid NH<sub>3</sub> was evaporated, and the residue was dissolved in water and extracted with Et<sub>2</sub>O (400 mL × 2). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated to give 1-(<i>tert</i>-butyl)-3-methylbenzene (crude, contaminated some mineral oil) as a colorless oil (27 g, 91%), which was used directly in the next step.</div><div class="NLM_p">To HNO<sub>3</sub> (95%, 13.8 mL) was added H<sub>2</sub>SO<sub>4</sub> (98%, 20 mL) at 0 °C followed by dropwise addition of 1-<i>tert</i>-butyl-3-methylbenzene (7.4 g, 50 mmol, crude from last step) with the temperature being controlled under 30 °C. The reaction mixture was stirred at 25 °C for 30 min, then poured onto crushed ice (100 g), and extracted with ethyl acetate (50 mL × 3). The combined organic layers were washed with water and brine, evaporated to give a brown oil, which was purified by column chromatography using a gradient of ethyl acetate in hexanes (0–20%) to give a mixture of 1-(<i>tert</i>-butyl)-5-methyl-2,4-dinitrobenzene and 1-(<i>tert</i>-butyl)-3-methyl-2,4-dinitrobenzene (2:1 based on <sup>1</sup>H NMR) as a yellow oil (9 g, 61%).</div><div class="NLM_p">To this mixture (9 g, 37.8 mmol) dissolved in DMF (50 mL) was added 1,1-dimethoxy-<i>N</i>,<i>N</i>-dimethylmethanamine (5.4 g, 45.4 mmol), and the mixture was heated to reflux for 2 h. After cooling to room temperature, the mixture was poured into ice–water and was extracted with EtOAc (50 mL × 3). The combined organic layers were washed with water and brine, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to give a brown oil, which was purified by column chromatography to give (<i>E</i>)-2-(5-(<i>tert</i>-butyl)-2,4-dinitrophenyl)-<i>N</i>,<i>N</i>-dimethylethenamine (5 g, 68%).</div><div class="NLM_p">A solution of (<i>E</i>)-2-(5-(<i>tert</i>-butyl)-2,4-dinitrophenyl)-<i>N</i>,<i>N</i>-dimethylethenamine (5.3 g, 18.1 mmol) and tin(II) chloride dihydrate (37.4 g, 0.18 mol) in ethanol (200 mL) was refluxed overnight. It was then cooled to room temperature, and the solvent was removed under vacuum. The residual slurry was diluted with water (500 mL), and a 10% aqueous solution of Na<sub>2</sub>CO<sub>3</sub> was added until pH ≈ 8 was obtained. The resulting suspension was extracted with ethyl acetate (100 × 3 mL). The ethyl acetate extract was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residual solid was washed with CH<sub>2</sub>Cl<sub>2</sub> to afford a yellow powder, which was purified by column chromatography using a gradient of ethyl acetate in hexanes (10–40%) to give 5-(<i>tert</i>-butyl)-1<i>H</i>-indol-6-amine (0.4 g, 12%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.34 (br s, 1 H), 7.23 (s, 1 H), 6.92 (s, 1 H), 6.65 (s, 1H), 6.14 (s, 1 H), 4.43 (br s, 2 H), 2.48 (s, 9 H).</div><div class="NLM_p last">To a mixture of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (38 mg, 0.2 mmol) and 5-(<i>tert</i>-butyl)-1<i>H</i>-indol-6-amine (38 mg, 0.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added HBTU (92 mg, 0.24 mmol) followed by the addition of triethylamine (66 μL, 0.48 mmol). The mixture was heated at 60 °C for 24 h and cooled to 25 °C. The solid was collected via filtration and washed with EtOH to provide <b>30</b> (43 mg, 60%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.78 (br s, 1H), 11.82 (s, 1H), 10.86 (s, 1H), 8.83 (s, 1H), 8.28 (dd, <i>J</i> = 8.1, 1.0 Hz, 1H), 7.75 (t, <i>J</i> = 8.3 Hz, 1H), 7.69 (d, <i>J</i> = 7.7 Hz, 1H), 7.49–7.43 (m, 3H), 7.23 (m, 1H), 6.32 (m, 1H), 1.39 (s, 9H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>, 360.1707; found, 360.1708.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i>-(3-Aminophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>31</b>)</h3><div class="NLM_p last">Compound <b>31</b> was prepared from benzene-1,3-diamine dihydrochloride (36 mg, 0.2 mmol) in a similar manner as described for compound <b>1</b>. Yield: 9.8 mg, 35%. <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.86 (s, 1H), 8.42 (d, <i>J</i> = 8.2 Hz, 1H), 7.81 (t, <i>J</i> = 7.7 Hz, 1H), 7.67 (d, <i>J</i> = 8.3 Hz, 1H), 7.55 (t, <i>J</i> = 7.6 Hz, 1H), 7.19–7.14 (m, 1H), 7.09 (t, <i>J</i> = 8.0 Hz, 1H), 7.00 (d, <i>J</i> = 7.7 Hz, 1H), 6.52 (d, <i>J</i> = 7.8 Hz, 1H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>, 280.1086; found, 280.1082.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>N</i>-(3-Amino-4-methylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>32</b>)</h3><div class="NLM_p last">To a solution of <b>49</b> (0.21 g, 1.11 mmol), HBTU (0.42 g, 1.11 mmol), and DIEA (0.58 mL, 3.3 mmol) in THF (10 mL) was added 4-methylbenzene-1,3-diamine (0.15 g, 1.2 mmol). The mixture was heated at 60 °C for 18 h, and then the solvent was removed under reduced pressure. The residue was purified by silica gel chromatography (0–10% methanol–dichloromethane) to yield <b>32</b> (0.14 g, 43%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.90 (s, 1H), 12.19 (s, 1H), 8.84 (s, 1H), 8.33 (d, <i>J</i> = 8.0 Hz, 1H), 7.89–7.71 (m, 2H), 7.55- 7.45 (m, 1H), 7.03 (s, 1H), 6.87 (s, 2H), 4.91 (s, 2H), 2.03 (s, 3H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>15</sub>N<sub>3</sub>O<sub>2</sub>, 294.1242; found, 294.1247.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>N</i>-(3-Amino-4-ethylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>33</b>)</h3><div class="NLM_p last">Compound <b>33</b> was prepared from 4-ethylbenzene-1,3-diamine<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(40)</a> (27 mg, 0.2 mmol) in a similar manner as described for compound <b>32</b>. Yield: 16 mg, 29%. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.86 (s, 1H), 8.42 (d, <i>J</i> = 8.5 Hz, 1H), 7.94 (s, 1H), 7.81 (t, <i>J</i> = 8.3 Hz, 1H), 7.67 (d, <i>J</i> = 8.3 Hz, 1H), 7.54–7.47 (m, 2H), 7.38 (d, <i>J</i> = 8.5 Hz, 1H), 2.71 (q, <i>J</i> = 7.7 Hz, 2H), 1.30 (t, <i>J</i> = 7.4 Hz, 3H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>, 308.1399; found, 308.1386.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>N</i>-(3-Amino-4-isopropylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>34</b>)</h3><div class="NLM_p last">Compound <b>34</b> was prepared from 4-isopropylbenzene-1,3-diamine (30 mg, 0.2 mmol) in a similar manner as described for compound <b>32</b>. Yield: 16 mg, 28%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.06 (d, <i>J</i> = 6.5 Hz, 1H), 12.51 (s, 1H), 8.88 (d, <i>J</i> = 6.6 Hz, 1H), 8.33 (dd, <i>J</i> = 8.1, 1.0 Hz, 1H), 7.85–7.74 (m, 3H), 7.55 (t, <i>J</i> = 8.1 Hz, 1H), 7.38 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 7.32 (d, <i>J</i> = 8.5 Hz, 1H), 3.03 (septet, <i>J</i> = 6.8 Hz, 1H), 1.20 (d, <i>J</i> = 6.7 Hz, 6H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub>, 322.1555; found, 322.1548.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> <i>N</i>-(3-Amino-4-propylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>35</b>)</h3><div class="NLM_p last">Compound <b>35</b> was prepared from 4-propylbenzene-1,3-diamine (30 mg, 0.2 mmol) in a similar manner as described for compound <b>32</b>. Yield: 3 mg, 5%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.06 (d, <i>J</i> = 6.5 Hz, 1H), 12.51 (s, 1H), 8.88 (d, <i>J</i> = 6.6 Hz, 1H), 8.33 (dd, <i>J</i> = 8.1, 1.0 Hz, 1H), 7.85–7.74 (m, 3H), 7.55 (t, <i>J</i> = 8.1 Hz, 1H), 7.38 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 7.32 (d, <i>J</i> = 8.5 Hz, 1H), 3.03 (septet, <i>J</i> = 6.8 Hz, 1H), 1.20 (d, <i>J</i> = 6.7 Hz, 6H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub>, 322.1555; found, 322.1570</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 1-<i>tert</i>-Butyl-2,4-dinitrobenzene (<b>58</b>)</h3><div class="NLM_p last">A prechilled mixture of fuming nitric acid (30 mL) and concentrated sulfuric acid (70 mL) was added portionwise with stirring to a mixture of <i>tert</i>-butylbenzene (10.0 g, 75 mmol) and concentrated sulfuric acid (100 mL) at 0 °C over 20 min. The cloudy yellow mixture was stirred for 30 min before warming to 25 °C. After 3 h, the mixture was poured over ice (400 g), and the green mixture was extracted with ether (2 × 100 mL). (<i>Caution</i>: During the workup, a violent gas evolution was observed from the aqueous phase during the draining of the aqueous phase from the first ether extraction.) The combined ether extracts were washed with water (100 mL) and brine (100 mL). The organics were dried over MgSO<sub>4</sub> and concentrated under reduced pressure to afford <b>58</b> as a yellow oil (16.0 g, 95%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.29, (dd, <i>J</i> = 2.4, 9.0 Hz, 1H), 8.21 (d, <i>J</i> = 2.4 Hz, 1H), 7.79 (d, <i>J</i> = 9.0 Hz, 1H), 1.46 (s, 9H).</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1-<i>tert</i>-Butyl-2,4-diaminobenzene (<b>59</b>)</h3><div class="NLM_p last">A 250 mL flask was charged with <b>58</b> (2.24 g, 10 mmol), 10% Pd/C (0.3 g), and methanol (100 mL), and the mixture was hydrogenated at 25 °C for 16 h. The mixture was filtered through a plug of Celite and concentrated under reduced pressure to afford a crude residue that was purified by silica gel chromatography (0–50% ethyl acetate–hexanes) to afford the dianiline <b>59</b> as a red-brown oil (0.68 g, 51%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.01 (d, <i>J</i> = 8.3 Hz, 1H), 6.10 (dd, <i>J</i> = 2.4, 8.3 Hz, 1H), 6.01 (d, <i>J</i> = 2.4 Hz, 1H), 3.59 (br s, 4H), 1.37 (s, 9H); ESI-MS <i>m</i>/<i>z</i> 164.9 (M + H)<sup>+</sup>.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 4-Oxo-1,4-dihydroquinoline-3-carboxylic Acid (4-<i>tert</i>-Butyl-3-aminophenyl)amide (<b>36</b>)</h3><div class="NLM_p last">DIEA (1.05 mL, 6 mmol, 3 equiv) was added to a suspension of <b>49</b> (0.38 g, 2.0 mmol) and HATU (0.76 g, 1 mmol) in DMF (5 mL). The mixture was stirred for 15 min and added dropwise over 5 min to a solution of <b>59</b> (0.4 g, 2.4 mmol) in a mixture of dichloromethane/methanol (8/1, 4.5 mL). The mixture was diluted with ethyl acetate (50 mL) and washed with brine (3 × 25 mL), a saturated aqueous solution of K<sub>2</sub>CO<sub>3</sub> (10 mL), and 0.5 M citric acid (10 mL). The organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford a brown solid that was suspended in dichloromethane (50 mL) and sonicated. The mixture was filtered, and the filter cake was washed with dichloromethane (100 mL). The filter cake was then dissolved in methanol (150 mL), filtered, and concentrated to afford the <b>36</b> as a pale yellow solid (0.42 g, 62%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.5 (br s, 1H), 12.20 (s, 1H), 8.85 (s, 1H), 8.33 (dd, <i>J</i> = 1.3, 8.1 Hz, 1H), 7.81 (app dt, <i>J</i> = 1.4, 7.6 Hz, 1H), 7.75 (d, <i>J</i> = 8.1 Hz, 1H), 7.53 (app t with fine str, <i>J</i> = 7.9 Hz, 1H), 7.03 (d, <i>J</i> = 5.3 Hz, 1H), 7.02 (s, 1H), 6.94 (dd, <i>J</i> = 2.1, 8.5 Hz, 1H), 4.83 (s, 2H), 1.33 (s, 9H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>, 336.1712; found, 336.1709.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>N</i>-(3-Acetamido-4-<i>tert</i>-butylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>37</b>)</h3><div class="NLM_p last">To a solution of <b>36</b> (74 mg, 0.22 mmol) in THF (1.0 mL) was added acetyl chloride (0.015 mL, 0.20 mmol), followed by DIEA (0.1 mL, 0.28 mmol), and the mixture was stirred at 25 °C for 40 min. The solvent was removed and the residue was purified by reverse-phase HPLC to yield <b>37</b> (10 mg, 12%) . <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.96 (d, <i>J</i> = 6.6 Hz, 1H), 12.43 (s, 1H), 9.27 (s, 1H), 8.86 (d, <i>J</i> = 6.8 Hz, 1H), 8.33 (d, <i>J</i> = 6.9 Hz, 1H), 7.82 (dd, <i>J</i> = 6.9, 1.4 Hz, 1H), 7.76 (d, <i>J</i> = 7.8 Hz, 1H), 7.55 (t, <i>J</i> = 7.5 Hz, 2H), 7.44 (d, <i>J</i> = 2.0 Hz, 1H), 7.36 (d, <i>J</i> = 8.7 Hz, 1H), 2.06 (s, 3H), 1.32 (s, 9H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>, 378.1817; found, 378.1802.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Methyl 2-<i>tert</i>-Butyl-5-(4-oxo-1,4-dihydroquinoline-3-carboxamido)phenylcarbamate (<b>38</b>)</h3><div class="NLM_p last">To a solution of <b>36</b> (34 mg, 0.10 mmol) in THF (1.0 mL) was added methyl chloroformate (0.01 mL, 0.15 mmol), followed by DIEA (0.04 mL, 0.20 mmol), and the mixture was stirred at 25 °C for 40 min. The mixture was dissolved in dichloromethane (0.5 mL) and treated with piperidine (7.5 equiv) for 30 min. The solvent was removed and the compound was purified by reverse-phase HPLC to yield <b>38</b> (3 mg, 8%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.97 (s, 1H), 12.45 (s, 1H), 8.87 (d, <i>J</i> = 6.7 Hz, 1H), 8.69 (s, 1H), 8.33 (d, <i>J</i> = 7.0 Hz, 1H), 7.85–7.71 (m, 2H), 7.57–7.48 (m, 3H), 7.36 (d, <i>J</i> = 8.4 Hz, 1H), 3.64 (s, 3H), 1.32 (s, 9H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>, 394.1767; found, 394.1754.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 2-Bromo-1-<i>tert</i>-butyl-4-nitrobenzene (<b>61</b>)</h3><div class="NLM_p last">To a solution of 1-<i>tert</i>-butyl-4-nitrobenzene (8.9 g, 50 mmol) and silver sulfate (10 g, 32 mmol) in 50 mL of 90% sulfuric acid was added bromine (7.95 g, 50 mmol) dropwise. Stirring was continued at 25 °C for 16 h, and then the mixture was poured into a dilute NaHSO<sub>3</sub> solution and was extracted with ethyl acetate (3 × 100 mL). The combined organic layers were washed with brine (300 mL), dried over MgSO<sub>4</sub>, and concentrated to give <b>61</b> (12.7 g, 98%) that was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.47 (d, <i>J</i> = 2.5 Hz, 1H), 8.11 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 7.63 (d, <i>J</i> = 8.8 Hz, 1H), 1.57 (s, 9H).</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 2-<i>tert</i>-Butyl-5-nitrobenzonitrile (<b>62</b>)</h3><div class="NLM_p last">To a solution of <b>61</b> (2.1 g, 8.2 mmol) and Zn(CN)<sub>2</sub> (0.77 g, 6.6 mmol) in DMF (10 mL) was added Pd(PPh<sub>3</sub>)<sub>4</sub> (0.5 g, 0.4 mmol) under nitrogen. The mixture was heated in a sealed vessel at 205 °C for 5 h. After cooling to 25 °C, the mixture was diluted with water and extracted with ethyl acetate (2 × 20 mL). The combined organic layers were washed with brine (20 mL) and dried over MgSO<sub>4.</sub> After removal of the solvent, the residue was purified by silica gel chromatography (0–10% ethyl acetate–hexane) to give <b>62</b> (1.3 g, 80%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.55 (d, <i>J</i> = 2.3 Hz, 1H), 8.36 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H), 7.73 (d, <i>J</i> = 8.9 Hz, 1H), 1.60 (s, 9H).</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (2-<i>tert</i>-Butyl-5-nitrophenyl)methanamine (<b>63</b>)</h3><div class="NLM_p last">To a solution of <b>62</b> (0.6 g, 3.0 mmol) in THF (10 mL) was added a 1 M solution of BH<sub>3</sub> in THF (12 mL, 12.0 mmol), and the reaction mixture was stirred at 70 °C for 16 h under nitrogen. The mixture was cooled to 0 °C, and methanol (2 mL) was added followed by 1 N HCl (2 mL). After heating at reflux for 30 min, the solution was diluted with water (10 mL) and extracted with ethyl acetate (20 mL). The aqueous layer was made basic by the addition of 1 N NaOH and extracted with ethyl acetate (2 × 20 mL). The combined organic layers were washed with brine (20 mL) and dried over MgSO<sub>4</sub>. After removal of the solvent, the residue was purified by silica gel chromatography (0–10% methanol–dichloromethane) to give <b>63</b> (0.3 g, 43%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.54 (d, <i>J</i> = 2.7 Hz, 1H), 7.99 (dd, <i>J</i> = 8.8, 2.8 Hz, 1H), 7.58 (d, <i>J</i> = 8.8 Hz, 1H), 4.03 (s, 2H), 2.00 (t, <i>J</i> = 2.1 Hz, 2H), 1.40 (s, 9H).</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>tert</i>-Butyl 2-<i>tert</i>-Butyl-5-nitrobenzylcarbamate (<b>64</b>)</h3><div class="NLM_p last">A solution of <b>63</b> (0.2 g, 1.0 mmol) and (Boc)<sub>2</sub>O (0.23 g, 1.1 mmol) in THF (5 mL) was heated at reflux for 30 min. After cooling to 25 °C, the solution was diluted with water (10 mL) and extracted with ethyl acetate (20 mL). The combined organic layers were washed with brine (20 mL), dried over MgSO<sub>4</sub>, and evaporated to dryness to give <b>64</b> (0.24 g, 78%) that was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.26 (d, <i>J</i> = 2.3 Hz, 1H), 8.09 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 7.79 (t, <i>J</i> = 5.9 Hz, 1H), 7.68 (d, <i>J</i> = 8.8 Hz, 1H), 4.52 (d, <i>J</i> = 6.0 Hz, 2H), 1.48 (s, 18H).</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>tert</i>-Butyl 2-<i>tert</i>-Butyl-5-aminobenzylcarbamate (<b>65</b>)</h3><div class="NLM_p last">To a solution of <b>64</b> (20 mg, 0.07 mmol) in 5% acetic acid in methanol (1 mL), 10% Pd/C (14 mg) was added under nitrogen. The mixture was hydrogenated at 25 °C using a hydrogen filled balloon for 1 h. The mixture was filtered through a plug of Celite, and the filtrate was evaporated to dryness to give <b>65 (</b>18 mg, 92% yield) that was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.09 (d, <i>J</i> = 8.5 Hz, 1H), 6.62 (d, <i>J</i> = 2.6 Hz, 1H), 6.47 (dd, <i>J</i> = 8.5, 2.6 Hz, 1H), 4.61 (br s, 1H), 4.40 (d, <i>J</i> = 5.1 Hz, 2H), 4.15 (br s, 2H), 1.39 (s, 9H), 1.29 (s, 9H).</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>N</i>-(3-(Aminomethyl)-4-<i>tert</i>-butylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>39</b>)</h3><div class="NLM_p"><i>Step 1.</i> A mixture of <b>49</b> (10 mg, 0.05 mmol), <b>65</b> (18 mg, 0.065 mmol), triethylamine (0.02 mL, 0.12 mmol), and HATU (23 mg, 0.06 mmol) in dichloromethane (1 mL) was heated at 60 °C for 16 h. The crude material was purified by reverse-phase HPLC to give <i>tert</i>-butyl 2-<i>tert</i>-butyl-5-(4-oxo-1,4-dihydroquinoline-3-carboxamido)benzylcarbamate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.94 (d, <i>J</i> = 6.0 Hz, 1H), 12.40 (s, 1H), 8.87 (d, <i>J</i> = 6.8 Hz, 1H), 8.33 (d, <i>J</i> = 8.2 Hz, 1H), 7.84–7.75 (m, 3H), 7.57–7.43 (m, 2H), 7.31 (d, <i>J</i> = 8.6 Hz, 1H), 4.40 (d, <i>J</i> = 5.8 Hz, 2H), 1.44 (s, 9H), 1.38 (s, 9H).</div><div class="NLM_p last"><i>Step 2.</i> To a solution of <i>tert</i>-butyl 2-<i>tert</i>-butyl-5-(4-oxo-1,4-dihydroquinoline-3-carboxamido)benzylcarbamate in dichloromethane (1 mL) was added trifluoroacetic acid (0.2 mL), and the mixture was stirred at 25 °C for 30 min. The solvent was evaporated to afford <b>29</b> as a TFA salt (16 mg, 53% over two steps). <sup>1</sup>H NMR (400 MHz, DMSO) δ 13.08 (d, <i>J</i> = 6.5 Hz, 1H), 12.56 (s, 1H), 8.89 (d, <i>J</i> = 6.7 Hz, 1H), 8.33 (d, <i>J</i> = 8.1 Hz, 1H), 8.27 (s, 3H), 7.98 (dd, <i>J</i> = 8.7, 1.9 Hz, 1H), 7.87–7.81 (m, 1H), 7.78 (d, <i>J</i> = 8.2 Hz, 1H), 7.60 (d, <i>J</i> = 2.0 Hz, 1H), 7.59–7.53 (m, 1H), 7.43 (d, <i>J</i> = 8.7 Hz, 1H), 4.33–4.27 (m, 2H), 1.38 (s, 9H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>, 350.1868; found, 350.186.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 2-<i>tert</i>-Butyl-5-nitrobenzoic Acid (<b>66</b>)</h3><div class="NLM_p last">A solution of <b>62</b> (0.2 g, 1.0 mmol) in 5 mL of 75% H<sub>2</sub>SO<sub>4</sub> was heated in a microwave oven at 200 °C for 30 min. The reaction mixture was poured over ice and extracted with ethyl acetate. The organics were washed with brine (5 mL), dried over MgSO<sub>4</sub>, and evaporated to dryness to give <b>66</b> (0.2 g, 90%) that was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.36 (d, <i>J</i> = 2.6 Hz, 1H), 8.24 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 7.72 (d, <i>J</i> = 8.9 Hz, 1H) 1.51 (s, 9H).</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Methyl 2-<i>tert</i>-Butyl-5-aminobenzoate (<b>67</b>)</h3><div class="NLM_p">Step 1. To a mixture of <b>66</b> (0.12 g, 0.53 mmol) and K<sub>2</sub>CO<sub>3</sub> (0.15 g, 1.1 mmol) in DMF (5.0 mL) was added iodomethane (0.04 mL, 0.64 mmol). The reaction mixture was stirred at 25 °C for 10 min, diluted with water (5 mL), and extracted with ethyl acetate (10 mL). The combined organic layers were washed with brine (10 mL), dried over MgSO<sub>4</sub>, and evaporated to dryness to give methyl 2-<i>tert</i>-butyl-5-nitrobenzoate (90 mg, 71%) that was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.20 (d, <i>J</i> = 2.6 Hz, 1H), 8.17 (t, <i>J</i> = 1.8 Hz, 1H), 7.66 (d, <i>J</i> = 8.6 Hz, 1H), 4.11 (s, 3H), 1.43 (s, 9H).</div><div class="NLM_p last"><i>Step 2.</i> To a solution of methyl 2-<i>tert</i>-butyl-5-nitrobenzoate (90 mg, 0.38 mmol) in ethanol (2 mL) was added a solution of potassium formate (0.4 g, 4.8 mmol) in water (1 mL), followed by 10% Pd/C (20 mg). The mixture was heated at reflux for 40 min, cooled to 25 °C and filtered though a plug of Celite. The filtrate was concentrated to dryness to give <b>67</b> (76 mg, 95%) that was used in the next step without further purification. <sup>1</sup>H NMR H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.24 (d, <i>J</i> = 8.6 Hz, 1H), 6.67 (dd, <i>J</i> = 8.6, 2.7 Hz, 1H), 6.60 (d, <i>J</i> = 2.7 Hz, 1H), 3.86 (s, 3H), 1.34 (s, 9H).</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> (2-<i>tert</i>-Butyl-5-aminophenyl)methanol (<b>68</b>)</h3><div class="NLM_p last">To a solution of compound <b>67</b> (0.16 g, 0.72 mmol) in THF (5 mL) at 0 °C was added a 1 M solution of lithium aluminum hydride in THF (1.4 mL, 1.4 mmol). The reaction mixture was refluxed for 2 h, diluted with water (5 mL), and extracted with ethyl acetate (2 × 10 mL). The combined organic layers were washed with brine (10 mL), dried over MgSO<sub>4</sub>, and evaporated to give <b>68</b> (25 mg, 20%) that was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.17 (d, <i>J</i> = 8.5 Hz, 1H), 6.87 (d, <i>J</i> = 2.6 Hz, 1H), 6.56 (dd, <i>J</i> = 8.4, 2.7 Hz, 1H), 4.83 (s, 2H), 1.36 (s, 9H).</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> <i>N</i>-(4-<i>tert</i>-Butyl-3-(hydroxymethyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>40</b>)</h3><div class="NLM_p last">To a solution of compound <b>49</b> (26 mg, 0.14 mmol), HATU (54 mg, 0.14 mmol), and triethylamine (0.06 mL, 0.4 mmol) in DMF (1 mL) was added compound <b>68</b> (25 mg, 0.14 mmol). The mixture was heated at 60 °C for 18 h, filtered, and purified by reverse-phase HPLC to give <b>40</b> (3 mg, 5%). <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.96 (s, 1H), 12.43 (s, 1H), 8.88 (s, 1H), 8.35 (d, <i>J</i> = 8.0 Hz, 1H), 7.86–7.81 (m, 1H), 7.78–7.70 (m, 3H), 7.56 (t, <i>J</i> = 7.5 Hz, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 5.24 (t, <i>J</i> = 5.5 Hz, 1H), 4.74 (d, <i>J</i> = 5.4 Hz, 2H), 1.37 (s, 9H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>22</sub>N<sub>2</sub>O<sub>3</sub>, 351.1708; found, 351.1704.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 2-<i>tert</i>-Butyl-5-(4-oxo-1,4-dihydroquinoline-3-carboxamido)benzoic Acid (<b>41</b>)</h3><div class="NLM_p"><i>Step 1.</i> To 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>) (62 mg, 0.3 mmol), methyl 5-amino-2-<i>tert</i>-butylbenzoate (<b>67</b>) (68 mg, 0.3 mmol), HATU (126 mg, 0.3 mmol), DMF (2.4 mL), and Et<sub>3</sub>N (138 μL, 1 mmol) were added, and the mixture was stirred at 60 °C for 18 h. DMF was evaporated under reduced pressure. The compound was dissolved in EtOAc (6 mL) and washed with 1 M HCl (3 mL × 2), a saturated aqueous solution of NaHCO<sub>3</sub> (3 mL × 2), and a saturated aqueous solution of NaCl (3 mL × 1). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the solvent was evaporated under reduced pressure. The crude product was purified by silica gel chromatography (0–30% ethyl acetate in dichloromethane) to yield methyl 2-<i>tert</i>-butyl-5-[(4-oxo-1<i>H</i>-quinoline-3-carbonyl)amino]benzoate (0.10 g, 80%) .</div><div class="NLM_p last"><i>Step 2.</i> To methyl 2-<i>tert</i>-butyl-5-[(4-oxo-1<i>H</i>-quinoline-3-carbonyl)amino]benzoate (50 mg, 0.13 mmol), THF (3 mL), MeOH (1.5 mL), and LiOH (1.52 mL of 2 M, 3.0 mmol) were added, and the mixture was heated at 140 °C for 1 h in the microwave instrument. The mixture was filtered, and the solvent was evaporated under reduced pressure. The compound was dissolved in MeOH, filtered, and purified by reverse-phase HPLC to give <b>41</b> (32 mg, 66%). <sup>1</sup> H NMR (400 MHz, MeOD) δ 8.84 (s, 1H), 8.41 (d, <i>J</i> = 8.2 Hz, 1H), 7.82–7.76 (m, 1H), 7.65 (d, <i>J</i> = 8.3 Hz, 1H), 7.62–7.57 (m, 1H), 7.57–7.49 (m, 2H), 7.39 (d, <i>J</i> = 8.7 Hz, 1H), 1.47 (s, 9H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>20</sub>N<sub>2</sub>O<sub>4</sub>, 365.1501; found, 365.1491.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 2-<i>tert</i>-Butyl-5-nitroaniline (<b>70</b>)</h3><div class="NLM_p last">To a solution of 90% sulfuric acid (50 mL) at 0 °C was added 2-<i>tert</i>-butylphenylamine (4.5 g, 30.0 mmol) dropwise. Potassium nitrate (4.5 g, 45.0 mmol) was added portionwise at 0 °C. The reaction mixture was stirred at 0–5 °C for 5 min, poured over ice–water, and extracted with ethyl acetate (3 × 30 mL). The combined organic layers were washed with brine (40 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to yield a residue that was recrystallized from 70% EtOH–H<sub>2</sub>O to give <b>70</b> (3.7 g, 64%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.56 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 7.48 (d, <i>J</i> = 2.4 Hz, 1H), 7.36 (d, <i>J</i> = 8.7 Hz, 1H), 4.17 (s, 2H), 1.46 (s, 9H).</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 2-<i>tert</i>-Butyl-5-aminophenol (<b>71</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a solution of <b>70</b> (1.9 g, 10.0 mmol) in 40 mL of 15% H<sub>2</sub>SO<sub>4</sub> at 0 °C was added a solution of NaNO<sub>2</sub> (0.76 g, 11.0 mmol in 3 mL of water) dropwise. The resulting mixture was stirred at 0–5 °C for 5 min. Excess NaNO<sub>2</sub> was neutralized with urea. Then 5 mL of H<sub>2</sub>SO<sub>4</sub>–H<sub>2</sub>O (v/v 1:2) was added and the mixture was heated at reflux for 5 min. Three additional 5 mL aliquots of H<sub>2</sub>SO<sub>4</sub>–H<sub>2</sub>O (v/v 1:2) were added while heating at reflux. The reaction mixture was cooled to 25 °C and extracted with ethyl acetate (2 × 20 mL). The combined organic layers were washed with brine (50 mL), dried over MgSO<sub>4</sub>, filtered, and evaporated to yield a crude residue that was purified by silica gel chromatography (0–10% ethyl acetate–hexane) to afford 2-<i>tert</i>-butyl-5-nitrophenol (1.2 g, 62%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.76 (dd, <i>J</i> = 8.6, 2.2 Hz, 1H), 7.58 (d, <i>J</i> = 2.1 Hz, 1H), 7.43 (d, <i>J</i> = 8.6 Hz, 1H), 5.41 (s, 1H), 1.45 (s, 9H).</div><div class="NLM_p last"><i>Step 2.</i> To a solution of 2-<i>tert</i>-butyl-5-nitrophenol (0.2 g, 1.0 mmol) in ethanol (10 mL) were added ammonium formate (0.2 g, 3.1 mmol) and 10% Pd/C (0.14 g). The reaction mixture was heated at reflux for 30 min, cooled to 25 °C, and filtered through a plug of Celite. The filtrate was concentrated to dryness and purified by silica gel chromatography (20–30% ethyl acetate–hexane) to give <b>71</b> (0.14 g, 87%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.76 (s, 1H), 6.74 (d, <i>J</i> = 8.3 Hz, 1H), 6.04 (d, <i>J</i> = 2.3 Hz, 1H), 5.93 (dd, <i>J</i> = 8.2, 2.3 Hz, 1H), 4.67 (s, 1H), 1.26 (s, 9H).</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 2-<i>tert</i>-Butyl-5-aminobenzene-1-sulfonamide (<b>72</b>)</h3><div class="NLM_p"><i>Step 1: 2-tert-Butyl-5-nitrobenzene-1-sulfonyl Chloride.</i> To a suspension of 2-<i>tert</i>-butyl-5-nitrobenzenamine (<b>70</b>, 0.97 g, 5.0 mmol) in concentrated HCl (5 mL) cooled to 5–10 °C was added a solution of NaNO<sub>2</sub> (0.43g, 6.3 mmol in 0.8 mL of H<sub>2</sub>O) dropwise. The mixture was stirred for 0.5 h and then vacuum filtered. The filtrate was added simultaneously with a solution of Na<sub>2</sub>SO<sub>3</sub> (1.6 g, 12.4 mmol in 2.7 mL of H<sub>2</sub>O) to a stirred solution of CuSO<sub>4</sub> (0.19 g, 0.76 mmol) and Na<sub>2</sub>SO<sub>3</sub> (1.6 g, 12.4 mmol) in HCl (11.7 mL) and H<sub>2</sub>O (2.7 mL) at 3–5 °C. Stirring was continued for 0.5 h and the resulting precipitate was filtered, washed with water and dried to give 2-<i>tert</i>-butyl-5-nitrobenzene-1-sulfonyl chloride (0.24 g, 17%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.13 (d, <i>J</i> = 2.5 Hz, 1H), 8.36 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 7.88 (d, <i>J</i> = 8.9 Hz, 1H), 1.59 (s, 9H).</div><div class="NLM_p"><i>Step 2: 2-tert-Butyl-5-nitrobenzene-1-sulfonamide.</i> To a solution of 2-<i>tert</i>-butyl-5-nitrobenzene-1-sulfonyl chloride (0.1 g, 0.36 mmol) in ether (2 mL) was added aqueous NH<sub>4</sub>OH (0.13 mL, 3.6 mmol) at 0 °C. The mixture was stirred at 25 °C for 16 h, diluted with water, and extracted with ether (3 × 10 mL). The combined ether extracts were washed with brine (20 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. After removal of solvent, the residue was purified by silica gel chromatography (0–50% ethyl acetate–hexane) to give 2-<i>tert</i>-butyl-5-nitrobenzene-1-sulfonamide (32 mg, 34%).</div><div class="NLM_p last"><i>Step 3: 2-tert-Butyl-5-aminobenzene-1-sulfonamide (<b>72</b>).</i> A solution of 2-<i>tert</i>-butyl-5-nitrobenzene-1-sulfonamide (32 mg, 0.12 mmol) and SnCl<sub>2</sub>·2H<sub>2</sub>O (0.14 g, 0.61 mmol) in ethanol (1.5 mL) was heated in a microwave oven at 100 °C for 30 min. The mixture was diluted with ethyl acetate (10 mL) and water (5 mL), basified with sat. NaHCO<sub>3</sub>, and filtered through a plug of Celite. The organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed by evaporation to provide compound <b>72</b> (28 mg, 100%), which was used in the next step without further purification.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> <i>N</i>-(4-<i>tert</i>-Butyl-3-sulfamoylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>42</b>)</h3><div class="NLM_p last">To a solution of <b>49</b> (23 mg, 0.12 mmol), HBTU (47 mg, 0.12 mmol), and triethylamine (0.05 mL, 0.37 mmol) in DMF (1.0 mL) was added <b>72</b> (28 mg, 0.12 mmol). The mixture was heated at 150 °C in the microwave oven for 50 min and the resulting solution was filtered and purified by reverse-phase HPLC to yield compound <b>42</b> (16 mg, 33%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.02 (s, 1H), 12.61 (s, 1H), 8.90 (s, 1H), 8.34 (dd, <i>J</i> = 8.1, 1.1 Hz, 1H), 8.22 (d, <i>J</i> = 2.4 Hz, 1H), 8.14 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 7.86–7.80 (m, 1H), 7.77 (d, <i>J</i> = 7.8 Hz, 1H), 7.66–7.54 (m, 4H), 1.52 (s, 9H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub>S, 400.1331; found, 400.1329.</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> <i>N</i>-(4-<i>tert</i>-Butylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>43</b>)</h3><div class="NLM_p last">A mixture of <b>49</b> (38 mg, 0.2 mmol), 4-<i>tert</i>-butylaniline (60 mg, 0.4 mmol), DIEA (0.7 mL, 0.4 mmol), and HATU (76 mg, 0.2 mmol) in DMF (1 mL) was stirred for 24 h. The reaction mixture was filtered and purified by reverse-phase HPLC to give <b>43</b> (35 mg, 55%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.96 (br s, 1H), 12.42 (s, 1H), 8.88 (s, 1H), 8.33 (dd, <i>J</i> = 8.2, 1.1 Hz, 1H), 7.82 (t, <i>J</i> = 8.3 Hz, 1H), 7.75 (d, <i>J</i> = 7.7 Hz, 1H), 7.66 (d, <i>J</i> = 8.7 Hz, 2H), 7.54 (t, <i>J</i> = 8.1 Hz, 1H), 7.39 (d, <i>J</i> = 8.7 Hz, 2H), 1.29 (s, 9H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>, 321.1603; found, 321.1601.</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 1-<i>tert</i>-Butyl-2-fluoro-4-nitrobenzene (<b>73</b>)</h3><div class="NLM_p last">To a stirred solution of <b>70</b> (5.0 g, 25.8 mmol) in H<sub>2</sub>O (20 mL) was added concentrated HCl (10 mL). The reaction mixture was cooled to 0 °C, and a solution of NaNO<sub>2</sub> (1.78 g, 25.8 mmol) in H<sub>2</sub>O (10 mL) was added dropwise. The reaction mixture was stirred at 0 °C for another 0.5 h, and a solution of HPF<sub>6</sub> (40 mL) was added in two batches. The precipitate that formed was collected by filtration and heated under an infrared light at 130–150 °C (the conversion was monitored by TLC). The resulting dark oil was purified by silica gel chromatography to afford <b>73</b> (0.6 g, 12% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.96 (dd, <i>J</i> = 2.4, 8.8 Hz, 1 H), 7.87 (dd, <i>J</i> = 2.4, 12.0 Hz, 1 H), 7.48 (t, <i>J</i> = 8.0 Hz, 1 H), 1.43 (s, 9 H).</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 4-<i>tert</i>-Butyl-3-fluoroaniline (<b>74</b>)</h3><div class="NLM_p last">NaBH<sub>4</sub> (0.29 g, 7.6 mmol) was added to a solution of <b>73</b> (0.75 g, 3.8 mmol) and NiCl<sub>2</sub>·6H<sub>2</sub>O (2.6 g, 11.4 mmol) in methanol (15 mL) at 15 °C. The mixture was stirred for 2 min, and then water was added to quench the reaction. The mixture was extracted with ethyl acetate (3 × 50 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated to afford <b>74</b> (0.47 g, 75%) that was used in the next step without further purification. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.08–7.02 (m, 1 H), 6.42–6.34 (m, 2 H), 1.32 (s, 9 H).</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> <i>N</i>-(4-<i>tert</i>-Butyl-3-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>44</b>)</h3><div class="NLM_p last">To a solution of <b>49</b> (30 mg, 0.16 mmol), HATU (65 mg, 0.17 mmol), and triethylamine (0.07 mL, 0.47 mmol) in THF (1.0 mL) was added <b>74</b> (29 mg, 0.17 mmol). The mixture was heated at 150 °C in the microwave oven for 50 min and the resulting solution was filtered and purified by reverse-phase HPLC to give <b>44 (</b>11 mg, 21%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.68 (s, 1H), 8.88 (s, 1H), 8.32 (d, <i>J</i> = 8.1, 1H), 7.83–7.71 (m, 3H), 7.52 (t, <i>J</i> = 7.5, 1H), 7.34–7.24 (m, 2H), 5.76 (s, 1H), 1.34 (s, 9H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>2</sub>, 339.1509; found, 339.1507.</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 2-<i>tert</i>-Butyl-5-aminophenol (<b>71</b>)</h3><div class="NLM_p last">To a solution of <b>70</b> (0.2 g, 1.0 mmol) in ethanol (10 mL) were added ammonium formate (0.2 g, 3.1 mmol) and 10% Pd/C (0.14 g), and the mixture was heated at reflux. After 30 min, the mixture was cooled to 25 °C and filtered through a plug of Celite. The filtrate was concentrated to dryness and was purified by silica gel chromatography (20–30% ethyl acetate–hexane) to give compound <b>71</b> (0.14 g, 87%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.76 (s, 1H), 6.74 (d, <i>J</i> = 8.3 Hz, 1H), 6.04 (d, <i>J</i> = 2.3 Hz, 1H), 5.93 (dd, <i>J</i> = 8.2, 2.3 Hz, 1H), 4.67 (s, 1H), 1.26 (s, 9H).</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> <i>N</i>-(4-<i>tert</i>-Butyl-3-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>45</b>)</h3><div class="NLM_p last">A mixture of <b>49</b> (57 mg, 0.30 mmol), <b>71</b> (59 mg, 0.36 mmol), triethylamine (0.1 mL, 0.72 mmol), and HATU (0.14 g, 0.36 mmol) in dichloromethane (3 mL) was heated at 70 °C for 12 h. The solvent was evaporated and the crude residue was purified by reverse-phase HPLC to give <b>45</b> (47 mg, 47%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.95 (br s, 1H), 12.31 (s, 1H), 9.44 (s, 1H), 8.86 (s, 1H), 8.33 (dd, <i>J</i> = 8.1, 1.1 Hz, 1H), 7.82 (td, <i>J</i> = 7.6, 1.4 Hz, 1H), 7.76 (d, <i>J</i> = 8.0 Hz, 1H), 7.54 (t, <i>J</i> = 8.0 Hz, 1H), 7.38 (d, <i>J</i> = 2.1 Hz, 1H), 7.10 (d, <i>J</i> = 8.4 Hz, 1H), 6.96 (dd, <i>J</i> = 8.4, 2.1 Hz, 1H), 1.34 (s, 9H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>20</sub>N<sub>2</sub>O<sub>3</sub>, 337.1552; found, 337.1564.</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 2-<i>tert</i>-Butyl-4-fluorophenol (<b>76</b>)</h3><div class="NLM_p last">4-Fluorophenol (5.0 g, 45 mmol) and <i>tert</i>-butanol (5.9 mL, 63 mmol) were dissolved in dichloromethane (80 mL) and treated with concentrated sulfuric acid (3 mL). The mixture was stirred at 25 °C for 16 h. The organic layer was washed with water, neutralized with a saturated solution of NaHCO<sub>3</sub>, dried over MgSO<sub>4</sub>, and concentrated. The residue was purified by silica gel chromatography (5–15% ethyl acetate–hexane) to give compound <b>76</b> (3.1 g, 42%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.32 (s, 1H), 6.89 (dd, <i>J</i> = 11.1, 3.1 Hz, 1H), 6.84–6.79 (m, 1H), 6.74 (dd, <i>J</i> = 8.7, 5.3 Hz, 1H), 1.33 (s, 9H).</div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 2-<i>tert</i>-Butyl-4-fluorophenyl Methyl Carbonate (<b>77</b>)</h3><div class="NLM_p last">To a solution of <b>76</b> (2.6 g, 15.7 mmol) and triethylamine (3.1 mL, 22.5 mmol) in dioxane (45 mL) was added methyl chloroformate (1.3 mL, 16.5 mmol), and the mixture was stirred at 25 °C for 1 h. The precipitate was removed, and the filtrate was diluted with water and extracted with diethyl ether. The ether extract was washed with water and dried over MgSO<sub>4</sub>. After removal of solvent, the residue was purified by silica gel chromatography to give compound <b>77</b> (2.1 g, 59%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.24 (dd, <i>J</i> = 8.8, 5.4 Hz, 1H), 7.17–7.10 (m, 2H), 3.86 (s, 3H), 1.29 (s, 9H).</div></div><div id="sec5_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 2-<i>tert</i>-Butyl-4-fluoro-5-nitrophenyl Methyl Carbonate (<b>78</b>)</h3><div class="NLM_p last">To a solution of <b>77</b> (1.8 g, 8.0 mmol) in concentrated H<sub>2</sub>SO<sub>4</sub> (1 mL) at 0 °C was added a mixture of H<sub>2</sub>SO<sub>4</sub> (1 mL) and HNO<sub>3</sub> (1 mL) dropwise. The mixture was stirred for 2 h while warming to 25 °C, before being poured over ice and extracted with diethyl ether (2 × 20 mL). The ether extract was washed with brine (10 mL), dried over MgSO<sub>4</sub>, and concentrated. The residue was purified by silica gel chromatography (0–10% ethyl acetate–hexane) to give compound <b>78</b> (1.2 g, 55%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.24 (d, <i>J</i> = 7.1 Hz, 1H), 7.55 (d, <i>J</i> = 13.4 Hz, 1H), 3.90 (s, 3H), 1.32 (s, 9H).</div></div><div id="sec5_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 2-<i>tert</i>-Butyl-4-fluoro-5-nitrophenol (<b>79</b>)</h3><div class="NLM_p last">To a solution of 2-<i>tert</i>-butyl-4-fluoro-5-nitrophenyl methyl carbonate (<b>78</b>) (1.1 g, 4.0 mmol) in dichloromethane (40 mL) was added piperidine (3.9 mL, 10 mmol). The mixture was stirred at 25 °C for 1 h and extracted with 1 N NaOH (3 × 10 mL). The aqueous layer was acidified with 1 N HCl and extracted with diethyl ether. The ether extract was washed with brine (20 mL), dried over MgSO<sub>4</sub>, and concentrated to give compound <b>79</b> (0.53 g, 62%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.40 (s, 1H), 7.49 (d, <i>J</i> = 6.8 Hz, 1H), 7.25 (d, <i>J</i> = 13.7 Hz, 1H), 1.36 (s, 9H).</div></div><div id="sec5_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 2-<i>tert</i>-Butyl-5-amino-4-fluorophenol (<b>80</b>)</h3><div class="NLM_p last">To a solution of <b>79</b> (0.4 g, 1.9 mmol) and ammonium formate (0.4 g, 6.1 mmol) in ethanol (20 mL) was added 5% Pd/C (0.26 g). The mixture was heated at reflux for 1 h, cooled to 25 °C, and filtered through a plug of Celite. The solvent was removed by evaporation to give compound <b>80</b> (0.55 g, 83%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.83 (br s, 1H), 6.66 (d, <i>J</i> = 13.7 Hz, 1H), 6.22 (d, <i>J</i> = 8.5 Hz, 1H), 4.74 (br s, 2H), 1.26 (s, 9H).</div></div><div id="sec5_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> <i>N</i>-(4-<i>tert</i>-Butyl-2-fluoro-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>46</b>)</h3><div class="NLM_p last">A mixture of <b>49</b> (0.19 g, 1 mmol), <b>80</b> (0.18 g, 1 mmol), triethylamine (0.28 mL, 2 mmol), and HATU (0.38 g, 1 mmol) in DMF (3 mL) was heated at 70 °C for 12 h. The solvent was evaporated, and the crude residue was suspended in water (5 mL) and extracted with ethyl acetate (3 × 20 mL). The organic layers were combined, dried over MgSO<sub>4</sub>, and evaporated. The crude residue was purified by silica gel chomatography (60–100% ethyl acetate–hexanes) to yield <b>46</b> (80 mg, 23%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.96 (d, <i>J</i> = 6.8 Hz, 1H), 12.56 (s, 1H), 9.44 (s, 1H), 8.87 (d, <i>J</i> = 6.8 Hz, 1H), 8.34 (dd, <i>J</i> = 8.2, 1.3 Hz, 1H), 8.08 (d, <i>J</i> = 7.4 Hz, 1H), 7.83 (t, <i>J</i> = 8.3 Hz, 1H), 7.76 (d, <i>J</i> = 7.7 Hz, 1H), 7.55 (t, <i>J</i> = 8.1 Hz, 1H), 7.00 (d, <i>J</i> = 13.3 Hz, 1H), 1.34 (s, 9H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>3</sub>, 355.1458; found, 355.1452.</div></div><div id="sec5_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 2-<i>tert-</i>Butyl-4-bromophenol (<b>82</b>)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(41)</a></h3><div class="NLM_p last">To a solution of 2-<i>tert</i>-butylphenol (5.0 g, 33 mmol) in CCl<sub>4</sub> (25 mL) was added silica gel 60 (EMD 230–400 mesh). The solution was cooled to 0 °C, and bromine (5.3 g, 33 mmol) was added dropwise over 15 min. The solution was stirred for 1 h, filtered, and the solid was washed with dichloromethane. The organic layers were washed with a 1 N Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution (30 mL), brine (30 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under reduced pressure and the crude product was purified by silica gel chromatography (0–7% ethyl acetate–hexanes) to yield <b>72</b> (5.2 g, 68%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34 (d, <i>J</i> = 2 Hz, 1H), 7.16 (dd, <i>J</i> = 9 and 2 Hz, 1H), 6.55 (d, <i>J</i> = 9 Hz, 1H), 4.95 (br s, 1H), 1.38 (s, 9H).</div></div><div id="sec5_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Methyl 2-<i>tert</i>-Butyl-4-bromophenylcarbonate (<b>83</b>)</h3><div class="NLM_p last">To a solution of <b>82</b> (5.2 g, 22.7 mmol) in dichloromethane (200 mL) at 0 °C was added triethylamine (3.8 mL, 27.2 mmol) and methyl chloroformate (3.5 mL, 45.4 mmol). The solution was stirred for 2 h and quenched with a saturated aqueous solution of NH<sub>4</sub>Cl. The organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent was removed under reduced pressure to yield <b>83</b> (4.5 g 72%) that was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.48 (d, <i>J</i> = 2 Hz, 1H), 7.35 (dd, <i>J</i> = 9 and 2 Hz, 1H), 6.98 (d, <i>J</i> = 9 Hz, 1H), 3.92 (s, 3H), 1.34 (s, 9H).</div></div><div id="sec5_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Methyl 2-<i>tert</i>-Butyl-4-bromo-5-nitrophenylcarbonate (<b>84</b>)</h3><div class="NLM_p last">To a solution of <b>83</b> (4.5 g, 16.4 mmol) in 10 mL of H<sub>2</sub>SO<sub>4</sub> at 0 °C was added KNO<sub>3</sub> (2.5 g, 24.6 mmol) in small batches over 15 min. The solution was stirred for 1 h at 25 °C, and a yellow precipitate was formed. Ice (∼20 g) was added to the solution, and the suspension was stirred for 15 min. The mixture was extracted with ethyl acetate (2 × 20 mL), and the organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under reduced pressure to yield a crude residue that was purified by silica gel chromatography (0–7% ethyl acetate–hexanes) to yield <b>84</b> (4.5 g, 83%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.78 (s, 1H), 7.72 (s, 1H), 3.95 (s, 3H), 1.37 (s, 9H).</div></div><div id="sec5_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> 2-<i>tert</i>-Butyl-4-bromo-5-nitrophenol (<b>85</b>)</h3><div class="NLM_p last">To a solution of <b>84</b> (2.4 g, 7.25 mmol) in methanol (20 mL) was added KOH (0.6 g, 10.7 mmol). The mixture was stirred for 10 min at 25 °C and quenched with 1 N HCl. The reaction mixture was partitioned between ethyl acetate and H<sub>2</sub>O. The aqueous layer was extracted with ethyl acetate (2 × 20 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The solvent was removed under reduced pressure to yield <b>85</b> (1.90 g, 96%) which was used in the next step without further purification.</div></div><div id="sec5_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> 1-<i>tert</i>-Butyl-2-(benzyloxy)-5-bromo-4-nitrobenzene (<b>86</b>)</h3><div class="NLM_p last">To a mixture of <b>85</b> (1.1 g, 4.0 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (1.6 g, 4.8 mmol) in DMF (8 mL) was added benzyl bromide (0.5 mL, 4.2 mmol). The mixture was stirred at 25 °C for 4 h, diluted with H<sub>2</sub>O, and extracted with ethyl acetate (2 × 20 mL). The combined organic layers were washed with brine (20 mL) and dried over MgSO<sub>4</sub>. The crude material was purified by silica gel chromatography (0–5% ethyl acetate–hexane) to yield <b>86</b> (1.37 g, 94%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.62 (s, 1H), 7.53 (s, 1H), 7.43 (m, 5H), 5.22 (s, 2H), 1.42 (s, 9H).</div></div><div id="sec5_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> 1-<i>tert</i>-Butyl-2-(benzyloxy)-5-(trifluoromethyl)-4-nitrobenzene (<b>87</b>)</h3><div class="NLM_p last">A mixture of <b>86</b> (0.9 g, 2.5 mmol), KF (0.3 g, 5 mmol), KBr (0.6 g, 5 mmol), CuI (0.6 g, 3 mmol), methyl chlorodifluoroacetate (1.6 mL, 15 mmol) in DMF (5 mL) was heated at 125 °C in a sealed tube overnight. After being cooled to 25 °C, the mixture was diluted with water and extracted with ethyl acetate (3 × 10 mL). The combined organic layers were washed with brine (20 mL) and dried over MgSO<sub>4</sub>. The residue was purified by silica gel chromatography (0–5% ethyl acetate–hexanes) to yield <b>87</b> (0.6 g, 67%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.66 (s, 1H), 7.37 (m, 5H), 7.19 (s, 1H), 5.21 (s, 2H), 1.32 (s, 9H).</div></div><div id="sec5_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> 5-Amino-2-<i>tert</i>-butyl-4-(trifluoromethyl)phenol (<b>88</b>)</h3><div class="NLM_p last">To a solution of <b>87</b> (0.35 g, 1.0 mmol) and ammonium formate (0.35 g, 5.4 mmol) in ethanol (10 mL) was added 10% Pd/C (0.25 g), and the mixture was heated at reflux for 2 h. The mixture was cooled to 25 °C and filtered through a plug of Celite. After removal of the solvent, the residue was purified by silica gel chromatography (50–80% ethyl acetate–hexanes) to give <b>88</b> (0.12 g, 52%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.21 (s, 1H), 6.05 (s, 1H), 1.28 (s, 9H).</div></div><div id="sec5_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> <i>N</i>-(4-<i>tert</i>-Butyl-5-hydroxy-2-(trifluoromethyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>47</b>)</h3><div class="NLM_p last">A mixture of <b>49</b> (9.5 mg, 0.05 mmol), <b>88</b> (14 mg, 0.06 mmol), triethylamine (0.02 mL, 0.12 mmol), and HATU (23 mg, 0.06 mmol) in dichloromethane (0.5 mL) was heated at 70 °C and was stirred for 24 h. The solvent was evaporated and the crude residue was purified by reverse-phase HPLC to give <b>47</b> (2 mg, 8%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.94 (d, <i>J</i> = 6.6 Hz, 1H), 12.57 (s, 1H), 10.37 (s, 1H), 8.88 (d, <i>J</i> = 6.8 Hz, 1H), 8.34–8.32 (m, 1H), 7.99 (s, 1H), 7.85–7.81 (m, 1H), 7.76 (d, <i>J</i> = 7.8 Hz, 1H), 7.56–7.52 (m, 1H), 7.38 (s, 1H), 1.37 (s, 9H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>19</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub>, 405.1426; found, 405.1429.</div></div><div id="sec5_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Carbonic Acid 2,4-Di-<i>tert</i>-butylphenyl Ester Methyl Ester (<b>90</b>)</h3><div class="NLM_p last">Methyl chloroformate (58 mL, 750 mmol) was added dropwise to a solution of 2,4-di-<i>tert</i>-butylphenol (<b>89</b>) (103.2 g, 500 mmol), triethylamine (139 mL, 1000 mmol), and DMAP (3.05 g, 25 mmol) in dichloromethane (400 mL) cooled to 0 °C in an ice–water bath. The mixture was allowed to warm to 25 °C over 16 h, then filtered through silica gel (approximately 1 L) using 10% ethyl acetate–hexanes (∼4 L) as the eluent. The combined filtrates were concentrated to yield <b>90</b> as a yellow oil (132 g, quant). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.35 (d, <i>J</i> = 2.4 Hz, 1H), 7.29 (dd, <i>J</i> = 8.5, 2.4 Hz, 1H), 7.06 (d, <i>J</i> = 8.4 Hz, 1H), 3.85 (s, 3H), 1.30 (s, 9H), 1.29 (s, 9H).</div></div><div id="sec5_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> Carbonic Acid 2,4-Di-<i>tert</i>-butyl-5-nitrophenyl Ester Methyl Ester (<b>91</b>) and Carbonic Acid 2,4-Di-<i>tert</i>-butyl-6-nitrophenyl Ester Methyl Ester (<b>92</b>)</h3><div class="NLM_p last">To a stirring mixture of carbonic acid 2,4-di-<i>tert</i>-butylphenyl ester methyl ester (<b>90</b>) (4.76 g, 18 mmol) in concentrated H<sub>2</sub>SO<sub>4</sub> (2 mL), cooled in an ice–water bath, was added a cooled mixture of H<sub>2</sub>SO<sub>4</sub> (2 mL) and nitric acid (2 mL). The addition was done slowly so that the reaction temperature did not exceed 50 °C. The mixture was allowed to warm to 25 °C over a period of 2 h. The reaction mixture was then poured into ice–water and extracted into diethyl ether. The ether layer was dried over MgSO<sub>4</sub>, concentrated, and purified by silica gel chromatography (0–10% ethyl acetate–hexanes) to yield a mixture of carbonic acid 2,4-di-<i>tert</i>-butyl-5-nitrophenyl ester methyl ester (<b>91</b>) and carbonic acid 2,4-di-<i>tert</i>-butyl-6-nitrophenyl ester methyl ester (<b>92</b>) as a pale yellow solid (4.3 g), which was used directly in the next step without further purification.</div></div><div id="sec5_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> 5-Nitro-2,4-di-<i>tert</i>-butylphenol (<b>94</b>)</h3><div class="NLM_p last">The mixture of carbonic acid 2,4-di-<i>tert</i>-butyl-5-nitrophenyl ester methyl ester (<b>91</b>) and carbonic acid 2,4-di-<i>tert</i>-butyl-6-nitrophenyl ester methyl ester (<b>92</b>) (4.2 g, 12.9 mmol) was dissolved in methanol (65 mL), and KOH (2.0 g, 36 mmol) was added. The mixture was stirred at 25 °C for 2 h. The reaction mixture was then made acidic (pH 2–3) by adding concentrated HCl and partitioned between water and diethyl ether. The ether layer was dried over MgSO<sub>4</sub>, concentrated, and purified by silica gel chromatography (0–5% ethyl acetate–hexanes) to provide <b>93</b> (1.31 g, 29% over two steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.14 (s, 1H), 7.34 (s, 1H), 6.83 (s, 1H), 1.36 (s, 9H), 1.30 (s, 9H).</div></div><div id="sec5_83" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> 5-Amino-2,4-di-<i>tert</i>-butylphenol (<b>94</b>)</h3><div class="NLM_p last">To a solution of <b>93</b> (1.86 g, 7.4 mmol) and ammonium formate (1.86 g) in ethanol (75 mL) was added 5% Pd/C (0.9 g). The reaction mixture was heated at reflux for 2 h, cooled to 25 °C, and filtered through a plug of Celite. The Celite was washed with methanol and the filtrate was concentrated to yield <b>94</b> as a gray solid (1.66 g, quant). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.64 (s, 1H), 6.84 (s, 1H), 6.08 (s, 1H), 4.39 (s, 2H, NH<sub>2</sub>), 1.27 (m, 18H).</div></div><div id="sec5_84" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> <i>N</i>-(2,4-Di-<i>tert</i>-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>48</b>)</h3><div class="NLM_p last">A mixture of <b>49</b> (0.14 g, 0.72 mmol), <b>95</b> (0.16 g, 0.72 mmol), triethylamine (2.0 mL, 14.4 mmol), and HATU (0.27 g, 0.72 mmol) in dichloromethane (0.5 mL) was stirred at 25 °C for 12 h. The solvent was evaporated, and the crude residue was diluted with H<sub>2</sub>O and extracted twice with dichloromethane. The combined organic extracts were washed with 1 N HCl, a saturated solution of NaHCO<sub>3</sub> and dried over MgSO<sub>4</sub>. After the removal of solvent, the residue was purified by silica gel chromatography (25–75% ethyl acetate–hexane) to yield <b>48</b> (0.2 g, 71%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.87 (s, 1H), 11.82 (s, 1H), 9.20 (s, 1H), 8.87 (s, 1H), 8.33 (dd, <i>J</i> = 8.2, 1.0 Hz, 1H), 7.84–7.78 (m, 1H), 7.76 (d, <i>J</i> = 7.7 Hz, 1H), 7.56–7.45 (m, 1H), 7.17 (s, 1H), 7.10 (s, 1H), 1.38 (s, 9H), 1.37 (s, 9H). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>28</sub>N<sub>2</sub>O<sub>3</sub>, 393.2178; found, 393.2164.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Biology</h3><div class="NLM_p">NIH-3T3 mouse fibroblasts stably expressing human F508del-CFTR (Michael J. Welsh, University of Iowa College of Medicine, Iowa City, IA) were cultured as previously described. All cells were maintained at 37 °C, unless otherwise indicated, in HyQ CCM5 (HyClone, Logan, UT) with 1% heat inactivated FBS.</div><div class="NLM_p">Whole lungs provided by the National Disease Research Interchange (Philadelphia, PA) were obtained from CF subjects following autopsy or from subjects undergoing lung transplantation. After removal, the intact lung was packed in PBS and shipped on wet ice. The tissue was received and processed within 24 h after autopsy or surgery. CF airway epithelia were isolated from bronchial tissue, cultured as previously described,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(42)</a> and plated onto Costar Snapwell filters that were precoated with NIH3T3-conditioned medium. After 4 days the apical medium was removed and the cells were grown at an air–liquid interface for >14 days prior to use. This resulted in a monolayer of fully differentiated columnar cells that were ciliated.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> Membrane Potential Optical Assay for Detecting F508del-CFTR Potentiator Activity<a onclick="showRef(event, 'ref8 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref11">(8, 11)</a></h4><div class="NLM_p last">To identify potentiators of F508del-CFTR, an HTS assay format utilizing fluorescent voltage sensing probes was developed using a FLIPR III (Molecular Devices Inc.) fluorescence plate reader. NIH-3T3 cells stably expressing F508del-CFTR were incubated for 16–24 h at 27 °C to correct the misfolded F508del-CFTR. Cells are then washed with a bath solution (160 mM NaCl, 4.5 mM KCl, 2 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, 10 mM HEPES, pH 7.4 with NaOH) and treated with fluorescent voltage sensing dyes combined with test compounds (or DMSO vehicle control) for 30 min at room temperature. The assay is run on FLIPR III using a single liquid addition step of Cl<sup>–</sup> free bath solution containing forskolin. Detected changes in membrane potential are due to the potentiator activity of test compounds on Cl<sup>–</sup> anion flux through F508del-CFTR.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> Ussing Chamber Recordings</h4><div class="NLM_p last">All cells were grown on Costar Snapwell cell culture inserts maintained at 37 °C, unless otherwise indicated, prior to recording. The cell culture inserts were mounted into an Ussing chamber (VCC MC8; Physiologic Instruments, Inc., San Diego, CA) to record ISC in the voltage-clamp mode (<i>V</i><sub>hold</sub> = 0 mV). For measurement of ISC, the basolateral bath solution contained the following (in mM): 135 NaCl, 1.2 CaCl<sub>2</sub>, 1.2 MgCl<sub>2</sub>, 2.4 K<sub>2</sub>HPO<sub>4</sub>, 0.6 KH<sub>2</sub>PO<sub>4</sub>, 10 <i>N</i>-2-hydroxyethylpiperazine-<i>N</i>′-2-ethanesulfonic acid (HEPES), and 10 dextrose (titrated to pH 7.4 with NaOH). The apical NaCl was replaced by equimolar Na<sup>+</sup> gluconate (titrated to pH 7.4 with NaOH). For HBE cells, the ISC was measured in the presence of a basolateral to apical Cl<sup>–</sup> gradient. The normal Cl<sup>–</sup> solution contained the following (in mM): 145 NaCl, 0.83 K<sub>2</sub>HPO<sub>4</sub>, 3.3 KH<sub>2</sub>PO<sub>4</sub>, 1.2 MgCl<sub>2</sub>, 1.2 CaCl<sub>2</sub>, 10 glucose, 10 HEPES (pH adjusted to 7.35 with NaOH). The low Cl<sup>–</sup> solution contained the following (in mM): 145 Na gluconate, 1.2 MgCl<sub>2</sub>, 1.2 CaCl<sub>2</sub>, 10 glucose, 10 HEPES (pH adjusted to 7.35 with NaOH). The ISCs were digitally acquired using Acquire and Analyze software (version 2; Physiologic Instruments, Inc., San Diego, CA).</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> cAMP Measurements</h4><div class="NLM_p last">The total cAMP concentration (cellular and secreted) in FRT cells following test compound application was determined using a cAMP-Screen 96-well immunoassay system according the manufactures directions (Applied Biosystems, catalog number T1502). Briefly, FRT cells were incubated for 15 min with test compound and then lysed and transferred to a 96-well assay plate provided with the kit. The plate was incubated at room temperature for 1 h after which it was developed and luminescence emission was measured using the Acquest 384.1536 by LJL Biosystems. The cAMP concentrations were determined using a cAMP standard curve present in each plate.</div></div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> In Vivo Pharmacokinetic Experiments</h3><div class="NLM_p last">Male mouse, Sprague–Dawley rats, beagle dog, and cynomolgus monkeys (<i>n</i> = 3/group) were administered a single iv dose of compound formulated in dimethyl isosorbide/ethanol/PEG400/5% dextrose in water (D5W) (10%/15%/35%/40%) at the nominal dose indicated in a dose volume of 1 mL/kg. Blood samples (0.3 mL, sodium heparin anticoagulant) were collected from an indwelling carotid cannula at the following nominal time points: at predose, 5, 15, 30, and 45 min and 1, 2, 4, 6, 8, 12, 24, 36, and 48 h following iv administration and at predose, 0.25, 0.50, 1, 1.5, 2, 4, 8, 12, and 24 h following oral administration. The concentration of compound in the plasma samples was determined with a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method, which had a lowest limit of quantitation (LLOQ) of 1 ng/mL and a linearity range between 1 and 2500 ng/mL. The mean plasma concentration–time profiles and the measured dose values were used to estimate the pharmacokinetic parameters using noncompartmental analysis modules in WinNonlin Professional Edition software, version 4.0.1 (Pharsight Corporation, Mountain View, CA).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i115"><a href="/doi/suppl/10.1021/jm5012808">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41700" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41700" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures for compounds <b>27</b>–<b>30</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5012808/suppl_file/jm5012808_si_001.pdf">jm5012808_si_001.pdf (34.4 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm5012808" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65218" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65218" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter D. J. Grootenhuis</span> - <span class="hlFld-Affiliation affiliation">Vertex Pharmaceuticals Incorporated, 11010 Torreyana Road, San Diego, California 92121, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#95e5f0e1f0e7caf2e7fafae1f0fbfde0fce6d5e3e7e1edbbf6faf8"><span class="__cf_email__" data-cfemail="adddc8d9c8dff2cadfc2c2d9c8c3c5d8c4deeddbdfd9d583cec2c0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sabine Hadida</span> - <span class="hlFld-Affiliation affiliation">Vertex Pharmaceuticals Incorporated, 11010 Torreyana Road, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fredrick Van Goor</span> - <span class="hlFld-Affiliation affiliation">Vertex Pharmaceuticals Incorporated, 11010 Torreyana Road, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinglan Zhou</span> - <span class="hlFld-Affiliation affiliation">Vertex Pharmaceuticals Incorporated, 11010 Torreyana Road, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vijayalaksmi Arumugam</span> - <span class="hlFld-Affiliation affiliation">Vertex Pharmaceuticals Incorporated, 11010 Torreyana Road, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason McCartney</span> - <span class="hlFld-Affiliation affiliation">Vertex Pharmaceuticals Incorporated, 11010 Torreyana Road, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Hazlewood</span> - <span class="hlFld-Affiliation affiliation">Vertex Pharmaceuticals Incorporated, 11010 Torreyana Road, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caroline Decker</span> - <span class="hlFld-Affiliation affiliation">Vertex Pharmaceuticals Incorporated, 11010 Torreyana Road, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Negulescu</span> - <span class="hlFld-Affiliation affiliation">Vertex Pharmaceuticals Incorporated, 11010 Torreyana Road, San Diego, California 92121, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2603e8218-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i116">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Bill Burton, Dong Cao, Amy Turnbull, Ashvani Singh, Jennifer Yang, Chris Young, Roger Tung, Eric Olson, Melissa Ashlock, John Chabala, and Eric Gordon for their contributions and collaboration. The work described in here was supported by Cystic Fibrosis Foundation Therapeutics.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i117" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i117"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i118" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i118"> Abbreviations Used</h2><tr><td class="NLM_term">AUC<sub>0–∞</sub></td><td class="NLM_def"><p class="first last">area under the plasma concentration–time curve from zero to infinite time</p></td></tr><tr><td class="NLM_term">CF</td><td class="NLM_def"><p class="first last">cystic fibrosis</p></td></tr><tr><td class="NLM_term">CFTR</td><td class="NLM_def"><p class="first last">cystic fibrosis transmembrane conductance regulator</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">F508del</td><td class="NLM_def"><p class="first last">deletion of Phe 508</p></td></tr><tr><td class="NLM_term">G551D</td><td class="NLM_def"><p class="first last">mutation of Gly 551 into Asp</p></td></tr><tr><td class="NLM_term">GABA<sub>A</sub></td><td class="NLM_def"><p class="first last">class A of the γ-aminobutyric acid receptors</p></td></tr><tr><td class="NLM_term">HBE</td><td class="NLM_def"><p class="first last">human bronchial epithelia</p></td></tr><tr><td class="NLM_term">ISC</td><td class="NLM_def"><p class="first last">short-circuit current</p></td></tr><tr><td class="NLM_term">LLOQ</td><td class="NLM_def"><p class="first last">lowest limit of quantitation</p></td></tr><tr><td class="NLM_term">NIH-3T3</td><td class="NLM_def"><p class="first last">National Institutes of Health 3T3 cells</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>o</sub></td><td class="NLM_def"><p class="first last">open probability</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">steady state volume of distribution</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i119">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05086" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05086" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 42 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>Cystic Fibrosis Foundation: <a href="http://www.cff.org/" class="extLink">http://www.cff.org/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cystic+Fibrosis+Foundation%3A+http%3A%2F%2Fwww.cff.org%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Welsh, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. E.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1016%2F0092-8674%2893%2990353-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=7686820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADyaK3sXkvFant70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1993&pages=1251-1254&author=M.+J.+Welshauthor=A.+E.+Smith&title=Molecular+mechanisms+of+CFTR+chloride+channel+dysfunction+in+cystic+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis</span></div><div class="casAuthors">Welsh, Michael J.; Smith, Alan E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1251-4</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">A review with 24 refs. on mol. mechanisms by which cystic fibrosis-assocd. mutations cause a loss of CFTR chloride channel function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbYfixTm46m7Vg90H21EOLACvtfcHk0liy97bT_mcRAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvFant70%253D&md5=a04cd81e1e4e5060cd4c94e66af7598d</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2893%2990353-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252893%252990353-R%26sid%3Dliteratum%253Aachs%26aulast%3DWelsh%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DA.%2BE.%26atitle%3DMolecular%2520mechanisms%2520of%2520CFTR%2520chloride%2520channel%2520dysfunction%2520in%2520cystic%2520fibrosis%26jtitle%3DCell%26date%3D1993%26volume%3D73%26spage%3D1251%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rowe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorscher, E. J.</span><span> </span><span class="NLM_article-title">Cystic Fibrosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">1992</span><span class="NLM_x">–</span> <span class="NLM_lpage">2001</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1056%2FNEJMra043184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=15888700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFyrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1992-2001&author=S.+M.+Roweauthor=S.+Millerauthor=E.+J.+Sorscher&title=Cystic+Fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Cystic fibrosis</span></div><div class="casAuthors">Rowe, Steven M.; Miller, Stacey; Sorscher, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1992-2001</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  Important advances have improved our understanding of the role of the CFTR protein in the progression of suppurative pulmonary failure in cystic fibrosis.  These discoveries are ushering in a new era of translational research that incorporates specific therapeutic targets and new cellular pathways.  Progress in research on cystic fibrosis will continue to rely on an improved understanding of CFTR function and its relationship to mucociliary clearance, airway secretion, and other ion channels.  Clin. advances directed at the correction of CFTR function predict an optimistic future for patients with cystic fibrosis and their families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKiiafli4tp7Vg90H21EOLACvtfcHk0liy97bT_mcRAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFyrtLY%253D&md5=e6bc05b49d7b177d43dd7592ad63f0fb</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1056%2FNEJMra043184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra043184%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DS.%2BM.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DSorscher%26aufirst%3DE.%2BJ.%26atitle%3DCystic%2520Fibrosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1992%26epage%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">O’Sullivan, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. D.</span><span> </span><span class="NLM_article-title">Cystic fibrosis</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">1891</span><span class="NLM_x">–</span> <span class="NLM_lpage">1904</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2009&pages=1891-1904&author=B.+P.+O%E2%80%99Sullivanauthor=S.+D.+Freedman&title=Cystic+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DB.%2BP.%26aulast%3DFreedman%26aufirst%3DS.%2BD.%26atitle%3DCystic%2520fibrosis%26jtitle%3DLancet%26date%3D2009%26volume%3D373%26spage%3D1891%26epage%3D1904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Boyle, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBoeck, K.</span><span> </span><span class="NLM_article-title">A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect</span> <span class="citation_source-journal">Lancet Respir. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1016%2FS2213-2600%2812%2970057-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=158-163&author=M.+P.+Boyleauthor=K.+DeBoeck&title=A+new+era+in+the+treatment+of+cystic+fibrosis%3A+correction+of+the+underlying+CFTR+defect"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1016%2FS2213-2600%2812%2970057-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS2213-2600%252812%252970057-7%26sid%3Dliteratum%253Aachs%26aulast%3DBoyle%26aufirst%3DM.%2BP.%26aulast%3DDeBoeck%26aufirst%3DK.%26atitle%3DA%2520new%2520era%2520in%2520the%2520treatment%2520of%2520cystic%2520fibrosis%253A%2520correction%2520of%2520the%2520underlying%2520CFTR%2520defect%26jtitle%3DLancet%2520Respir.%2520Med.%26date%3D2013%26volume%3D12%26spage%3D158%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Rowe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clancy, J. P.</span><span> </span><span class="NLM_article-title">Advances in cystic fibrosis therapies</span> <span class="citation_source-journal">Curr. Opin. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">604</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1097%2FMOP.0b013e3280109b90" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=17099358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A280%3ADC%252BD28nmt1Cktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=604-613&author=S.+M.+Roweauthor=J.+P.+Clancy&title=Advances+in+cystic+fibrosis+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in cystic fibrosis therapies</span></div><div class="casAuthors">Rowe Steven M; Clancy John P</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in pediatrics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">604-13</span>
        ISSN:<span class="NLM_cas:issn">1040-8703</span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Over the past four decades, outcomes for patients with cystic fibrosis have improved dramatically.  Major contributors to this improvement are a better understanding of disease pathogenesis and the systematic conduct of clinical trials evaluating new therapies designed to address these defects.  This review describes recent developments in cystic fibrosis pulmonary therapies intended to treat various facets of the disease, including several treatments currently in development.  RECENT FINDINGS:  The mainstays of therapy for cystic fibrosis, such as nutritional support and mechanical mucus clearance, are now supplemented with aggressive antibiotic regimens intended to suppress or eradicate bacterial colonization, anti-inflammatory agents, and new approaches that improve mucociliary clearance.  Therapies in development address the underlying ion transport defect found in cystic fibrosis airways and also include small-molecule agents that restore function to the mutant cystic fibrosis transmembrane conductance regulator.  SUMMARY:  Recent advances in therapies for cystic fibrosis offer the promise of improved outcomes and longer lives for patients with cystic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDX7KjsEQJ0nwOGIfWJ7-GfW6udTcc2ebDkVmdkp3Szbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nmt1Cktw%253D%253D&md5=a46bb8048fca7651d5f8ece637031e81</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2FMOP.0b013e3280109b90&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMOP.0b013e3280109b90%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DS.%2BM.%26aulast%3DClancy%26aufirst%3DJ.%2BP.%26atitle%3DAdvances%2520in%2520cystic%2520fibrosis%2520therapies%26jtitle%3DCurr.%2520Opin.%2520Pediatr.%26date%3D2006%26volume%3D18%26spage%3D604%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Van Goor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P. D. J.</span><span> </span><span class="NLM_article-title">Pharmacological rescue of mutant CFTR function for the treatment of cystic fibrosis</span> <span class="citation_source-journal">Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1007%2F7355_2008_022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=91-120&author=F.+Van+Goorauthor=S.+Hadidaauthor=P.+D.+J.+Grootenhuis&title=Pharmacological+rescue+of+mutant+CFTR+function+for+the+treatment+of+cystic+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2F7355_2008_022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F7355_2008_022%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DHadida%26aufirst%3DS.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%2BJ.%26atitle%3DPharmacological%2520rescue%2520of%2520mutant%2520CFTR%2520function%2520for%2520the%2520treatment%2520of%2520cystic%2520fibrosis%26jtitle%3DTop.%2520Med.%2520Chem.%26date%3D2008%26volume%3D3%26spage%3D91%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hadida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P. D. J.</span><span> </span><span class="NLM_article-title">CFTR modulators for the treatment of cystic fibrosis</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=157-173&author=S.+Hadidaauthor=F.+Van+Goorauthor=P.+D.+J.+Grootenhuis&title=CFTR+modulators+for+the+treatment+of+cystic+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHadida%26aufirst%3DS.%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%2BJ.%26atitle%3DCFTR%2520modulators%2520for%2520the%2520treatment%2520of%2520cystic%2520fibrosis%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D157%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pedemonte, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zegarra-Moran, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galietta, L. J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkman, A. S.</span><span> </span><span class="NLM_article-title">Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">2564</span><span class="NLM_x">–</span> <span class="NLM_lpage">2571</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1172%2FJCI24898" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=16127463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVSjs7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=2564-2571&author=N.+Pedemonteauthor=G.+L.+Lukacsauthor=K.+Duauthor=E.+Caciauthor=O.+Zegarra-Moranauthor=L.+J.+V.+Galiettaauthor=A.+S.+Verkman&title=Small-molecule+correctors+of+defective+DeltaF508-CFTR+cellular+processing+identified+by+high-throughput+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening</span></div><div class="casAuthors">Pedemonte, Nicoletta; Lukacs, Gergely L.; Du, Kai; Caci, Emanuela; Zegarra-Moran, Olga; Galietta, Luis J. V.; Verkman, A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2564-2571</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">The most common cause of cystic fibrosis (CF) is deletion of phenylalanine 508 (ΔF508) in the CF transmembrane conductance regulator (CFTR) chloride channel.  The ΔF508 mutation produces defects in folding, stability, and channel gating.  To identify small-mol. correctors of defective cellular processing, the authors assayed iodide flux in ΔF508-CFTR-transfected epithelial cells using a fluorescent halide indicator.  Screening of 150,000 chem. diverse compds. and more than 1500 analogs of active compds. yielded several classes of ΔF508-CFTR correctors (aminoarylthiazoles, quinazolinylaminopyrimidinones, and bisaminomethylbithiazoles) with micromolar potency that produced greater apical membrane chloride current than did low-temp. rescue.  Correction was seen within 3-6 h and persisted for more than 12 h after washout.  Functional correction was correlated with plasma membrane expression of complex-glycosylated ΔF508-CFTR protein.  Biochem. studies suggested a mechanism of action involving improved ΔF508-CFTR folding at the ER and stability at the cell surface.  The bisaminomethylbithiazoles cor. ΔF508-CFTR in ΔF508/ΔF508 human bronchial epithelia but did not correct a different temp.-sensitive CFTR mutant (P574H-CFTR) or a dopamine receptor mutant.  Small-mol. correctors may be useful in the treatment of CF caused by the ΔF508 mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0JvKffZOaLbVg90H21EOLACvtfcHk0lgFHqEaeKoiHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVSjs7%252FN&md5=514c68e675dd7a127e7fbe763cd9c4e8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1172%2FJCI24898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI24898%26sid%3Dliteratum%253Aachs%26aulast%3DPedemonte%26aufirst%3DN.%26aulast%3DLukacs%26aufirst%3DG.%2BL.%26aulast%3DDu%26aufirst%3DK.%26aulast%3DCaci%26aufirst%3DE.%26aulast%3DZegarra-Moran%26aufirst%3DO.%26aulast%3DGalietta%26aufirst%3DL.%2BJ.%2BV.%26aulast%3DVerkman%26aufirst%3DA.%2BS.%26atitle%3DSmall-molecule%2520correctors%2520of%2520defective%2520DeltaF508-CFTR%2520cellular%2520processing%2520identified%2520by%2520high-throughput%2520screening%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D2564%26epage%3D2571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naren, A. P.</span><span> </span><span class="NLM_article-title">Recent advance and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.4155%2Ffmc.12.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlGkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=329-345&author=W.+Zhangauthor=N.+Fujiiauthor=A.+P.+Naren&title=Recent+advance+and+new+perspectives+in+targeting+CFTR+for+therapy+of+cystic+fibrosis+and+enterotoxin-induced+secretory+diarrheas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas</span></div><div class="casAuthors">Zhang, Weiqiang; Fujii, Naoaki; Naren, Anjaparavanda P.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-345</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated chloride channel localized primarily at the apical surfaces of epithelial cells lining airway, gut, and exocrine glands, where it is responsible for transepithelial salt and water transport.  Several human diseases are assocd. with an altered channel function of CFTR.  Cystic fibrosis (CF) is caused by the loss or dysfunction of CFTR-channel activity resulting from the mutations on the gene; whereas enterotoxin-induced secretory diarrheas are caused by the hyperactivation of CFTR channel function.  CFTR is a validated target for drug development to treat these diseases.  Significant progress was made in developing CFTR modulator therapy by high-throughput screening followed by hit-to-lead optimization.  Several oral administrated investigational drugs are currently being evaluated in clin. trials for CF.  Also importantly, new ideas and methodologies are emerging.  Targeting CFTR-contg. macromol. complexes is one such novel approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFOzCPzfAWhLVg90H21EOLACvtfcHk0lgFHqEaeKoiHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlGkt7k%253D&md5=e30c647656b9e188a2cbfbc3b9e51c27</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.1%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DNaren%26aufirst%3DA.%2BP.%26atitle%3DRecent%2520advance%2520and%2520new%2520perspectives%2520in%2520targeting%2520CFTR%2520for%2520therapy%2520of%2520cystic%2520fibrosis%2520and%2520enterotoxin-induced%2520secretory%2520diarrheas%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D329%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Merk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz</span><span> </span><span class="NLM_article-title">Repairing mutated proteins—development of small molecules targeting defects in the cystic fibrosis transmembrane conductance regulator</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=691-708&author=D.+Merkauthor=+Schubert-Zsilavecz&title=Repairing+mutated+proteins%E2%80%94development+of+small+molecules+targeting+defects+in+the+cystic+fibrosis+transmembrane+conductance+regulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerk%26aufirst%3DD.%26aulast%3DSchubert-Zsilavecz%26atitle%3DRepairing%2520mutated%2520proteins%25E2%2580%2594development%2520of%2520small%2520molecules%2520targeting%2520defects%2520in%2520the%2520cystic%2520fibrosis%2520transmembrane%2520conductance%2520regulator%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26spage%3D691%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Van Goor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straley, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazlewood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchenco, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negulescu, P.</span><span> </span><span class="NLM_article-title">Rescue of ΔF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules</span> <span class="citation_source-journal">Am. J. Physiol.: Lung Cell. Mol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">L1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">L1130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2006&pages=L1117-L1130&author=F.+Van+Goorauthor=K.+S.+Straleyauthor=D.+Caoauthor=J.+Gonzalezauthor=S.+Hadidaauthor=A.+Hazlewoodauthor=J.+Joubranauthor=T.+Knappauthor=M.+Millerauthor=T.+Neubergerauthor=E.+Olsonauthor=V.+Panchencoauthor=J.+Raderauthor=A.+Singhauthor=J.+H.+Stackauthor=R.+Tungauthor=P.+D.+J.+Grootenhuisauthor=P.+Negulescu&title=Rescue+of+%CE%94F508-CFTR+trafficking+and+gating+in+human+cystic+fibrosis+airway+primary+cultures+by+small+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DHadida%26aufirst%3DS.%26aulast%3DHazlewood%26aufirst%3DA.%26aulast%3DJoubran%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DNeuberger%26aufirst%3DT.%26aulast%3DOlson%26aufirst%3DE.%26aulast%3DPanchenco%26aufirst%3DV.%26aulast%3DRader%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DStack%26aufirst%3DJ.%2BH.%26aulast%3DTung%26aufirst%3DR.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%2BJ.%26aulast%3DNegulescu%26aufirst%3DP.%26atitle%3DRescue%2520of%2520%25CE%2594F508-CFTR%2520trafficking%2520and%2520gating%2520in%2520human%2520cystic%2520fibrosis%2520airway%2520primary%2520cultures%2520by%2520small%2520molecules%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Lung%2520Cell.%2520Mol.%2520Physiol.%26date%3D2006%26volume%3D290%26spage%3DL1117%26epage%3DL1130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Zegarra-Moran, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteverde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galietta, L. J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, O.</span><span> </span><span class="NLM_article-title">functional analysis of mutations in the putative binding site for cystic fibrosis transmembrane conductance regulator potentiators: interaction between activation and inhibition</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">9098</span><span class="NLM_x">–</span> <span class="NLM_lpage">9104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=9098-9104&author=O.+Zegarra-Moranauthor=M.+Monteverdeauthor=L.+J.+V.+Galiettaauthor=O.+Moran&title=functional+analysis+of+mutations+in+the+putative+binding+site+for+cystic+fibrosis+transmembrane+conductance+regulator+potentiators%3A+interaction+between+activation+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZegarra-Moran%26aufirst%3DO.%26aulast%3DMonteverde%26aufirst%3DM.%26aulast%3DGalietta%26aufirst%3DL.%2BJ.%2BV.%26aulast%3DMoran%26aufirst%3DO.%26atitle%3Dfunctional%2520analysis%2520of%2520mutations%2520in%2520the%2520putative%2520binding%2520site%2520for%2520cystic%2520fibrosis%2520transmembrane%2520conductance%2520regulator%2520potentiators%253A%2520interaction%2520between%2520activation%2520and%2520inhibition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D9098%26epage%3D9104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Pedemonte, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonawane, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zegarra-Moran, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suen, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicus, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willenbring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantz, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurth, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galietta, L. J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkman, A. S.</span><span> </span><span class="NLM_article-title">Phenylglycine and sulfonamide correctors of defective ΔF508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1797</span><span class="NLM_x">–</span> <span class="NLM_lpage">1807</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=1797-1807&author=N.+Pedemonteauthor=N.+D.+Sonawaneauthor=A.+Taddeiauthor=J.+Huauthor=O.+Zegarra-Moranauthor=Y.+T.+Suenauthor=L.+I.+Robinsauthor=C.+W.+Dicusauthor=D.+Willenbringauthor=M.+H.+Nantzauthor=M.+J.+Kurthauthor=L.+J.+V.+Galiettaauthor=A.+S.+Verkman&title=Phenylglycine+and+sulfonamide+correctors+of+defective+%CE%94F508+and+G551D+cystic+fibrosis+transmembrane+conductance+regulator+chloride-channel+gating"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPedemonte%26aufirst%3DN.%26aulast%3DSonawane%26aufirst%3DN.%2BD.%26aulast%3DTaddei%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DZegarra-Moran%26aufirst%3DO.%26aulast%3DSuen%26aufirst%3DY.%2BT.%26aulast%3DRobins%26aufirst%3DL.%2BI.%26aulast%3DDicus%26aufirst%3DC.%2BW.%26aulast%3DWillenbring%26aufirst%3DD.%26aulast%3DNantz%26aufirst%3DM.%2BH.%26aulast%3DKurth%26aufirst%3DM.%2BJ.%26aulast%3DGalietta%26aufirst%3DL.%2BJ.%2BV.%26aulast%3DVerkman%26aufirst%3DA.%2BS.%26atitle%3DPhenylglycine%2520and%2520sulfonamide%2520correctors%2520of%2520defective%2520%25CE%2594F508%2520and%2520G551D%2520cystic%2520fibrosis%2520transmembrane%2520conductance%2520regulator%2520chloride-channel%2520gating%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D67%26spage%3D1797%26epage%3D1807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Van Goor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazlewood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCartney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arumugam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frizzell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashlock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negulescu, P.</span><span> </span><span class="NLM_article-title">Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">18825</span><span class="NLM_x">–</span> <span class="NLM_lpage">18830</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1073%2Fpnas.0904709106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=19846789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKmsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=18825-18830&author=F.+Van+Goorauthor=S.+Hadidaauthor=P.+D.+J.+Grootenhuisauthor=B.+Burtonauthor=D.+Caoauthor=T.+Neubergerauthor=A.+Turnbullauthor=A.+Singhauthor=J.+Joubranauthor=A.+Hazlewoodauthor=J.+Zhouauthor=J.+McCartneyauthor=V.+Arumugamauthor=C.+Deckerauthor=J.+Yangauthor=C.+Youngauthor=E.+R.+Olsonauthor=J.+Wineauthor=R.+A.+Frizzellauthor=M.+Ashlockauthor=P.+Negulescu&title=Rescue+of+CF+airway+epithelial+cell+function+in+vitro+by+a+CFTR+potentiator%2C+VX-770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770</span></div><div class="casAuthors">Van Goor, Fredrick; Hadida, Sabine; Grootenhuis, Peter D. J.; Burton, Bill; Cao, Dong; Neuberger, Tim; Turnbull, Amanda; Singh, Ashvani; Joubran, John; Hazlewood, Anna; Zhou, Jinglan; McCartney, Jason; Arumugam, Vijayalaksmi; Decker, Caroline; Yang, Jennifer; Young, Chris; Olson, Eric R.; Wine, Jeffrey J.; Frizzell, Raymond A.; Ashlock, Melissa; Negulescu, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">18825-18830, S18825/1-S18825/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cystic fibrosis (CF) is a fatal genetic disease caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR), a protein kinase A (PKA)-activated epithelial anion channel involved in salt and fluid transport in multiple organs, including the lung.  Most CF mutations either reduce the no. of CFTR channels at the cell surface (e.g., synthesis or processing mutations) or impair channel function (e.g., gating or conductance mutations) or both.  There are currently no approved therapies that target CFTR.  Here we describe the in vitro pharmacol. of VX-770, an orally bioavailable CFTR potentiator in clin. development for the treatment of CF.  In recombinant cells VX-770 increased CFTR channel open probability (Po) in both the F508del processing mutation and the G551D gating mutation.  VX-770 also increased Cl- secretion in cultured human CF bronchial epithelia (HBE) carrying the G551D gating mutation on one allele and the F508del processing mutation on the other allele by ≈ 10-fold, to ≈ 50% of that obsd. in HBE isolated from individuals without CF.  Furthermore, VX-770 reduced excessive Na+ and fluid absorption to prevent dehydration of the apical surface and increased cilia, beating in these epithelial cultures.  These results support the hypothesis that pharmacol. agents that restore or increase CFTR function can rescue epithelial cell function in human CF airway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo89BTNOARZ5bVg90H21EOLACvtfcHk0ljL16hhvwEFPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKmsLrI&md5=786c6c860d90115c29863a706f0e1248</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0904709106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0904709106%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DHadida%26aufirst%3DS.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%2BJ.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DNeuberger%26aufirst%3DT.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DJoubran%26aufirst%3DJ.%26aulast%3DHazlewood%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DMcCartney%26aufirst%3DJ.%26aulast%3DArumugam%26aufirst%3DV.%26aulast%3DDecker%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DOlson%26aufirst%3DE.%2BR.%26aulast%3DWine%26aufirst%3DJ.%26aulast%3DFrizzell%26aufirst%3DR.%2BA.%26aulast%3DAshlock%26aufirst%3DM.%26aulast%3DNegulescu%26aufirst%3DP.%26atitle%3DRescue%2520of%2520CF%2520airway%2520epithelial%2520cell%2520function%2520in%2520vitro%2520by%2520a%2520CFTR%2520potentiator%252C%2520VX-770%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D18825%26epage%3D18830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Accurso, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clancy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunitz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durie, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagel, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornick, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konstan, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donalson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilewski, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubenstein, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uluer, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aitken, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer-Hamblett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ordoñez, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashlock, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey, B. W.</span><span> </span><span class="NLM_article-title">Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1991</span><span class="NLM_x">–</span> <span class="NLM_lpage">2003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1056%2FNEJMoa0909825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=21083385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVykt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1991-2003&author=F.+J.+Accursoauthor=S.+M.+Roweauthor=J.+P.+Clancyauthor=M.+P.+Boyleauthor=J.+M.+Dunitzauthor=P.+R.+Durieauthor=S.+D.+Sagelauthor=D.+B.+Hornickauthor=M.+W.+Konstanauthor=S.+H.+Donalsonauthor=R.+B.+Mossauthor=J.+M.+Pilewskiauthor=R.+C.+Rubensteinauthor=A.+Z.+Uluerauthor=M.+L.+Aitkenauthor=S.+D.+Freedmanauthor=M.+R.+Lynnauthor=N.+Mayer-Hamblettauthor=Q.+Dongauthor=J.+Zhaauthor=A.+J.+Stoneauthor=E.+R.+Olsonauthor=C.+L.+Ordo%C3%B1ezauthor=P.+W.+Campbellauthor=M.+A.+Ashlockauthor=B.+W.+Ramsey&title=Effect+of+VX-770+in+persons+with+cystic+fibrosis+and+the+G551D-CFTR+mutation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation</span></div><div class="casAuthors">Accurso, Frank J.; Rowe, Steven M.; Clancy, J. P.; Boyle, Michael P.; Dunitz, Jordan M.; Durie, Peter R.; Sagel, Scott D.; Hornick, Douglas B.; Konstan, Michael W.; Donaldson, Scott H.; Moss, Richard B.; Pilewski, Joseph M.; Rubenstein, Ronald C.; Uluer, Ahmet Z.; Aitken, Moira L.; Freedman, Steven D.; Rose, Lynn M.; Mayer-Hamblett, Nicole; Dong, Qunming; Zha, Jiuhong; Stone, Annej.; Olson, Eric R.; Ordonez, Claudia L.; Campbell, Preston W.; Ashlock, Melissa A.; Ramsey, Bonnie W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1991-2003</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND A new approach in the treatment of cystic fibrosis involves improving the function of mutant cystic fibrosis transmembrane conductance regulator (CFTR).  VX-770, a CFTR potentiator, has been shown to increase the activity of wild-type and defective cell-surface CFTR in vitro.  METHODS We randomly assigned 39 adults with cystic fibrosis and at least one G551D-CFTR allele to receive oral VX-770 every 12 h at a dose of 25, 75, or 150 mg or placebo for 14 days (in part 1 of the study) or VX-770 every 12 h at a dose of 150 or 250 mg or placebo for 28 days (in part 2 of the study).  RESULTS At day 28, in the group of subjects who received 150 mg of VX-770, the median change in the nasal p.d. (in response to the administration of a chloride-free isoproterenol soln.) from baseline was -3.5 mV (range, -8.3 to 0.5; P = 0.02 for the within-subject comparison, P = 0.13 vs. placebo), and the median change in the level of sweat chloride was -59.5 mmol per L (range, -66.0 to -19.0; P = 0.008 within-subject, P = 0.02 vs. placebo).  The median change from baseline in the percent of predicted forced expiratory vol. in 1 s was 8.7% (range, 2.3 to 31.3; P = 0.008 for the within-subject comparison, P = 0.56 vs. placebo).  None of the subjects withdrew from the study.  Six severe adverse events occurred in two subjects (diffuse macular rash in one subject and five incidents of elevated blood and urine glucose levels in one subject with diabetes).  All severe adverse events resolved without the discontinuation of VX-770.  CONCLUSIONS This study to evaluate the safety and adverse-event profile of VX-770 showed that VX-770 was assocd. with within-subject improvements in CFTR and lung function.  These findings provide support for further studies of pharmacol. potentiation of CFTR as a means to treat cystic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiAWkJr_XSVrVg90H21EOLACvtfcHk0liDdg2Y6EJGqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVykt7jO&md5=35cd4c36f7676daec0f318e74abd25fa</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0909825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0909825%26sid%3Dliteratum%253Aachs%26aulast%3DAccurso%26aufirst%3DF.%2BJ.%26aulast%3DRowe%26aufirst%3DS.%2BM.%26aulast%3DClancy%26aufirst%3DJ.%2BP.%26aulast%3DBoyle%26aufirst%3DM.%2BP.%26aulast%3DDunitz%26aufirst%3DJ.%2BM.%26aulast%3DDurie%26aufirst%3DP.%2BR.%26aulast%3DSagel%26aufirst%3DS.%2BD.%26aulast%3DHornick%26aufirst%3DD.%2BB.%26aulast%3DKonstan%26aufirst%3DM.%2BW.%26aulast%3DDonalson%26aufirst%3DS.%2BH.%26aulast%3DMoss%26aufirst%3DR.%2BB.%26aulast%3DPilewski%26aufirst%3DJ.%2BM.%26aulast%3DRubenstein%26aufirst%3DR.%2BC.%26aulast%3DUluer%26aufirst%3DA.%2BZ.%26aulast%3DAitken%26aufirst%3DM.%2BL.%26aulast%3DFreedman%26aufirst%3DS.%2BD.%26aulast%3DLynn%26aufirst%3DM.%2BR.%26aulast%3DMayer-Hamblett%26aufirst%3DN.%26aulast%3DDong%26aufirst%3DQ.%26aulast%3DZha%26aufirst%3DJ.%26aulast%3DStone%26aufirst%3DA.%2BJ.%26aulast%3DOlson%26aufirst%3DE.%2BR.%26aulast%3DOrdo%25C3%25B1ez%26aufirst%3DC.%2BL.%26aulast%3DCampbell%26aufirst%3DP.%2BW.%26aulast%3DAshlock%26aufirst%3DM.%2BA.%26aulast%3DRamsey%26aufirst%3DB.%2BW.%26atitle%3DEffect%2520of%2520VX-770%2520in%2520persons%2520with%2520cystic%2520fibrosis%2520and%2520the%2520G551D-CFTR%2520mutation%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D1991%26epage%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ramsey, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElvaney, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tullis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dřevı́nek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKone, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainwright, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konstan, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratjen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sermet-Gaudelus, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ordoñez, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elborn, J. S.</span><span> </span><span class="NLM_article-title">A CFTR potentiator in patients with cystic fibrosis and the G551D mutation</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">1663</span><span class="NLM_x">–</span> <span class="NLM_lpage">1672</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1056%2FNEJMoa1105185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=22047557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWqtbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2011&pages=1663-1672&author=B.+W.+Ramseyauthor=J.+Daviesauthor=N.+G.+McElvaneyauthor=E.+Tullisauthor=S.+C.+Bellauthor=P.+D%C5%99ev%C4%B1%CC%81nekauthor=M.+Grieseauthor=E.+F.+McKoneauthor=C.+E.+Wainwrightauthor=M.+W.+Konstanauthor=R.+Mossauthor=F.+Ratjenauthor=I.+Sermet-Gaudelusauthor=S.+M.+Roweauthor=Q.+Dongauthor=S.+Rodriguezauthor=K.+Yenauthor=C.+L.+Ordo%C3%B1ezauthor=J.+S.+Elborn&title=A+CFTR+potentiator+in+patients+with+cystic+fibrosis+and+the+G551D+mutation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A CFTR potentiator in patients with cystic fibrosis and the G551D mutation</span></div><div class="casAuthors">Ramsey, Bonnie W.; Davis, Jane; McElvaney, Gerard; Tullis, Elizabeth; Bell, Scott C.; Dievinek, Pavel; Griese, Matthias; McKone, Edward F.; Wainwright, Claire E.; Konstan, Michael W.; Moss, Richard; Ratjen, Felix; Sermet-Gaudelus, Isabelle; Rowe, Steven M.; Dong, Qunming; Rodriguez, Sally; Yen, Karl; Ordonez, Claudia; Elborn, J. Stuart</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1663-1672</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Increasing the activity of defective cystic fibrosis transmembrane conductance regulator (CFTR) protein is a potential treatment for cystic fibrosis.  METHODS: We conducted a randomized, double-blind, placebo-controlled trial to evaluate ivacaftor (VX-770), a CFTR potentiator, in subjects 12 years of age or older with cystic fibrosis and at least one G551D-CFTR mutation.  Subjects were randomly assigned to receive 150 mg of ivacaftor every 12 h (84 subjects, of whom 83 received at least one dose) or placebo (83, of whom 78 received at least one dose) for 48 wk.  The primary end point was the estd. mean change from baseline through week 24 in the percent of predicted forced expiratory vol. in 1 s (FEV1).  RESULTS: The change from baseline through week 24 in the percent of predicted FEV1 was greater by 10.6 percentage points in the ivacaftor group than in the placebo group (P < 0.001).  Effects on pulmonary function were noted by 2 wk, and a significant treatment effect was maintained through week 48.  Subjects receiving ivacaftor were 55% less likely to have a pulmonary exacerbation than were patients receiving placebo, through week 48 (P < 0.001).  In addn., through week 48, subjects in the ivacaftor group scored 8.6 points higher than did subjects in the placebo group on the respiratory-symptoms domain of the Cystic Fibrosis Questionnaire-revised instrument (a 100-point scale, with higher nos. indicating a lower effect of symptoms on the patient's quality of life) (P < 0.001).  By 48 wk, patients treated with ivacaftor had gained, on av., 2.7 kg more wt. than had patients receiving placebo (P < 0.001).  The change from baseline through week 48 in the concn. of sweat chloride, a measure of CFTR activity, with ivacaftor as compared with placebo was -48.1 mmol per L (P < 0.001).  The incidence of adverse events was similar with ivacaftor and placebo, with a lower proportion of serious adverse events with ivacaftor than with placebo (24% vs. 42%).  CONCLUSIONS: Ivacaftor was assocd. with improvements in lung function at 2 wk that were sustained through 48 wk.  Substantial improvements were also obsd. in the risk of pulmonary exacerbations, patient-reported respiratory symptoms, wt., and concn. of sweat chloride.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-6U5nty7i_rVg90H21EOLACvtfcHk0liDdg2Y6EJGqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWqtbbE&md5=c9f4abffc063d6269677eb32dc9a83e8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1105185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1105185%26sid%3Dliteratum%253Aachs%26aulast%3DRamsey%26aufirst%3DB.%2BW.%26aulast%3DDavies%26aufirst%3DJ.%26aulast%3DMcElvaney%26aufirst%3DN.%2BG.%26aulast%3DTullis%26aufirst%3DE.%26aulast%3DBell%26aufirst%3DS.%2BC.%26aulast%3DD%25C5%2599ev%25C4%25B1%25CC%2581nek%26aufirst%3DP.%26aulast%3DGriese%26aufirst%3DM.%26aulast%3DMcKone%26aufirst%3DE.%2BF.%26aulast%3DWainwright%26aufirst%3DC.%2BE.%26aulast%3DKonstan%26aufirst%3DM.%2BW.%26aulast%3DMoss%26aufirst%3DR.%26aulast%3DRatjen%26aufirst%3DF.%26aulast%3DSermet-Gaudelus%26aufirst%3DI.%26aulast%3DRowe%26aufirst%3DS.%2BM.%26aulast%3DDong%26aufirst%3DQ.%26aulast%3DRodriguez%26aufirst%3DS.%26aulast%3DYen%26aufirst%3DK.%26aulast%3DOrdo%25C3%25B1ez%26aufirst%3DC.%2BL.%26aulast%3DElborn%26aufirst%3DJ.%2BS.%26atitle%3DA%2520CFTR%2520potentiator%2520in%2520patients%2520with%2520cystic%2520fibrosis%2520and%2520the%2520G551D%2520mutation%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D365%26spage%3D1663%26epage%3D1672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span>U.S. Food and Drug Administration: <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="9cd8eee9fbefdcdad8dd">[email protected]</a>, FDA Approved Drug Products. <a href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203188s007lbl.pdf" class="extLink">http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203188s007lbl.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=U.S.+Food+and+Drug+Administration%3A+Drugs%40FDA%2C+FDA+Approved+Drug+Products.+http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2014%2F203188s007lbl.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first">When compound <b>1</b> is drawn as the quinolin-4-ol, the cLogP is calculated to be 5.2, more than 2 log units higher than that of the corresponding quinolin-4(1<i>H</i>)-one. Experimental log <i>P</i> values were determined for compounds <b>16</b> and <b>45</b>. Experimental determinations were closer to the quinolin-4-ol value than the corresponding quinolin-4(1<i>H</i>)-one value. See the table below.</p><p class="last"><div class="NLM_array"><table class="array-table"><tbody><tr>compdcLogP,cLogP,exptl log P</tr><tr> quinolin-4-olquinolin-4(1H)-one </tr><tr>164.61.63.2</tr><tr>455.62.64.8</tr></tbody></table></div></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">Compounds showing less that 50% activity at 30 μM were not tested in a dose–response format; their activity is expressed as a percent response at that concentration.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span>For additional information on the GABA<sub>A</sub> binding assay at Ricerca Biosciences, see <a href="http://www.ricerca.com" class="extLink">www.ricerca.com</a>. Percent activity at 10 μM was also measured for compounds <b>36</b> (47%), <b>45</b> (52%), and <b>48</b> (18%).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+additional+information+on+the+GABAA+binding+assay+at+Ricerca+Biosciences%2C+see+www.ricerca.com.+Percent+activity+at+10+%CE%BCM+was+also+measured+for+compounds+36+%2847%25%29%2C+45+%2852%25%29%2C+and+48+%2818%25%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">Measured thermodynamic solubility of compound <b>16</b>: water, not detectable; ethanol, 1.2 mg/mL; miglyol 810, 0.057 mg/mL)</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span> Torsional potentials were evaluated using internally developed software that utilizes the Szybki Toolkit from OpenEye Scientific Software [OpenEye Scientific Software, Santa Fe, NM; <a href="http://www.eyesopen.com/products/applications/szybki.html" class="extLink">http://www.eyesopen.com/products/applications/szybki.html</a>]. Potentials were evaluated by restraining the torsion angle in question at 5° increments and energy minimizing the remainder of the molecule using the MMFF force field as reported by the following:</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Torsional+potentials+were+evaluated+using+internally+developed+software+that+utilizes+the+Szybki+Toolkit+from+OpenEye+Scientific+Software+%5BOpenEye+Scientific+Software%2C+Santa+Fe%2C+NM%3B+http%3A%2F%2Fwww.eyesopen.com%2Fproducts%2Fapplications%2Fszybki.html%5D.+Potentials+were+evaluated+by+restraining+the+torsion+angle+in+question+at+5%C2%B0+increments+and+energy+minimizing+the+remainder+of+the+molecule+using+the+MMFF+force+field+as+reported+by+the+following%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b1"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span> </span><span class="NLM_article-title">Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b1&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b1&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1996&pages=490-519&author=T.+A.+Halgren&title=Merck+molecular+force+field.+I.+Basis%2C+form%2C+scope%2C+parameterization%2C+and+performance+of+MMFF94"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19b1R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5 & 6</span>),
    <span class="NLM_cas:pages">490-519</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">This article introduces MMFF94, the initial published version of the Merck mol. force field (MMFF).  It describes the objectives set for MMFF, the form it takes, and the range of systems to which it applies.  This study also outlines the methodol. employed in parameterizing MMFF94 and summarizes its performance in reproducing computational and exptl. data.  Though similar to MM3 in some respects, MMFF94 differs in ways intended to facilitate application to condensed-phase processes in mol.-dynamics simulations.  Indeed, MMFF94 seeks to achieve MM3-like accuracy for small mols. in a combined "org./protein" force field that is equally applicable to proteins and other systems of biol. significance.  A second distinguishing feature is that the core protion of MMFF94 has primarily been derived from high-quality computational data-ca. 500 mol. structures optimized at the HF/6-31G* level, 475 structures optimized at the MP2/6-31G* level, 380 MP2/6-31* structures evaluated at a defined approxn. to the MP4SDQ/TZP level, and 1450 structures partly derived from MP2/6-31G* geometries and evaluated at the MP2/TZP level.  A third distinguishing feature is that MMFF94 has been parameterized for a wide variety of chem. systems of interest to org. and combinations of functional groups for which little, if any, useful exptl. data are available.  The methodol. used in parameterizing MMFF94 represents a fourth distinguishing feature.  Rather than using the common "functional group" approach, nearly all MMFF parameters have been detd. in a mutually consistent fashion from the full set of available computational data.  MMFF94 reproduces the computational data used in its parameterization very well.  In addn., MMFF94 reproduces exptl. bond lengths (0.014 Å root mean square [rms]), bond angles (1.2° rms), vibrational frequencies (61 cm-1 rms), conformational energies (0.38 kcal/mol rms), and rotational barriers (0.39 kcal/mol rms) very nearly as well as does MM3 for comparable systems.  MMFF94 also describes intermol. interactions in hydrogen-bonded systems in a way that closely parallels that given by the highly regarded OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAzCYfKnN83rVg90H21EOLACvtfcHk0lhfdRWiVeVTBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D&md5=56fb073477b4f49d1dfbd786fc56a480</span></div><a href="/servlet/linkout?suffix=cit19b1&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%2528199604%252917%253A5%252F6%253C490%253A%253AAID-JCC1%253E3.0.CO%253B2-P%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26atitle%3DMerck%2520molecular%2520force%2520field.%2520I.%2520Basis%252C%2520form%252C%2520scope%252C%2520parameterization%252C%2520and%2520performance%2520of%2520MMFF94%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1996%26volume%3D17%26spage%3D490%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="ref19_3"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span> </span><span class="NLM_article-title">MMFF VI. MMFF94s option for energy minimization studies</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/ref19_3&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1002%2F%28SICI%291096-987X%28199905%2920%3A7%3C720%3A%3AAID-JCC7%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/ref19_3&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVSlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=720-729&author=T.+A.+Halgren&title=MMFF+VI.+MMFF94s+option+for+energy+minimization+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref19_3R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">MMFF VI. MMFF94s option for energy minimization studies</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">720-729</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">This article describes the derivation of MMFF94s, which is the "s" (static) variant of MMFF94.  MMFF94s incorporates altered out of plane bending parameters that yield planar (or nearly planar) energy-minimized geometries at unstrained delocalized trigonal nitrogen centers.  Some exptl. and most theor. structures show appreciable puckering at nitrogen in isolated structures.  However, condensed-phase effects or even strong intermol. hydrogen bonding tends to reduce, but need not eliminate, such puckering; in contravention to results reported on the lower level Hartree-Fock surface, we show in the correlated LMP2/6-31G** calcns. for the Watson-Crick guanine-cytosine base pair that one of the hydrogen-bonded NH2 groups remains appreciably puckered.  The resultant MMFF94s geometries emulate the "time-averaged" structures typically obsd. in crystallog. and most other exptl. structure detns.  MMFF94s also employs modified torsion parameters for interactions that involve such centers, but is identical to MMFF94 for other systems.  Isolated instances are found in which MMFF94s fails to locate a (probably shallow) local min. found on the MMFF94 and ref. MP2/6-31G* surfaces.  In general, however, MMFF94s describes conformation energies for delocalized trigonal nitrogen systems nearly as well as MMFF94 does.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr9BF4aVDzDLVg90H21EOLACvtfcHk0lhfdRWiVeVTBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVSlsrc%253D&md5=bd4da8a3fed88ecf5cc27bcb0b0a3679</span></div><a href="/servlet/linkout?suffix=ref19_3&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%28199905%2920%3A7%3C720%3A%3AAID-JCC7%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%2528199905%252920%253A7%253C720%253A%253AAID-JCC7%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26atitle%3DMMFF%2520VI.%2520MMFF94s%2520option%2520for%2520energy%2520minimization%2520studies%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1999%26volume%3D20%26spage%3D720%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">The energy difference between the superimposed conformation of <b>18</b> and the solid state conformation of <b>10</b> exceeded 10 kcal/mol and can explain the reduction of activity of sulfonamide linker.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Patani, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVoie, E. J.</span><span> </span><span class="NLM_article-title">Bioisosterism: a rational approach in drug design</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3147</span><span class="NLM_x">–</span> <span class="NLM_lpage">3176</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr950066q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1996&pages=3147-3176&author=G.+A.+Pataniauthor=E.+J.+LaVoie&title=Bioisosterism%3A+a+rational+approach+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosterism: A rational approach in drug design</span></div><div class="casAuthors">Patani, George A.; LaVoie, Edmond J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3147-3176</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with 191 refs., on bioisosteres that incorporates sufficient detail to enable the reader to understand the concepts being delineated.  Classical bioisosteres, such as monovalent atoms and groups, divalent isosteres, trivalent atoms and groups, tetra substituted atoms, and ring equiv., and non-classical bioisosteres, such as cyclic vs. non-cyclic non-classical bioisosteric replacements and non-classical bioisosteric replacements of functional groups, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrADeNoRGbU9LVg90H21EOLACvtfcHk0liMkD5g-tK_3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D&md5=4b3ec55087feabc53e0490ebd5a3ddcd</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fcr950066q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr950066q%26sid%3Dliteratum%253Aachs%26aulast%3DPatani%26aufirst%3DG.%2BA.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26atitle%3DBioisosterism%253A%2520a%2520rational%2520approach%2520in%2520drug%2520design%26jtitle%3DChem.%2520Rev.%26date%3D1996%26volume%3D96%26spage%3D3147%26epage%3D3176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Asselin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humber, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, G.</span><span> </span><span class="NLM_article-title">Drug design via pharmacophore identification. Dopaminergic activity of 3<i>H</i>-benz[<i>e</i>]indol-8-amines and their mode of interaction with the dopamine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">654</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00155a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=648-654&author=A.+A.+Asselinauthor=L.+G.+Humberauthor=K.+Voithauthor=G.+Metcalf&title=Drug+design+via+pharmacophore+identification.+Dopaminergic+activity+of+3H-benz%5Be%5Dindol-8-amines+and+their+mode+of+interaction+with+the+dopamine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm00155a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00155a011%26sid%3Dliteratum%253Aachs%26aulast%3DAsselin%26aufirst%3DA.%2BA.%26aulast%3DHumber%26aufirst%3DL.%2BG.%26aulast%3DVoith%26aufirst%3DK.%26aulast%3DMetcalf%26aufirst%3DG.%26atitle%3DDrug%2520design%2520via%2520pharmacophore%2520identification.%2520Dopaminergic%2520activity%2520of%25203H-benz%255Be%255Dindol-8-amines%2520and%2520their%2520mode%2520of%2520interaction%2520with%2520the%2520dopamine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D648%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Asselin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humber, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosilla, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojdan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaslip, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimele, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, C.</span><span> </span><span class="NLM_article-title">Indole-phenol bioisosterism. Synthesis and antihypertensive activity of pyrrolo analog of labetalol</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00156a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=1009-1015&author=A.+A.+Asselinauthor=L.+G.+Humberauthor=D.+Crosillaauthor=G.+Oshiroauthor=A.+Wojdanauthor=D.+Grimesauthor=R.+J.+Heaslipauthor=T.+J.+Rimeleauthor=C.+Shaw&title=Indole-phenol+bioisosterism.+Synthesis+and+antihypertensive+activity+of+pyrrolo+analog+of+labetalol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fjm00156a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00156a019%26sid%3Dliteratum%253Aachs%26aulast%3DAsselin%26aufirst%3DA.%2BA.%26aulast%3DHumber%26aufirst%3DL.%2BG.%26aulast%3DCrosilla%26aufirst%3DD.%26aulast%3DOshiro%26aufirst%3DG.%26aulast%3DWojdan%26aufirst%3DA.%26aulast%3DGrimes%26aufirst%3DD.%26aulast%3DHeaslip%26aufirst%3DR.%2BJ.%26aulast%3DRimele%26aufirst%3DT.%2BJ.%26aulast%3DShaw%26aufirst%3DC.%26atitle%3DIndole-phenol%2520bioisosterism.%2520Synthesis%2520and%2520antihypertensive%2520activity%2520of%2520pyrrolo%2520analog%2520of%2520labetalol%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D1009%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="note"><p class="first last">Measured thermodynamic solubility of compound <b>38</b>: water, not detectable; ethanol, 5.7 mg/mL; miglyol 810, 15.2 mg/mL.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urrutia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seepersaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goor, F.</span><span> </span><span class="NLM_article-title">Ivacaftor potentiation of multiple CFTR channels with gating mutations</span> <span class="citation_source-journal">J. Cystic Fibrosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1016%2Fj.jcf.2011.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=22293084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1ektbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=237-245&author=H.+Yuauthor=B.+Burtonauthor=C.-J.+Huangauthor=J.+Worleyauthor=D.+Caoauthor=J.+P.+Johnsonauthor=A.+Urrutiaauthor=J.+Joubranauthor=S.+Seepersaudauthor=K.+Susskyauthor=B.+J.+Hoffmanauthor=F.+Van+Goor&title=Ivacaftor+potentiation+of+multiple+CFTR+channels+with+gating+mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Ivacaftor potentiation of multiple CFTR channels with gating mutations</span></div><div class="casAuthors">Yu, Haihui; Burton, Bill; Huang, Chien-Jung; Worley, Jennings; Cao, Dong; Johnson, James P., Jr.; Urrutia, Art; Joubran, John; Seepersaud, Sheila; Sussky, Katherine; Hoffman, Beth J.; Van Goor, Fredrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cystic Fibrosis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-245</span>CODEN:
                <span class="NLM_cas:coden">JCFOAC</span>;
        ISSN:<span class="NLM_cas:issn">1569-1993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background: The investigational CFTR potentiator ivacaftor (VX-770) increased CFTR channel activity and improved lung function in subjects with CF who have the G551D CFTR gating mutation.  The aim of this in vitro study was to det. whether ivacaftor potentiates mutant CFTR with gating defects caused by other CFTR gating mutations.  Methods: The effects of ivacaftor on CFTR channel open probability and chloride transport were tested in electrophysiol. studies using Fischer rat thyroid (FRT) cells expressing different CFTR gating mutations.  Results: Ivacaftor potentiated multiple mutant CFTR forms with defects in CFTR channel gating.  These included the G551D, G178R, S549N, S549R, G551S, G970R, G1244E, S1251N, S1255P and G1349D CFTR gating mutations.  Conclusion: These in vitro data suggest that ivacaftor has a similar effect on all CFTR forms with gating defects and support investigation of the potential clin. benefit of ivacaftor in CF patients who have CFTR gating mutations beyond G551D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTZOkxP_soI7Vg90H21EOLACvtfcHk0liMkD5g-tK_3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1ektbc%253D&md5=b03927bc525b3b2ac2cfece02c8b67f6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jcf.2011.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jcf.2011.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DC.-J.%26aulast%3DWorley%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DUrrutia%26aufirst%3DA.%26aulast%3DJoubran%26aufirst%3DJ.%26aulast%3DSeepersaud%26aufirst%3DS.%26aulast%3DSussky%26aufirst%3DK.%26aulast%3DHoffman%26aufirst%3DB.%2BJ.%26aulast%3DVan%2BGoor%26aufirst%3DF.%26atitle%3DIvacaftor%2520potentiation%2520of%2520multiple%2520CFTR%2520channels%2520with%2520gating%2520mutations%26jtitle%3DJ.%2520Cystic%2520Fibrosis%26date%3D2012%26volume%3D11%26spage%3D237%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Van Goor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, B. J.</span><span> </span><span class="NLM_article-title">Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function</span> <span class="citation_source-journal">J. Cystic Fibrosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1016%2Fj.jcf.2013.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=23891399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A280%3ADC%252BC3sfksFKqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=29-36&author=F.+Van+Goorauthor=H.+Yuauthor=B.+Nurtonauthor=B.+J.+Hoffman&title=Effect+of+ivacaftor+on+CFTR+forms+with+missense+mutations+associated+with+defects+in+protein+processing+or+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function</span></div><div class="casAuthors">Van Goor Fredrick; Yu Haihui; Burton Bill; Hoffman Beth J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-36</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Ivacaftor (KALYDECO®, VX-770) is a CFTR potentiator that increased CFTR channel activity and improved lung function in patients age 6 years and older with CF who have the G551D-CFTR gating mutation.  The aim of this in vitro study was to evaluate the effect of ivacaftor on mutant CFTR protein forms with defects in protein processing and/or channel function.  METHODS:  The effect of ivacaftor on CFTR function was tested in electrophysiological studies using a panel of Fischer rat thyroid (FRT) cells expressing 54 missense CFTR mutations that cause defects in the amount or function of CFTR at the cell surface.  RESULTS:  Ivacaftor potentiated multiple mutant CFTR protein forms that produce functional CFTR at the cell surface.  These included mutant CFTR forms with mild defects in CFTR processing or mild defects in CFTR channel conductance.  CONCLUSIONS:  These in vitro data indicated that ivacaftor is a broad acting CFTR potentiator and could be used to help stratify patients with CF who have different CFTR genotypes for studies investigating the potential clinical benefit of ivacaftor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEKnRMau2Mr5dYoSR9eyvsfW6udTcc2eaWNE7zrk6pfbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfksFKqtQ%253D%253D&md5=e707cbc6ade54f57820ffc358f6d79db</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.jcf.2013.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jcf.2013.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DNurton%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DB.%2BJ.%26atitle%3DEffect%2520of%2520ivacaftor%2520on%2520CFTR%2520forms%2520with%2520missense%2520mutations%2520associated%2520with%2520defects%2520in%2520protein%2520processing%2520or%2520function%26jtitle%3DJ.%2520Cystic%2520Fibrosis%26date%3D2014%26volume%3D13%26spage%3D29%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pellowska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span> </span><span class="NLM_article-title">Advances in personalized medicine—medicinal chemistry and pharmacology of vemurafenib and ivacaftor</span> <span class="citation_source-journal">Pharmazie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=484-491&author=M.+Pellowskaauthor=D.+Merkauthor=M.+Schubert-Zsilavecz&title=Advances+in+personalized+medicine%E2%80%94medicinal+chemistry+and+pharmacology+of+vemurafenib+and+ivacaftor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPellowska%26aufirst%3DM.%26aulast%3DMerk%26aufirst%3DD.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26atitle%3DAdvances%2520in%2520personalized%2520medicine%25E2%2580%2594medicinal%2520chemistry%2520and%2520pharmacology%2520of%2520vemurafenib%2520and%2520ivacaftor%26jtitle%3DPharmazie%26date%3D2013%26volume%3D68%26spage%3D484%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Milla, C. E.</span><span> </span><span class="NLM_article-title">Cystic fibrosis in the era of genomic medicine</span> <span class="citation_source-journal">Curr. Opin. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1097%2FMOP.0b013e328360dbf5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=23652683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlaiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2013&pages=323-328&author=C.+E.+Milla&title=Cystic+fibrosis+in+the+era+of+genomic+medicine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Cystic fibrosis in the era of genomic medicine</span></div><div class="casAuthors">Milla, Carlos E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pediatrics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-328</span>CODEN:
                <span class="NLM_cas:coden">COPEE9</span>;
        ISSN:<span class="NLM_cas:issn">1040-8703</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: The field of cystic fibrosis (CF) is changing dramatically as the scientific knowledge accumulated since the cloning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is being translated into effective therapies to correct the basic defect and provide better disease models and in-depth understanding of the basic mechanisms of disease.  Recent findings: This review focuses on three main aspects of the recent advances in the field: understanding the lung disease pathophysiol. (in particular, the early events that condition its onset), better definition of the complex microbiol. of the CF airway, and therapeutic developments.  Although the most recently developed therapies, whether approved or under study, do not constitute a definitive cure, the benefit to patients is already becoming clearly apparent.  Summary: As the field continues to change rapidly and new therapies are being identified, CF has become a paradigm for the application of concepts such as translational medicine, genomic medicine, and personalized care, with measurable clin. benefit for the patients affected by this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnw4RR6-jtb7Vg90H21EOLACvtfcHk0lgRxFGIf6-NOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlaiu7g%253D&md5=3c5712c30c3c932d47dba34350026e6e</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1097%2FMOP.0b013e328360dbf5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMOP.0b013e328360dbf5%26sid%3Dliteratum%253Aachs%26aulast%3DMilla%26aufirst%3DC.%2BE.%26atitle%3DCystic%2520fibrosis%2520in%2520the%2520era%2520of%2520genomic%2520medicine%26jtitle%3DCurr.%2520Opin.%2520Pediatr.%26date%3D2013%26volume%3D25%26spage%3D323%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Rommens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannuzzi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerem, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drumm, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melmer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozmahel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zsiga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riordan, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, L.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F. S.</span><span> </span><span class="NLM_article-title">Identification of the cystic fibrosis gene: chromosome walking and jumping</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">245</span><span class="NLM_x">, </span> <span class="NLM_fpage">1059</span><span class="NLM_x">–</span> <span class="NLM_lpage">1065</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1126%2Fscience.2772657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=2772657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADyaL1MXls1yms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1989&pages=1059-1065&author=J.+M.+Rommensauthor=M.+C.+Iannuzziauthor=B.+Keremauthor=M.+L.+Drummauthor=G.+Melmerauthor=M.+Deanauthor=R.+Rozmahelauthor=J.+L.+Coleauthor=D.+Kennedyauthor=N.+Hidakaauthor=M.+Zsigaauthor=M.+Buchwaldauthor=J.+R.+Riordanauthor=L.-C.+Tsuiauthor=F.+S.+Collins&title=Identification+of+the+cystic+fibrosis+gene%3A+chromosome+walking+and+jumping"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the cystic fibrosis gene:  chromosome walking and jumping</span></div><div class="casAuthors">Rommens, Johanna M.; Iannuzzi, Michael C.; Kerem, Bat Sheva; Drumm, Mitchell L.; Melmer, Georg; Dean, Michael; Rozmahel, Richard; Cole, Jeffery L.; Kennedy, Dara; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue">4922</span>),
    <span class="NLM_cas:pages">1059-65</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">An understanding of the basic defect in the inherited disorder cystic fibrosis requires cloning in the cystic fibrosis gene and definition of its protein product.  In the absence of direct functional information, chromosomal map position is a guide for locating the gene.  Chromosome walking and jumping and cDNA hybridization were used to isolate DNA sequences, encompassing more than 500,000 base pairs, from the cystic fibrosis region on the long arm of human chromosome 7.  Several transcribed sequences and conserved segments were identified in this cloned region.  One of these corresponds to the cystic fibrosis gene and spans approx. 250,000 base pairs of genomic DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYv4p8ba0LILVg90H21EOLACvtfcHk0lgRxFGIf6-NOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXls1yms7c%253D&md5=fe61f569e3324cd0a55037ce8d8b8207</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscience.2772657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2772657%26sid%3Dliteratum%253Aachs%26aulast%3DRommens%26aufirst%3DJ.%2BM.%26aulast%3DIannuzzi%26aufirst%3DM.%2BC.%26aulast%3DKerem%26aufirst%3DB.%26aulast%3DDrumm%26aufirst%3DM.%2BL.%26aulast%3DMelmer%26aufirst%3DG.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DRozmahel%26aufirst%3DR.%26aulast%3DCole%26aufirst%3DJ.%2BL.%26aulast%3DKennedy%26aufirst%3DD.%26aulast%3DHidaka%26aufirst%3DN.%26aulast%3DZsiga%26aufirst%3DM.%26aulast%3DBuchwald%26aufirst%3DM.%26aulast%3DRiordan%26aufirst%3DJ.%2BR.%26aulast%3DTsui%26aufirst%3DL.-C.%26aulast%3DCollins%26aufirst%3DF.%2BS.%26atitle%3DIdentification%2520of%2520the%2520cystic%2520fibrosis%2520gene%253A%2520chromosome%2520walking%2520and%2520jumping%26jtitle%3DScience%26date%3D1989%26volume%3D245%26spage%3D1059%26epage%3D1065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Koga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irikura, T.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1358</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00186a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1980&pages=1358-1363&author=H.+Kogaauthor=A.+Itohauthor=S.+Murayamaauthor=S.+Suzueauthor=T.+Irikura&title=Structure%E2%80%93activity+relationships+of+antibacterial+6%2C7-+and+7%2C8-disubstituted+1-alkyl-1%2C4-dihydro-4-oxoquinoline-3-carboxylic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1021%2Fjm00186a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00186a014%26sid%3Dliteratum%253Aachs%26aulast%3DKoga%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DA.%26aulast%3DMurayama%26aufirst%3DS.%26aulast%3DSuzue%26aufirst%3DS.%26aulast%3DIrikura%26aufirst%3DT.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520antibacterial%25206%252C7-%2520and%25207%252C8-disubstituted%25201-alkyl-1%252C4-dihydro-4-oxoquinoline-3-carboxylic%2520acids%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1980%26volume%3D23%26spage%3D1358%26epage%3D1363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shah, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coats, E. A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and correlation analysis of 7-substituted 4-hydroxyquinoline-3-carboxylic acids as inhibitors of cellular respiration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00218a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1977&pages=1001-1006&author=K.+J.+Shahauthor=E.+A.+Coats&title=Design%2C+synthesis%2C+and+correlation+analysis+of+7-substituted+4-hydroxyquinoline-3-carboxylic+acids+as+inhibitors+of+cellular+respiration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1021%2Fjm00218a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00218a003%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DK.%2BJ.%26aulast%3DCoats%26aufirst%3DE.%2BA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520correlation%2520analysis%2520of%25207-substituted%25204-hydroxyquinoline-3-carboxylic%2520acids%2520as%2520inhibitors%2520of%2520cellular%2520respiration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1977%26volume%3D20%26spage%3D1001%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Davies, R. V.; Fraser, J.; Nichol, K. J.</span> EP 206616A2,<span class="NLM_x"> </span><span class="NLM_year">1986</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Davies%2C+R.+V.%3B+Fraser%2C+J.%3B+Nichol%2C+K.+J.+EP+206616A2%2C+1986."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DR.%2BV.%26date%3D1986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Coppola, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardtmann, G. E.</span><span> </span><span class="NLM_article-title">The chemistry of 2<i>H</i>-3,1-benzoxazine-2,4(1<i>H</i>)-dione (isatoic anhydride). 7. Reactions with anions of active methylenes to form quinolines</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1610</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=1605-1610&author=G.+M.+Coppolaauthor=G.+E.+Hardtmann&title=The+chemistry+of+2H-3%2C1-benzoxazine-2%2C4%281H%29-dione+%28isatoic+anhydride%29.+7.+Reactions+with+anions+of+active+methylenes+to+form+quinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DHardtmann%26aufirst%3DG.%2BE.%26atitle%3DThe%2520chemistry%2520of%25202H-3%252C1-benzoxazine-2%252C4%25281H%2529-dione%2520%2528isatoic%2520anhydride%2529.%25207.%2520Reactions%2520with%2520anions%2520of%2520active%2520methylenes%2520to%2520form%2520quinolines%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1979%26volume%3D16%26spage%3D1605%26epage%3D1610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabio, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuck, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, R. T.</span><span> </span><span class="NLM_article-title">Pyrido[3,4-<i>e</i>]-1,2,4-triazines and related heterocycles as potential antifungal agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2474</span><span class="NLM_x">–</span> <span class="NLM_lpage">2485</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00131a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=2474-2485&author=M.+F.+Reichauthor=P.+F.+Fabioauthor=V.+J.+Leeauthor=N.+A.+Kuckauthor=R.+T.+Testa&title=Pyrido%5B3%2C4-e%5D-1%2C2%2C4-triazines+and+related+heterocycles+as+potential+antifungal+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm00131a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00131a010%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DFabio%26aufirst%3DP.%2BF.%26aulast%3DLee%26aufirst%3DV.%2BJ.%26aulast%3DKuck%26aufirst%3DN.%2BA.%26aulast%3DTesta%26aufirst%3DR.%2BT.%26atitle%3DPyrido%255B3%252C4-e%255D-1%252C2%252C4-triazines%2520and%2520related%2520heterocycles%2520as%2520potential%2520antifungal%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D2474%26epage%3D2485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Murphy, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridd, J. H.</span><span> </span><span class="NLM_article-title">The rearrangement of aromatic nitro compounds. Part I. The reactions of nitroanilines in aqueous sulphuric acid</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans 2</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1767</span><span class="NLM_x">–</span> <span class="NLM_lpage">1772</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1039%2Fp29870001767" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1987&pages=1767-1772&author=J.+T.+Murphyauthor=J.+H.+Ridd&title=The+rearrangement+of+aromatic+nitro+compounds.+Part+I.+The+reactions+of+nitroanilines+in+aqueous+sulphuric+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2Fp29870001767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp29870001767%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DJ.%2BT.%26aulast%3DRidd%26aufirst%3DJ.%2BH.%26atitle%3DThe%2520rearrangement%2520of%2520aromatic%2520nitro%2520compounds.%2520Part%2520I.%2520The%2520reactions%2520of%2520nitroanilines%2520in%2520aqueous%2520sulphuric%2520acid%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans%25202%26date%3D1987%26volume%3D12%26spage%3D1767%26epage%3D1772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Derbyshire, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, W. A.</span><span> </span><span class="NLM_article-title">108. The Significance of bromine cation in aromatic substitution. Part II. Preparative applicability</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1950&pages=573-577&author=D.+H.+Derbyshireauthor=W.+A.+Waters&title=108.+The+Significance+of+bromine+cation+in+aromatic+substitution.+Part+II.+Preparative+applicability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDerbyshire%26aufirst%3DD.%2BH.%26aulast%3DWaters%26aufirst%3DW.%2BA.%26atitle%3D108.%2520The%2520Significance%2520of%2520bromine%2520cation%2520in%2520aromatic%2520substitution.%2520Part%2520II.%2520Preparative%2520applicability%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1950%26spage%3D573%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Tschaen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmond, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pipik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeven, T. R.</span><span> </span><span class="NLM_article-title">An improved procedure for aromatic cyanation</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">887</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1080%2F00397919408011310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADyaK2cXktVyrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=887-890&issue=6&author=D.+M.+Tschaenauthor=R.+Desmondauthor=A.+O.+Kingauthor=M.+C.+Fortinauthor=B.+Pipikauthor=S.+Kingauthor=T.+R.+Verhoeven&title=An+improved+procedure+for+aromatic+cyanation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">An improved procedure for aromatic cyanation</span></div><div class="casAuthors">Tschaen, D. M.; Desmond, R.; King, A. O.; Fortin, M. C.; Pipik, B.; King, S.; Verhoeven, T. R.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">887-90</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">An effective method for conversion of aryl bromides to aryl cyanides is described.  The procedure involves treatment of the aryl halide with zinc cyanide in the presence of a catalytic amt. of Pd(PPh3)4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkwjVF7zhEyrVg90H21EOLACvtfcHk0lgBNmnFoYhBOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktVyrsb8%253D&md5=f56e0d59d6ff886e3d549832dce904f3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1080%2F00397919408011310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919408011310%26sid%3Dliteratum%253Aachs%26aulast%3DTschaen%26aufirst%3DD.%2BM.%26aulast%3DDesmond%26aufirst%3DR.%26aulast%3DKing%26aufirst%3DA.%2BO.%26aulast%3DFortin%26aufirst%3DM.%2BC.%26aulast%3DPipik%26aufirst%3DB.%26aulast%3DKing%26aufirst%3DS.%26aulast%3DVerhoeven%26aufirst%3DT.%2BR.%26atitle%3DAn%2520improved%2520procedure%2520for%2520aromatic%2520cyanation%26jtitle%3DSynth.%2520Commun.%26date%3D1994%26volume%3D24%26issue%3D6%26spage%3D887%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kovendi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kircz, M.</span><span> </span><span class="NLM_article-title">Synthesis of halo-, amino-, sulfonyl-, and aminosulfonyl(nitro)(ethyl)benzenes</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1896</span><span class="NLM_x">–</span> <span class="NLM_lpage">1901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1964&pages=1896-1901&author=A.+Kovendiauthor=M.+Kircz&title=Synthesis+of+halo-%2C+amino-%2C+sulfonyl-%2C+and+aminosulfonyl%28nitro%29%28ethyl%29benzenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKovendi%26aufirst%3DA.%26aulast%3DKircz%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520halo-%252C%2520amino-%252C%2520sulfonyl-%252C%2520and%2520aminosulfonyl%2528nitro%2529%2528ethyl%2529benzenes%26jtitle%3DChem.%2520Ber.%26date%3D1964%26volume%3D97%26spage%3D1896%26epage%3D1901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Capon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claudon, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornubert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivant, G.</span><span> </span><span class="NLM_article-title">Cyclane stereochemistry. XLI. 2,4-, 3,4-, and 3,5-Dimethylcyclohexanones</span> <span class="citation_source-journal">Bull. Soc. Chim. Fr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1958&pages=847-853&author=D.+Caponauthor=M.+M.+Claudonauthor=R.+Cornubertauthor=H.+Lemoineauthor=G.+Vivant&title=Cyclane+stereochemistry.+XLI.+2%2C4-%2C+3%2C4-%2C+and+3%2C5-Dimethylcyclohexanones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCapon%26aufirst%3DD.%26aulast%3DClaudon%26aufirst%3DM.%2BM.%26aulast%3DCornubert%26aufirst%3DR.%26aulast%3DLemoine%26aufirst%3DH.%26aulast%3DVivant%26aufirst%3DG.%26atitle%3DCyclane%2520stereochemistry.%2520XLI.%25202%252C4-%252C%25203%252C4-%252C%2520and%25203%252C5-Dimethylcyclohexanones%26jtitle%3DBull.%2520Soc.%2520Chim.%2520Fr.%26date%3D1958%26spage%3D847%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Oya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coenen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">New PET imaging agent for the serotonin transporter: [<sup>18</sup>F]ACF (2-[(2-amino-4-chloro-5-fluorophenyl)thio]-<i>N</i>,<i>N</i>-dimethyl-benzenemethanamine)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4716</span><span class="NLM_x">–</span> <span class="NLM_lpage">4723</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020167y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4716-4723&author=S.+Oyaauthor=S.+R.+Choiauthor=H.+Coenenauthor=H.+F.+Kung&title=New+PET+imaging+agent+for+the+serotonin+transporter%3A+%5B18F%5DACF+%282-%5B%282-amino-4-chloro-5-fluorophenyl%29thio%5D-N%2CN-dimethyl-benzenemethanamine%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm020167y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020167y%26sid%3Dliteratum%253Aachs%26aulast%3DOya%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DS.%2BR.%26aulast%3DCoenen%26aufirst%3DH.%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DNew%2520PET%2520imaging%2520agent%2520for%2520the%2520serotonin%2520transporter%253A%2520%255B18F%255DACF%2520%25282-%255B%25282-amino-4-chloro-5-fluorophenyl%2529thio%255D-N%252CN-dimethyl-benzenemethanamine%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4716%26epage%3D4723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Charpentier, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardon, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eustache, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shroot, B.</span><span> </span><span class="NLM_article-title">Synthesis, structure–affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4993</span><span class="NLM_x">–</span> <span class="NLM_lpage">5006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=4993-5006&author=B.+O.+Charpentierauthor=J.-M.+Bernardonauthor=J.+Eustacheauthor=C.+Milloisauthor=B.+Martinauthor=S.+Michelauthor=B.+Shroot&title=Synthesis%2C+structure%E2%80%93affinity+relationships%2C+and+biological+activities+of+ligands+binding+to+retinoic+acid+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharpentier%26aufirst%3DB.%2BO.%26aulast%3DBernardon%26aufirst%3DJ.-M.%26aulast%3DEustache%26aufirst%3DJ.%26aulast%3DMillois%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DB.%26aulast%3DMichel%26aufirst%3DS.%26aulast%3DShroot%26aufirst%3DB.%26atitle%3DSynthesis%252C%2520structure%25E2%2580%2593affinity%2520relationships%252C%2520and%2520biological%2520activities%2520of%2520ligands%2520binding%2520to%2520retinoic%2520acid%2520receptor%2520subtypes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D38%26spage%3D4993%26epage%3D5006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Hennequin, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, E. S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, J.-J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curwen, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrew, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert-van der Brempt, C.</span><span> </span><span class="NLM_article-title">Design and structure–activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5369</span><span class="NLM_x">–</span> <span class="NLM_lpage">5389</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990345w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5369-5389&author=L.+F.+Hennequinauthor=A.+P.+Thomasauthor=C.+Johnstoneauthor=E.+S.+E.+Stokesauthor=P.+A.+Pleauthor=J.-J.+M.+Lohmannauthor=D.+J.+Ogilvieauthor=M.+Dukesauthor=S.+R.+Wedgeauthor=J.+O.+Curwenauthor=J.+Kendrewauthor=C.+Lambert-van+der+Brempt&title=Design+and+structure%E2%80%93activity+relationship+of+a+new+class+of+potent+VEGF+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm990345w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990345w%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26aulast%3DThomas%26aufirst%3DA.%2BP.%26aulast%3DJohnstone%26aufirst%3DC.%26aulast%3DStokes%26aufirst%3DE.%2BS.%2BE.%26aulast%3DPle%26aufirst%3DP.%2BA.%26aulast%3DLohmann%26aufirst%3DJ.-J.%2BM.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26aulast%3DDukes%26aufirst%3DM.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DCurwen%26aufirst%3DJ.%2BO.%26aulast%3DKendrew%26aufirst%3DJ.%26aulast%3DLambert-van%2Bder%2BBrempt%26aufirst%3DC.%26atitle%3DDesign%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520a%2520new%2520class%2520of%2520potent%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5369%26epage%3D5389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Su, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span> </span><span class="NLM_article-title">Synthesis of functionalized long-chain perfluoroalkanes from methyl halodifluoroacetates: a process of difluorocarbene insertion into copper–carbon bonds</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">1–2</span><span class="NLM_x">) </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1016%2FS0022-1139%2800%2980465-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADyaK2cXhvFWjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1993&pages=11-14&issue=1%E2%80%932&author=D.+Suauthor=J.+Duanauthor=A.+Yuauthor=Q.+Chen&title=Synthesis+of+functionalized+long-chain+perfluoroalkanes+from+methyl+halodifluoroacetates%3A+a+process+of+difluorocarbene+insertion+into+copper%E2%80%93carbon+bonds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of functionalized long-chain perfluoroalkanes from methyl halodifluoroacetates: a process of difluorocarbene insertion into copper-carbon bonds</span></div><div class="casAuthors">Su, Debao; Duan, Jianxing; Yu, Anjuan; Chen, Qingyun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">11-14</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    </div><div class="casAbstract">Treatment of XCF2CO2Me (X = Cl, Br) with org. halides RX (PhI, PhBr, 1-iodonaphthalene, PhCH2Br, allyl bromide) in the presence of KF and catalytic amts. of CuI at 80-120° for 3-8 h in DMF gave long-chain perfluoroalkylated compds. R(CF2)nCF3, which are considered to be formed by the insertions of CF2: into carbon-copper bonds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1owjFliboYrVg90H21EOLACvtfcHk0lhoQifmxqYXEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhvFWjt7g%253D&md5=4d5f698958e699b1b9802d930b556900</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0022-1139%2800%2980465-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-1139%252800%252980465-0%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DD.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DQ.%26atitle%3DSynthesis%2520of%2520functionalized%2520long-chain%2520perfluoroalkanes%2520from%2520methyl%2520halodifluoroacetates%253A%2520a%2520process%2520of%2520difluorocarbene%2520insertion%2520into%2520copper%25E2%2580%2593carbon%2520bonds%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D1993%26volume%3D65%26issue%3D1%25E2%2580%25932%26spage%3D11%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Hansch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helmkamp, G.</span><span> </span><span class="NLM_article-title">Catalytic synthesis of heterocycles. VI. Dehydrocyclization of <i>o</i>-alkylbenzenes to indoles</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1951</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">3080</span><span class="NLM_x">–</span> <span class="NLM_lpage">3082</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01151a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1951&pages=3080-3082&author=C.+Hanschauthor=G.+Helmkamp&title=Catalytic+synthesis+of+heterocycles.+VI.+Dehydrocyclization+of+o-alkylbenzenes+to+indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fja01151a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01151a031%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26aulast%3DHelmkamp%26aufirst%3DG.%26atitle%3DCatalytic%2520synthesis%2520of%2520heterocycles.%2520VI.%2520Dehydrocyclization%2520of%2520o-alkylbenzenes%2520to%2520indoles%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1951%26volume%3D73%26spage%3D3080%26epage%3D3082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Barlett, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallbillich, G. E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wingrove, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenton, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, B. D.</span><span> </span><span class="NLM_article-title">Cycloaddition. V. 2-Alkylbutadienes and 1,1-dichloro-2,2-difluoroethylene. The effect of diene conformation on mode of cycloaddition</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">2049</span><span class="NLM_x">–</span> <span class="NLM_lpage">2056</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1968&pages=2049-2056&author=P.+D.+Barlettauthor=G.+E.+H.+Wallbillichauthor=A.+S.+Wingroveauthor=J.+S.+Swentonauthor=L.+K.+Montgomeryauthor=B.+D.+Kramer&title=Cycloaddition.+V.+2-Alkylbutadienes+and+1%2C1-dichloro-2%2C2-difluoroethylene.+The+effect+of+diene+conformation+on+mode+of+cycloaddition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarlett%26aufirst%3DP.%2BD.%26aulast%3DWallbillich%26aufirst%3DG.%2BE.%2BH.%26aulast%3DWingrove%26aufirst%3DA.%2BS.%26aulast%3DSwenton%26aufirst%3DJ.%2BS.%26aulast%3DMontgomery%26aufirst%3DL.%2BK.%26aulast%3DKramer%26aufirst%3DB.%2BD.%26atitle%3DCycloaddition.%2520V.%25202-Alkylbutadienes%2520and%25201%252C1-dichloro-2%252C2-difluoroethylene.%2520The%2520effect%2520of%2520diene%2520conformation%2520on%2520mode%2520of%2520cycloaddition%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1968%26volume%3D90%26spage%3D2049%26epage%3D2056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Carpenter, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easter, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, T. F.</span><span> </span><span class="NLM_article-title">Nitro musks. Isomers, homologs, and analogs of musk ambrette</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1951</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01144a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1951&pages=586-617&author=M.+S.+Carpenterauthor=W.+M.+Easterauthor=T.+F.+Wood&title=Nitro+musks.+Isomers%2C+homologs%2C+and+analogs+of+musk+ambrette"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1021%2Fjo01144a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01144a011%26sid%3Dliteratum%253Aachs%26aulast%3DCarpenter%26aufirst%3DM.%2BS.%26aulast%3DEaster%26aufirst%3DW.%2BM.%26aulast%3DWood%26aufirst%3DT.%2BF.%26atitle%3DNitro%2520musks.%2520Isomers%252C%2520homologs%252C%2520and%2520analogs%2520of%2520musk%2520ambrette%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1951%26volume%3D16%26spage%3D586%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Galietta, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lantero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazzolo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacco, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zegarra-Moran, O.</span><span> </span><span class="NLM_article-title">An improved method to obtain highly differenciated monolayers of human bronchial epithelial cells</span> <span class="citation_source-journal">In Vitro Cell. Dev. Biol.: Anim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">478</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1998&pages=478-481&author=L.+J.+Galiettaauthor=S.+Lanteroauthor=A.+Gazzoloauthor=O.+Saccoauthor=L.+Romanoauthor=G.+A.+Rossiauthor=O.+Zegarra-Moran&title=An+improved+method+to+obtain+highly+differenciated+monolayers+of+human+bronchial+epithelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalietta%26aufirst%3DL.%2BJ.%26aulast%3DLantero%26aufirst%3DS.%26aulast%3DGazzolo%26aufirst%3DA.%26aulast%3DSacco%26aufirst%3DO.%26aulast%3DRomano%26aufirst%3DL.%26aulast%3DRossi%26aufirst%3DG.%2BA.%26aulast%3DZegarra-Moran%26aufirst%3DO.%26atitle%3DAn%2520improved%2520method%2520to%2520obtain%2520highly%2520differenciated%2520monolayers%2520of%2520human%2520bronchial%2520epithelial%2520cells%26jtitle%3DIn%2520Vitro%2520Cell.%2520Dev.%2520Biol.%253A%2520Anim.%26date%3D1998%26volume%3D34%26spage%3D478%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b','cit2c','cit2d'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':[],'ref16':[],'ref17':['cit17'],'ref18':[],'ref19':['cit19a','cit19b1','ref19_3'],'ref20':[],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':[],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':['cit28a','cit28b'],'ref29':['cit29a','cit29b'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42a','cit42b'],'ref43':['cit43']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 54 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Darren Le Grand, Martin Gosling, Urs Baettig, Parmjit Bahra, Kamlesh Bala, Cara Brocklehurst, Emma Budd, Rebecca Butler, Atwood K. Cheung, Hedaythul Choudhury, Stephen P. Collingwood, Brian Cox, Henry Danahay, Lee Edwards, Brian Everatt, Ulrike Glaenzel, Anne-Lise Glotin, Paul Groot-Kormelink, Edward Hall, Julia Hatto, Catherine Howsham, Glyn Hughes, Anna King, Julia Koehler, Swarupa Kulkarni, Megan Lightfoot, Ian Nicholls, Christopher Page, Giles Pergl-Wilson, Mariana Oana Popa, Richard Robinson, David Rowlands, Tom Sharp, Matthew Spendiff, Emily Stanley, Oliver Steward, Roger J. Taylor, Pamela Tranter, Trixie Wagner, Hazel Watson, Gareth Williams, Penny Wright, Alice Young, <span class="NLM_string-name hlFld-ContribAuthor">David A. Sandham</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7241-7260. <a href="https://doi.org/10.1021/acs.jmedchem.1c00343" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00343</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00343%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BIcenticaftor%252B%252528QBW251%252529%25252C%252Ba%252BCystic%252BFibrosis%252BTransmembrane%252BConductance%252BRegulator%252BPotentiator%252Bwith%252BClinical%252BEfficacy%252Bin%252BCystic%252BFibrosis%252Band%252BChronic%252BObstructive%252BPulmonary%252BDisease%26aulast%3DGrand%26aufirst%3DDarren%2BLe%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D24022021%26date%3D24052021%26volume%3D64%26issue%3D11%26spage%3D7241%26epage%3D7260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Steven E. Van der Plas, Hans Kelgtermans, Oscar Mammoliti, Christel Menet, Giovanni Tricarico, Ann De Blieck, Caroline Joannesse, Tom De Munck, Dominique Lambin, Marlon Cowart, Sebastien Dropsit, Sebastien L. X. Martina, Maarten Gees, Anne-Sophie Wesse, Katja Conrath, <span class="NLM_string-name hlFld-ContribAuthor">Martin Andrews</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 343-353. <a href="https://doi.org/10.1021/acs.jmedchem.0c01796" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01796</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01796%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BGLPG2451%25252C%252Ba%252BNovel%252BOnce%252BDaily%252BPotentiator%252Bfor%252Bthe%252BTreatment%252Bof%252BCystic%252BFibrosis%26aulast%3DVan%2Bder%2BPlas%26aufirst%3DSteven%2BE.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D14102020%26date%3D05012021%26volume%3D64%26issue%3D1%26spage%3D343%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dong Wang, Yuanyang Jiang, Linru Dong, Gaoyu Li, Baoying Sun, Laurent Désaubry, <span class="NLM_string-name hlFld-ContribAuthor">Peng Yu</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Selective Saturation and Functionalization of Heteroaromatics Leading to Dihydropyridines and Dihydroquinolines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (7)
                                     , 5027-5037. <a href="https://doi.org/10.1021/acs.joc.0c00314" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00314%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOne-Pot%252BSelective%252BSaturation%252Band%252BFunctionalization%252Bof%252BHeteroaromatics%252BLeading%252Bto%252BDihydropyridines%252Band%252BDihydroquinolines%26aulast%3DWang%26aufirst%3DDong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07022020%26date%3D18032020%26date%3D10032020%26volume%3D85%26issue%3D7%26spage%3D5027%26epage%3D5037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">David L. Hughes</span>. </span><span class="cited-content_cbyCitation_article-title">Patent Review of Synthetic Routes and Crystalline Forms of the CFTR-Modulator Drugs Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2019,</strong> <em>23 </em>
                                    (11)
                                     , 2302-2322. <a href="https://doi.org/10.1021/acs.oprd.9b00326" title="DOI URL">https://doi.org/10.1021/acs.oprd.9b00326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.9b00326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.9b00326%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DPatent%252BReview%252Bof%252BSynthetic%252BRoutes%252Band%252BCrystalline%252BForms%252Bof%252Bthe%252BCFTR-Modulator%252BDrugs%252BIvacaftor%25252C%252BLumacaftor%25252C%252BTezacaftor%25252C%252Band%252BElexacaftor%26aulast%3DHughes%26aufirst%3DDavid%2BL.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D23072019%26date%3D02102019%26date%3D19092019%26volume%3D23%26issue%3D11%26spage%3D2302%26epage%3D2322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seongil  Kang</span>, <span class="hlFld-ContribAuthor ">Subin  Park</span>, <span class="hlFld-ContribAuthor ">Kyung-su  Kim</span>, <span class="hlFld-ContribAuthor ">Changsik  Song</span>, and <span class="hlFld-ContribAuthor ">Yunmi  Lee</span>  . </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Aza-Michael Addition of 2-Aminobenzoate to β-Substituted α,β-Unsaturated Ketones: One-Pot Synthesis of 3-Carbonyl-2-Substituted Quinolin-4(1H)-ones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (5)
                                     , 2694-2705. <a href="https://doi.org/10.1021/acs.joc.7b03162" title="DOI URL">https://doi.org/10.1021/acs.joc.7b03162</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b03162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b03162%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper-Catalyzed%252BAza-Michael%252BAddition%252Bof%252B2-Aminobenzoate%252Bto%252B%2525CE%2525B2-Substituted%252B%2525CE%2525B1%25252C%2525CE%2525B2-Unsaturated%252BKetones%25253A%252BOne-Pot%252BSynthesis%252Bof%252B3-Carbonyl-2-Substituted%252BQuinolin-4%2525281H%252529-ones%26aulast%3DKang%26aufirst%3DSeongil%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D15122017%26date%3D09022018%26date%3D02032018%26volume%3D83%26issue%3D5%26spage%3D2694%26epage%3D2705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven E.  Van der Plas</span>, <span class="hlFld-ContribAuthor ">Hans  Kelgtermans</span>, <span class="hlFld-ContribAuthor ">Tom  De Munck</span>, <span class="hlFld-ContribAuthor ">Sébastien L. X.  Martina</span>, <span class="hlFld-ContribAuthor ">Sébastien  Dropsit</span>, <span class="hlFld-ContribAuthor ">Evelyne  Quinton</span>, <span class="hlFld-ContribAuthor ">Ann  De Blieck</span>, <span class="hlFld-ContribAuthor ">Caroline  Joannesse</span>, <span class="hlFld-ContribAuthor ">Linda  Tomaskovic</span>, <span class="hlFld-ContribAuthor ">Mia  Jans</span>, <span class="hlFld-ContribAuthor ">Thierry  Christophe</span>, <span class="hlFld-ContribAuthor ">Ellen  van der Aar</span>, <span class="hlFld-ContribAuthor ">Monica  Borgonovi</span>, <span class="hlFld-ContribAuthor ">Luc  Nelles</span>, <span class="hlFld-ContribAuthor ">Maarten  Gees</span>, <span class="hlFld-ContribAuthor ">Pieter  Stouten</span>, <span class="hlFld-ContribAuthor ">Jan  Van Der Schueren</span>, <span class="hlFld-ContribAuthor ">Oscar  Mammoliti</span>, <span class="hlFld-ContribAuthor ">Katja  Conrath</span>, and <span class="hlFld-ContribAuthor ">Martin  Andrews</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of N-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-lH-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High Extent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (4)
                                     , 1425-1435. <a href="https://doi.org/10.1021/acs.jmedchem.7b01288" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01288</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01288%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%2525283-Carbamoyl-5%25252C5%25252C7%25252C7-tetramethyl-5%25252C7-dihydro-4H-thieno%25255B2%25252C3-c%25255Dpyran-2-yl%252529-lH-pyrazole-5-carboxamide%252B%252528GLPG1837%252529%25252C%252Ba%252BNovel%252BPotentiator%252BWhich%252BCan%252BOpen%252BClass%252BIII%252BMutant%252BCystic%252BFibrosis%252BTransmembrane%252BConductance%252BRegulator%252B%252528CFTR%252529%252BChannels%252Bto%252Ba%252BHigh%252BExtent%26aulast%3DVan%2Bder%2BPlas%26aufirst%3DSteven%2BE.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D31082017%26date%3D10012018%26date%3D22022018%26date%3D17112017%26volume%3D61%26issue%3D4%26spage%3D1425%26epage%3D1435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueqing  Wang</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Xenia  Searle</span>, <span class="hlFld-ContribAuthor ">Clinton  Yeung</span>, <span class="hlFld-ContribAuthor ">Andrew  Bogdan</span>, <span class="hlFld-ContribAuthor ">Stephen  Greszler</span>, <span class="hlFld-ContribAuthor ">Ashvani  Singh</span>, <span class="hlFld-ContribAuthor ">Yihong  Fan</span>, <span class="hlFld-ContribAuthor ">Andrew M  Swensen</span>, <span class="hlFld-ContribAuthor ">Timothy  Vortherms</span>, <span class="hlFld-ContribAuthor ">Corina  Balut</span>, <span class="hlFld-ContribAuthor ">Ying  Jia</span>, <span class="hlFld-ContribAuthor ">Kelly  Desino</span>, <span class="hlFld-ContribAuthor ">Wenqing  Gao</span>, <span class="hlFld-ContribAuthor ">Hong  Yong</span>, <span class="hlFld-ContribAuthor ">Chris  Tse</span>, and <span class="hlFld-ContribAuthor ">Philip  Kym</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-[(2R,4R)-4-({[1-(2,2-Difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl}amino)-7-(difluoromethoxy)-3,4-dihydro-2H-chromen-2-yl]benzoic Acid (ABBV/GLPG-2222), a Potent Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Corrector for the Treatment of Cystic Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (4)
                                     , 1436-1449. <a href="https://doi.org/10.1021/acs.jmedchem.7b01339" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01339%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-%25255B%2525282R%25252C4R%252529-4-%252528%25257B%25255B1-%2525282%25252C2-Difluoro-1%25252C3-benzodioxol-5-yl%252529cyclopropyl%25255Dcarbonyl%25257Damino%252529-7-%252528difluoromethoxy%252529-3%25252C4-dihydro-2H-chromen-2-yl%25255Dbenzoic%252BAcid%252B%252528ABBV%25252FGLPG-2222%252529%25252C%252Ba%252BPotent%252BCystic%252BFibrosis%252BTransmembrane%252BConductance%252BRegulator%252B%252528CFTR%252529%252BCorrector%252Bfor%252Bthe%252BTreatment%252Bof%252BCystic%252BFibrosis%26aulast%3DWang%26aufirst%3DXueqing%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D11092017%26date%3D05012018%26date%3D22022018%26date%3D18122017%26volume%3D61%26issue%3D4%26spage%3D1436%26epage%3D1449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chi B.  Vu</span>, <span class="hlFld-ContribAuthor ">Robert J.  Bridges</span>, <span class="hlFld-ContribAuthor ">Cecilia  Pena-Rasgado</span>, <span class="hlFld-ContribAuthor ">Antonio E.  Lacerda</span>, <span class="hlFld-ContribAuthor ">Curtis  Bordwell</span>, <span class="hlFld-ContribAuthor ">Abby  Sewell</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Nichols</span>, <span class="hlFld-ContribAuthor ">Sachin  Chandran</span>, <span class="hlFld-ContribAuthor ">Pallavi  Lonkar</span>, <span class="hlFld-ContribAuthor ">Dominic  Picarella</span>, <span class="hlFld-ContribAuthor ">Amal  Ting</span>, <span class="hlFld-ContribAuthor ">Allison  Wensley</span>, <span class="hlFld-ContribAuthor ">Maisy  Yeager</span>, and <span class="hlFld-ContribAuthor ">Feng  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (1)
                                     , 458-473. <a href="https://doi.org/10.1021/acs.jmedchem.6b01539" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01539</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01539%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFatty%252BAcid%252BCysteamine%252BConjugates%252Bas%252BNovel%252Band%252BPotent%252BAutophagy%252BActivators%252BThat%252BEnhance%252Bthe%252BCorrection%252Bof%252BMisfolded%252BF508del-Cystic%252BFibrosis%252BTransmembrane%252BConductance%252BRegulator%252B%252528CFTR%252529%26aulast%3DVu%26aufirst%3DChi%2BB.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D18102016%26date%3D23122016%26date%3D12012017%26date%3D15122016%26volume%3D60%26issue%3D1%26spage%3D458%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John A.  Lowe, III</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery Heralds New Approach to the Treatment of Cystic Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 9774-9775. <a href="https://doi.org/10.1021/jm5016928" title="DOI URL">https://doi.org/10.1021/jm5016928</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5016928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5016928%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252BHeralds%252BNew%252BApproach%252Bto%252Bthe%252BTreatment%252Bof%252BCystic%252BFibrosis%26aulast%3DLowe%26aufirst%3DJohn%2BA.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D31102014%26date%3D10112014%26date%3D11122014%26volume%3D57%26issue%3D23%26spage%3D9774%26epage%3D9775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Payandeh</span>, <span class="hlFld-ContribAuthor ">Matthew  Volgraf</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand binding at the protein–lipid interface: strategic considerations for drug design. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2021,</strong> <em>5 </em><a href="https://doi.org/10.1038/s41573-021-00240-2" title="DOI URL">https://doi.org/10.1038/s41573-021-00240-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-021-00240-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-021-00240-2%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DLigand%252Bbinding%252Bat%252Bthe%252Bprotein%2525E2%252580%252593lipid%252Binterface%25253A%252Bstrategic%252Bconsiderations%252Bfor%252Bdrug%252Bdesign%26aulast%3DPayandeh%26aufirst%3DJian%26date%3D2021%26date%3D2021%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Onofrio  Laselva</span>, <span class="hlFld-ContribAuthor ">Zafar  Qureshi</span>, <span class="hlFld-ContribAuthor ">Zhi-Wei  Zeng</span>, <span class="hlFld-ContribAuthor ">Evgeniy V.  Petrotchenko</span>, <span class="hlFld-ContribAuthor ">Mohabir  Ramjeesingh</span>, <span class="hlFld-ContribAuthor ">C. Michael  Hamilton</span>, <span class="hlFld-ContribAuthor ">Ling-Jun  Huan</span>, <span class="hlFld-ContribAuthor ">Christoph H.  Borchers</span>, <span class="hlFld-ContribAuthor ">Régis  Pomès</span>, <span class="hlFld-ContribAuthor ">Robert  Young</span>, <span class="hlFld-ContribAuthor ">Christine E.  Bear</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of binding sites for ivacaftor on the cystic fibrosis transmembrane conductance regulator. </span><span class="cited-content_cbyCitation_journal-name">iScience</span><span> <strong>2021,</strong> <em>24 </em>
                                    (6)
                                     , 102542. <a href="https://doi.org/10.1016/j.isci.2021.102542" title="DOI URL">https://doi.org/10.1016/j.isci.2021.102542</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.isci.2021.102542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.isci.2021.102542%26sid%3Dliteratum%253Aachs%26jtitle%3DiScience%26atitle%3DIdentification%252Bof%252Bbinding%252Bsites%252Bfor%252Bivacaftor%252Bon%252Bthe%252Bcystic%252Bfibrosis%252Btransmembrane%252Bconductance%252Bregulator%26aulast%3DLaselva%26aufirst%3DOnofrio%26date%3D2021%26volume%3D24%26issue%3D6%26spage%3D102542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John E.  Bell</span>, <span class="hlFld-ContribAuthor ">Jessica K.  Bell</span>. </span><span class="cited-content_cbyCitation_article-title">Allosterism and Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-78. <a href="https://doi.org/10.1002/0471266949.bmc299" title="DOI URL">https://doi.org/10.1002/0471266949.bmc299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc299%26sid%3Dliteratum%253Aachs%26atitle%3DAllosterism%252Band%252BDrug%252BDiscovery%26aulast%3DBell%26aufirst%3DJohn%2BE.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D78%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Mesiti</span>, <span class="hlFld-ContribAuthor ">Annalisa  Maruca</span>, <span class="hlFld-ContribAuthor ">Vera  Silva</span>, <span class="hlFld-ContribAuthor ">Roberta  Rocca</span>, <span class="hlFld-ContribAuthor ">Carlos  Fernandes</span>, <span class="hlFld-ContribAuthor ">Fernando  Remião</span>, <span class="hlFld-ContribAuthor ">Eugenio  Uriarte</span>, <span class="hlFld-ContribAuthor ">Stefano  Alcaro</span>, <span class="hlFld-ContribAuthor ">Alexandra  Gaspar</span>, <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>. </span><span class="cited-content_cbyCitation_article-title">4-Oxoquinolines and monoamine oxidase: When tautomerism matters. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113183. <a href="https://doi.org/10.1016/j.ejmech.2021.113183" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113183%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D4-Oxoquinolines%252Band%252Bmonoamine%252Boxidase%25253A%252BWhen%252Btautomerism%252Bmatters%26aulast%3DMesiti%26aufirst%3DFrancesco%26date%3D2021%26volume%3D213%26spage%3D113183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manish  Kumar Mehra</span>, <span class="hlFld-ContribAuthor ">Monika  Malik</span>, <span class="hlFld-ContribAuthor ">Bintu  Kumar</span>, <span class="hlFld-ContribAuthor ">Dalip  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoselective Cu-catalyzed synthesis of diverse
              N
              -arylindole carboxamides, β-oxo amides and
              N
              -arylindole-3-carbonitriles using diaryliodonium salts. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (5)
                                     , 1109-1114. <a href="https://doi.org/10.1039/D0OB02247K" title="DOI URL">https://doi.org/10.1039/D0OB02247K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB02247K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB02247K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DChemoselective%252BCu-catalyzed%252Bsynthesis%252Bof%252Bdiverse%252BN%252B-arylindole%252Bcarboxamides%25252C%252B%2525CE%2525B2-oxo%252Bamides%252Band%252BN%252B-arylindole-3-carbonitriles%252Busing%252Bdiaryliodonium%252Bsalts%26aulast%3DKumar%2BMehra%26aufirst%3DManish%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D5%26spage%3D1109%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Li</span>, <span class="hlFld-ContribAuthor ">Pascal F.  Egea</span>, <span class="hlFld-ContribAuthor ">Alex J.  Vecchio</span>, <span class="hlFld-ContribAuthor ">Ignacio  Asial</span>, <span class="hlFld-ContribAuthor ">Meghna  Gupta</span>, <span class="hlFld-ContribAuthor ">Joana  Paulino</span>, <span class="hlFld-ContribAuthor ">Ruchika  Bajaj</span>, <span class="hlFld-ContribAuthor ">Miles Sasha  Dickinson</span>, <span class="hlFld-ContribAuthor ">Shelagh  Ferguson-Miller</span>, <span class="hlFld-ContribAuthor ">Brian C.  Monk</span>, <span class="hlFld-ContribAuthor ">Robert M.  Stroud</span>. </span><span class="cited-content_cbyCitation_article-title">Highlighting membrane protein structure and function: A celebration of the Protein Data Bank. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>296 </em>, 100557. <a href="https://doi.org/10.1016/j.jbc.2021.100557" title="DOI URL">https://doi.org/10.1016/j.jbc.2021.100557</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jbc.2021.100557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jbc.2021.100557%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DHighlighting%252Bmembrane%252Bprotein%252Bstructure%252Band%252Bfunction%25253A%252BA%2525C2%2525A0celebration%252Bof%252Bthe%252BProtein%252BData%252BBank%26aulast%3DLi%26aufirst%3DFei%26date%3D2021%26volume%3D296%26spage%3D100557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabien  Vincent</span>, <span class="hlFld-ContribAuthor ">Paula M.  Loria</span>, <span class="hlFld-ContribAuthor ">Andrea D.  Weston</span>, <span class="hlFld-ContribAuthor ">Claire M.  Steppan</span>, <span class="hlFld-ContribAuthor ">Regis  Doyonnas</span>, <span class="hlFld-ContribAuthor ">Yue-Ming  Wang</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Rockwell</span>, <span class="hlFld-ContribAuthor ">Marie-Claire  Peakman</span>. </span><span class="cited-content_cbyCitation_article-title">Hit Triage and Validation in Phenotypic Screening: Considerations and Strategies. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2020,</strong> <em>27 </em>
                                    (11)
                                     , 1332-1346. <a href="https://doi.org/10.1016/j.chembiol.2020.08.009" title="DOI URL">https://doi.org/10.1016/j.chembiol.2020.08.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2020.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2020.08.009%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DHit%252BTriage%252Band%252BValidation%252Bin%252BPhenotypic%252BScreening%25253A%252BConsiderations%252Band%252BStrategies%26aulast%3DVincent%26aufirst%3DFabien%26date%3D2020%26volume%3D27%26issue%3D11%26spage%3D1332%26epage%3D1346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susan E.  Birket</span>, <span class="hlFld-ContribAuthor ">Joy M.  Davis</span>, <span class="hlFld-ContribAuthor ">Courtney M.  Fernandez-Petty</span>, <span class="hlFld-ContribAuthor ">Alexander G.  Henderson</span>, <span class="hlFld-ContribAuthor ">Ashley M.  Oden</span>, <span class="hlFld-ContribAuthor ">LiPing  Tang</span>, <span class="hlFld-ContribAuthor ">Hui  Wen</span>, <span class="hlFld-ContribAuthor ">Jeong  Hong</span>, <span class="hlFld-ContribAuthor ">Lianwu  Fu</span>, <span class="hlFld-ContribAuthor ">Andre  Chambers</span>, <span class="hlFld-ContribAuthor ">Alvin  Fields</span>, <span class="hlFld-ContribAuthor ">Gojun  Zhao</span>, <span class="hlFld-ContribAuthor ">Guillermo J.  Tearney</span>, <span class="hlFld-ContribAuthor ">Eric J.  Sorscher</span>, <span class="hlFld-ContribAuthor ">Steven M.  Rowe</span>. </span><span class="cited-content_cbyCitation_article-title">Ivacaftor Reverses Airway Mucus Abnormalities in a Rat Model Harboring a Humanized G551D-CFTR. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Respiratory and Critical Care Medicine</span><span> <strong>2020,</strong> <em>202 </em>
                                    (9)
                                     , 1271-1282. <a href="https://doi.org/10.1164/rccm.202002-0369OC" title="DOI URL">https://doi.org/10.1164/rccm.202002-0369OC</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1164/rccm.202002-0369OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1164%2Frccm.202002-0369OC%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Respiratory%2520and%2520Critical%2520Care%2520Medicine%26atitle%3DIvacaftor%252BReverses%252BAirway%252BMucus%252BAbnormalities%252Bin%252Ba%252BRat%252BModel%252BHarboring%252Ba%252BHumanized%252BG551D-CFTR%26aulast%3DBirket%26aufirst%3DSusan%2BE.%26date%3D2020%26volume%3D202%26issue%3D9%26spage%3D1271%26epage%3D1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John H  Van Drie</span>, <span class="hlFld-ContribAuthor ">Liang  Tong</span>. </span><span class="cited-content_cbyCitation_article-title">Cryo-EM as a powerful tool for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (22)
                                     , 127524. <a href="https://doi.org/10.1016/j.bmcl.2020.127524" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127524</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127524%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCryo-EM%252Bas%252Ba%252Bpowerful%252Btool%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DVan%2BDrie%26aufirst%3DJohn%2BH%26date%3D2020%26volume%3D30%26issue%3D22%26spage%3D127524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Virginia  Spanò</span>, <span class="hlFld-ContribAuthor ">Arianna  Venturini</span>, <span class="hlFld-ContribAuthor ">Michele  Genovese</span>, <span class="hlFld-ContribAuthor ">Marilia  Barreca</span>, <span class="hlFld-ContribAuthor ">Maria Valeria  Raimondi</span>, <span class="hlFld-ContribAuthor ">Alessandra  Montalbano</span>, <span class="hlFld-ContribAuthor ">Luis J.V.  Galietta</span>, <span class="hlFld-ContribAuthor ">Paola  Barraja</span>. </span><span class="cited-content_cbyCitation_article-title">Current development of CFTR potentiators in the last decade. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112631. <a href="https://doi.org/10.1016/j.ejmech.2020.112631" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112631%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCurrent%252Bdevelopment%252Bof%252BCFTR%252Bpotentiators%252Bin%252Bthe%252Blast%252Bdecade%26aulast%3DSpan%25C3%25B2%26aufirst%3DVirginia%26date%3D2020%26volume%3D204%26spage%3D112631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jake E.  Doiron</span>, <span class="hlFld-ContribAuthor ">Christina A.  Le</span>, <span class="hlFld-ContribAuthor ">John  Bacsa</span>, <span class="hlFld-ContribAuthor ">Gary W.  Breton</span>, <span class="hlFld-ContribAuthor ">Kenneth L.  Martin</span>, <span class="hlFld-ContribAuthor ">Stephen G.  Aller</span>, <span class="hlFld-ContribAuthor ">Mark  Turlington</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Consequences of the 1,2,3‐Triazole as an Amide Bioisostere in Analogues of the Cystic Fibrosis Drugs VX‐809 and VX‐770. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (18)
                                     , 1720-1730. <a href="https://doi.org/10.1002/cmdc.202000220" title="DOI URL">https://doi.org/10.1002/cmdc.202000220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000220%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructural%252BConsequences%252Bof%252Bthe%252B1%25252C2%25252C3%2525E2%252580%252590Triazole%252Bas%252Ban%252BAmide%252BBioisostere%252Bin%252BAnalogues%252Bof%252Bthe%252BCystic%252BFibrosis%252BDrugs%252BVX%2525E2%252580%252590809%2525E2%252580%252589and%252BVX%2525E2%252580%252590770%26aulast%3DDoiron%26aufirst%3DJake%2BE.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D18%26spage%3D1720%26epage%3D1730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. Catarina  Silva</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Haggarty</span>. </span><span class="cited-content_cbyCitation_article-title">Human pluripotent stem cell–derived models and drug screening in CNS precision medicine. </span><span class="cited-content_cbyCitation_journal-name">Annals of the New York Academy of Sciences</span><span> <strong>2020,</strong> <em>1471 </em>
                                    (1)
                                     , 18-56. <a href="https://doi.org/10.1111/nyas.14012" title="DOI URL">https://doi.org/10.1111/nyas.14012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/nyas.14012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fnyas.14012%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520the%2520New%2520York%2520Academy%2520of%2520Sciences%26atitle%3DHuman%252Bpluripotent%252Bstem%252Bcell%2525E2%252580%252593derived%252Bmodels%252Band%252Bdrug%252Bscreening%252Bin%252BCNS%252Bprecision%252Bmedicine%26aulast%3DSilva%26aufirst%3DM.%2BCatarina%26date%3D2020%26date%3D2019%26volume%3D1471%26issue%3D1%26spage%3D18%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baihui  Li</span>, <span class="hlFld-ContribAuthor ">Yangli  Shen</span>, <span class="hlFld-ContribAuthor ">Hu  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaobo  Wu</span>, <span class="hlFld-ContribAuthor ">Lvjiang  Yuan</span>, <span class="hlFld-ContribAuthor ">Qinggang  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>195 </em>, 112278. <a href="https://doi.org/10.1016/j.ejmech.2020.112278" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112278%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B3%25252C4-dihydro-2%2525281H%252529-quinolinone%252Bderivatives%252Bas%252Bpotential%252Bchitin%252Bsynthase%252Binhibitors%252Band%252Bantifungal%252Bagents%26aulast%3DLi%26aufirst%3DBaihui%26date%3D2020%26volume%3D195%26spage%3D112278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew D.  Strub</span>, <span class="hlFld-ContribAuthor ">Paul B.  McCray, Jr.</span>. </span><span class="cited-content_cbyCitation_article-title">Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease. </span><span class="cited-content_cbyCitation_journal-name">Genes</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 546. <a href="https://doi.org/10.3390/genes11050546" title="DOI URL">https://doi.org/10.3390/genes11050546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/genes11050546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fgenes11050546%26sid%3Dliteratum%253Aachs%26jtitle%3DGenes%26atitle%3DTranscriptomic%252Band%252BProteostasis%252BNetworks%252Bof%252BCFTR%252Band%252Bthe%252BDevelopment%252Bof%252BSmall%252BMolecule%252BModulators%252Bfor%252Bthe%252BTreatment%252Bof%252BCystic%252BFibrosis%252BLung%252BDisease%26aulast%3DStrub%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D5%26spage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Lei</span>, <span class="hlFld-ContribAuthor ">Yong  Li</span>, <span class="hlFld-ContribAuthor ">Liu-Jun  He</span>, <span class="hlFld-ContribAuthor ">Ya-Fei  Luo</span>, <span class="hlFld-ContribAuthor ">Dian-Yong  Tang</span>, <span class="hlFld-ContribAuthor ">Wei  Yan</span>, <span class="hlFld-ContribAuthor ">Hui-Kuan  Lin</span>, <span class="hlFld-ContribAuthor ">Hong-yu  Li</span>, <span class="hlFld-ContribAuthor ">Zhong-Zhu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhi-Gang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Expeditious access of chromone analogues
              via
              a Michael addition-driven multicomponent reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (8)
                                     , 987-992. <a href="https://doi.org/10.1039/D0QO00145G" title="DOI URL">https://doi.org/10.1039/D0QO00145G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00145G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00145G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DExpeditious%252Baccess%252Bof%252Bchromone%252Banalogues%252Bvia%252Ba%252BMichael%252Baddition-driven%252Bmulticomponent%252Breaction%26aulast%3DLei%26aufirst%3DJie%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D8%26spage%3D987%26epage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Colm  Kerr</span>, <span class="hlFld-ContribAuthor ">David  Morrissy</span>, <span class="hlFld-ContribAuthor ">Mary  Horgan</span>, <span class="hlFld-ContribAuthor ">Barry J  Plant</span>. </span><span class="cited-content_cbyCitation_article-title">Microbial clues lead to a diagnosis of cystic fibrosis in late adulthood. </span><span class="cited-content_cbyCitation_journal-name">BMJ Case Reports</span><span> <strong>2020,</strong> <em>13 </em>
                                    (4)
                                     , e233470. <a href="https://doi.org/10.1136/bcr-2019-233470" title="DOI URL">https://doi.org/10.1136/bcr-2019-233470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1136/bcr-2019-233470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1136%2Fbcr-2019-233470%26sid%3Dliteratum%253Aachs%26jtitle%3DBMJ%2520Case%2520Reports%26atitle%3DMicrobial%252Bclues%252Blead%252Bto%252Ba%252Bdiagnosis%252Bof%252Bcystic%252Bfibrosis%252Bin%252Blate%252Badulthood%26aulast%3DKerr%26aufirst%3DColm%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D4%26spage%3De233470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K. M.  Lee</span>, <span class="hlFld-ContribAuthor ">Z. H.  Hawi</span>, <span class="hlFld-ContribAuthor ">H. C.  Parkington</span>, <span class="hlFld-ContribAuthor ">C. L.  Parish</span>, <span class="hlFld-ContribAuthor ">P. V.  Kumar</span>, <span class="hlFld-ContribAuthor ">J. M.  Polo</span>, <span class="hlFld-ContribAuthor ">M. A.  Bellgrove</span>, <span class="hlFld-ContribAuthor ">J.  Tong</span>. </span><span class="cited-content_cbyCitation_article-title">The application of human pluripotent stem cells to model the neuronal and glial components of neurodevelopmental disorders. </span><span class="cited-content_cbyCitation_journal-name">Molecular Psychiatry</span><span> <strong>2020,</strong> <em>25 </em>
                                    (2)
                                     , 368-378. <a href="https://doi.org/10.1038/s41380-019-0495-0" title="DOI URL">https://doi.org/10.1038/s41380-019-0495-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41380-019-0495-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41380-019-0495-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Psychiatry%26atitle%3DThe%252Bapplication%252Bof%252Bhuman%252Bpluripotent%252Bstem%252Bcells%252Bto%252Bmodel%252Bthe%252Bneuronal%252Band%252Bglial%252Bcomponents%252Bof%252Bneurodevelopmental%252Bdisorders%26aulast%3DLee%26aufirst%3DK.%2BM.%26date%3D2020%26date%3D2019%26volume%3D25%26issue%3D2%26spage%3D368%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tracey L.  Bonfield</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Modeling for Therapeutic Development in Cystic Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Respiratory and Critical Care Medicine</span><span> <strong>2020,</strong> <em>201 </em>
                                    (3)
                                     , 267-268. <a href="https://doi.org/10.1164/rccm.201910-2056ED" title="DOI URL">https://doi.org/10.1164/rccm.201910-2056ED</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1164/rccm.201910-2056ED&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1164%2Frccm.201910-2056ED%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Respiratory%2520and%2520Critical%2520Care%2520Medicine%26atitle%3DPreclinical%252BModeling%252Bfor%252BTherapeutic%252BDevelopment%252Bin%252BCystic%252BFibrosis%26aulast%3DBonfield%26aufirst%3DTracey%2BL.%26date%3D2020%26volume%3D201%26issue%3D3%26spage%3D267%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suraj M.  Sutar</span>, <span class="hlFld-ContribAuthor ">Hemantkumar M.  Savanur</span>, <span class="hlFld-ContribAuthor ">Shruti S.  Malunavar</span>, <span class="hlFld-ContribAuthor ">Geeta M.  Pawashe</span>, <span class="hlFld-ContribAuthor ">Gopalakrishnan  Aridoss</span>, <span class="hlFld-ContribAuthor ">Kang Min  Kim</span>, <span class="hlFld-ContribAuthor ">Jin Young  Lee</span>, <span class="hlFld-ContribAuthor ">Rajesh G.  Kalkhambkar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Molecular Modelling Studies of Coumarin and 1‐Aza‐Coumarin Linked Miconazole Analogues and Their Antimicrobial Properties. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (4)
                                     , 1322-1330. <a href="https://doi.org/10.1002/slct.201903572" title="DOI URL">https://doi.org/10.1002/slct.201903572</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201903572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201903572%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Band%252BMolecular%252BModelling%252BStudies%252Bof%252BCoumarin%252Band%252B1%2525E2%252580%252590Aza%2525E2%252580%252590Coumarin%252BLinked%252BMiconazole%252BAnalogues%252Band%252BTheir%252BAntimicrobial%252BProperties%26aulast%3DSutar%26aufirst%3DSuraj%2BM.%26date%3D2020%26volume%3D5%26issue%3D4%26spage%3D1322%26epage%3D1330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingjun  Liu</span>, <span class="hlFld-ContribAuthor ">Jiyuan  Li</span>, <span class="hlFld-ContribAuthor ">Wenhao  Dai</span>, <span class="hlFld-ContribAuthor ">Feng  Gao</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium(III)-Catalyzed Redox-Neutral [3+3] Annulation of N-nitrosoanilines with Cyclopropenones: A Traceless Approach to Quinolin-4(1H)-One Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (2)
                                     , 268. <a href="https://doi.org/10.3390/molecules25020268" title="DOI URL">https://doi.org/10.3390/molecules25020268</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25020268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25020268%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRhodium%252528III%252529-Catalyzed%252BRedox-Neutral%252B%25255B3%25252B3%25255D%252BAnnulation%252Bof%252BN-nitrosoanilines%252Bwith%252BCyclopropenones%25253A%252BA%252BTraceless%252BApproach%252Bto%252BQuinolin-4%2525281H%252529-One%252BScaffolds%26aulast%3DLiu%26aufirst%3DLingjun%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D2%26spage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han-I  Yeh</span>, <span class="hlFld-ContribAuthor ">Liming  Qiu</span>, <span class="hlFld-ContribAuthor ">Yoshiro  Sohma</span>, <span class="hlFld-ContribAuthor ">Katja  Conrath</span>, <span class="hlFld-ContribAuthor ">Xiaoqin  Zou</span>, <span class="hlFld-ContribAuthor ">Tzyh-Chang  Hwang</span>. </span><span class="cited-content_cbyCitation_article-title">Identifying the molecular target sites for CFTR potentiators GLPG1837 and VX-770. </span><span class="cited-content_cbyCitation_journal-name">Journal of General Physiology</span><span> <strong>2019,</strong> <em>151 </em>
                                    (7)
                                     , 912-928. <a href="https://doi.org/10.1085/jgp.201912360" title="DOI URL">https://doi.org/10.1085/jgp.201912360</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1085/jgp.201912360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1085%2Fjgp.201912360%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520General%2520Physiology%26atitle%3DIdentifying%252Bthe%252Bmolecular%252Btarget%252Bsites%252Bfor%252BCFTR%252Bpotentiators%252BGLPG1837%252Band%252BVX-770%26aulast%3DYeh%26aufirst%3DHan-I%26date%3D2019%26date%3D2019%26volume%3D151%26issue%3D7%26spage%3D912%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangyu  Liu</span>, <span class="hlFld-ContribAuthor ">Zhe  Zhang</span>, <span class="hlFld-ContribAuthor ">Anat  Levit</span>, <span class="hlFld-ContribAuthor ">Jesper  Levring</span>, <span class="hlFld-ContribAuthor ">Kouki K.  Touhara</span>, <span class="hlFld-ContribAuthor ">Brian K.  Shoichet</span>, <span class="hlFld-ContribAuthor ">Jue  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Structural identification of a hotspot on CFTR for potentiation. </span><span class="cited-content_cbyCitation_journal-name">Science</span><span> <strong>2019,</strong> <em>364 </em>
                                    (6446)
                                     , 1184-1188. <a href="https://doi.org/10.1126/science.aaw7611" title="DOI URL">https://doi.org/10.1126/science.aaw7611</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/science.aaw7611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscience.aaw7611%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%26atitle%3DStructural%252Bidentification%252Bof%252Ba%252Bhotspot%252Bon%252BCFTR%252Bfor%252Bpotentiation%26aulast%3DLiu%26aufirst%3DFangyu%26date%3D2019%26date%3D2019%26volume%3D364%26issue%3D6446%26spage%3D1184%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michele  Fiore</span>, <span class="hlFld-ContribAuthor ">Claudia  Cossu</span>, <span class="hlFld-ContribAuthor ">Valeria  Capurro</span>, <span class="hlFld-ContribAuthor ">Cristiana  Picco</span>, <span class="hlFld-ContribAuthor ">Alessandra  Ludovico</span>, <span class="hlFld-ContribAuthor ">Marcin  Mielczarek</span>, <span class="hlFld-ContribAuthor ">Israel  Carreira‐Barral</span>, <span class="hlFld-ContribAuthor ">Emanuela  Caci</span>, <span class="hlFld-ContribAuthor ">Debora  Baroni</span>, <span class="hlFld-ContribAuthor ">Roberto  Quesada</span>, <span class="hlFld-ContribAuthor ">Oscar  Moran</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule‐facilitated anion transporters in cells for a novel therapeutic approach to cystic fibrosis. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2019,</strong> <em>176 </em>
                                    (11)
                                     , 1764-1779. <a href="https://doi.org/10.1111/bph.14649" title="DOI URL">https://doi.org/10.1111/bph.14649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14649%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DSmall%252Bmolecule%2525E2%252580%252590facilitated%252Banion%252Btransporters%252Bin%252Bcells%252Bfor%252Ba%252Bnovel%252Btherapeutic%252Bapproach%252Bto%252Bcystic%252Bfibrosis%26aulast%3DFiore%26aufirst%3DMichele%26date%3D2019%26date%3D2019%26volume%3D176%26issue%3D11%26spage%3D1764%26epage%3D1779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jake E.  Doiron</span>, <span class="hlFld-ContribAuthor ">Christina A.  Le</span>, <span class="hlFld-ContribAuthor ">Britton K.  Ody</span>, <span class="hlFld-ContribAuthor ">Jonathon B.  Brace</span>, <span class="hlFld-ContribAuthor ">Savannah J.  Post</span>, <span class="hlFld-ContribAuthor ">Nathan L.  Thacker</span>, <span class="hlFld-ContribAuthor ">Harrison M.  Hill</span>, <span class="hlFld-ContribAuthor ">Gary W.  Breton</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Mulder</span>, <span class="hlFld-ContribAuthor ">Sichen  Chang</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Bridges</span>, <span class="hlFld-ContribAuthor ">Liping  Tang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Steven M.  Rowe</span>, <span class="hlFld-ContribAuthor ">Stephen G.  Aller</span>, <span class="hlFld-ContribAuthor ">Mark  Turlington</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of 1,2,3‐Triazoles as Amide Bioisosteres In Cystic Fibrosis Transmembrane Conductance Regulator Modulators VX‐770 and VX‐809. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (14)
                                     , 3662-3674. <a href="https://doi.org/10.1002/chem.201805919" title="DOI URL">https://doi.org/10.1002/chem.201805919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201805919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201805919%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DEvaluation%252Bof%252B1%25252C2%25252C3%2525E2%252580%252590Triazoles%252Bas%252BAmide%252BBioisosteres%252BIn%252BCystic%252BFibrosis%252BTransmembrane%252BConductance%252BRegulator%252BModulators%252BVX%2525E2%252580%252590770%252Band%252BVX%2525E2%252580%252590809%26aulast%3DDoiron%26aufirst%3DJake%2BE.%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D14%26spage%3D3662%26epage%3D3674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">On-Yu  Kang</span>, <span class="hlFld-ContribAuthor ">Seong Jun  Park</span>, <span class="hlFld-ContribAuthor ">Hyojung  Ahn</span>, <span class="hlFld-ContribAuthor ">Kyung Chae  Jeong</span>, <span class="hlFld-ContribAuthor ">Hwan Jung  Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Structural assignment of the enol–keto tautomers of one-pot synthesized 4-hydroxyquinolines/4-quinolones. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2019,</strong> <em>6 </em>
                                    (2)
                                     , 183-189. <a href="https://doi.org/10.1039/C8QO00884A" title="DOI URL">https://doi.org/10.1039/C8QO00884A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8QO00884A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8QO00884A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DStructural%252Bassignment%252Bof%252Bthe%252Benol%2525E2%252580%252593keto%252Btautomers%252Bof%252Bone-pot%252Bsynthesized%252B4-hydroxyquinolines%25252F4-quinolones%26aulast%3DKang%26aufirst%3DOn-Yu%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D2%26spage%3D183%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingyao  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying-Chun  Yu</span>, <span class="hlFld-ContribAuthor ">Jiunn-Tyng  Yeh</span>, <span class="hlFld-ContribAuthor ">Tzyh-Chang  Hwang</span>, . </span><span class="cited-content_cbyCitation_article-title">Functional characterization reveals that zebrafish CFTR prefers to occupy closed channel conformations. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2018,</strong> <em>13 </em>
                                    (12)
                                     , e0209862. <a href="https://doi.org/10.1371/journal.pone.0209862" title="DOI URL">https://doi.org/10.1371/journal.pone.0209862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0209862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0209862%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DFunctional%252Bcharacterization%252Breveals%252Bthat%252Bzebrafish%252BCFTR%252Bprefers%252Bto%252Boccupy%252Bclosed%252Bchannel%252Bconformations%26aulast%3DZhang%26aufirst%3DJingyao%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D12%26spage%3De0209862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maarten  Gees</span>, <span class="hlFld-ContribAuthor ">Sara  Musch</span>, <span class="hlFld-ContribAuthor ">Steven  Van der Plas</span>, <span class="hlFld-ContribAuthor ">Anne-Sophie  Wesse</span>, <span class="hlFld-ContribAuthor ">Ann  Vandevelde</span>, <span class="hlFld-ContribAuthor ">Katleen  Verdonck</span>, <span class="hlFld-ContribAuthor ">Oscar  Mammoliti</span>, <span class="hlFld-ContribAuthor ">Tzyh-Chang  Hwang</span>, <span class="hlFld-ContribAuthor ">Kathleen  Sonck</span>, <span class="hlFld-ContribAuthor ">Pieter  Stouten</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Swensen</span>, <span class="hlFld-ContribAuthor ">Mia  Jans</span>, <span class="hlFld-ContribAuthor ">Jan  Van der Schueren</span>, <span class="hlFld-ContribAuthor ">Luc  Nelles</span>, <span class="hlFld-ContribAuthor ">Martin  Andrews</span>, <span class="hlFld-ContribAuthor ">Katja  Conrath</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Characterization of Novel CFTR Potentiators. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fphar.2018.01221" title="DOI URL">https://doi.org/10.3389/fphar.2018.01221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2018.01221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2018.01221%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DIdentification%252Band%252BCharacterization%252Bof%252BNovel%252BCFTR%252BPotentiators%26aulast%3DGees%26aufirst%3DMaarten%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. Michael  Hamilton</span>, <span class="hlFld-ContribAuthor ">Maurita  Hung</span>, <span class="hlFld-ContribAuthor ">Gang  Chen</span>, <span class="hlFld-ContribAuthor ">Zafar  Qureshi</span>, <span class="hlFld-ContribAuthor ">John R.  Thompson</span>, <span class="hlFld-ContribAuthor ">Bingyun  Sun</span>, <span class="hlFld-ContribAuthor ">Christine E.  Bear</span>, <span class="hlFld-ContribAuthor ">Robert N.  Young</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and characterization of a photoaffinity labelling probe based on the structure of the cystic fibrosis drug ivacaftor. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (38)
                                     , 5528-5538. <a href="https://doi.org/10.1016/j.tet.2018.06.016" title="DOI URL">https://doi.org/10.1016/j.tet.2018.06.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.06.016%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Band%252Bcharacterization%252Bof%252Ba%252Bphotoaffinity%252Blabelling%252Bprobe%252Bbased%252Bon%252Bthe%252Bstructure%252Bof%252Bthe%252Bcystic%252Bfibrosis%252Bdrug%252Bivacaftor%26aulast%3DHamilton%26aufirst%3DC.%2BMichael%26date%3D2018%26volume%3D74%26issue%3D38%26spage%3D5528%26epage%3D5538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sunil M.  Patil</span>, <span class="hlFld-ContribAuthor ">Ramesh S.  Vadavi</span>, <span class="hlFld-ContribAuthor ">Suneel  Dodamani</span>, <span class="hlFld-ContribAuthor ">Umashri  Kendur</span>, <span class="hlFld-ContribAuthor ">Geeta  Chimmalagi</span>, <span class="hlFld-ContribAuthor ">Sunil  Jalalpure</span>, <span class="hlFld-ContribAuthor ">Christopher S.  Frampton</span>, <span class="hlFld-ContribAuthor ">Kalagouda B.  Gudasi</span>. </span><span class="cited-content_cbyCitation_article-title">Transition metal complexes of a hydrazone derived from hydralazine hydrochloride and 3,5-di-tert-butylsalicylaldehyde. </span><span class="cited-content_cbyCitation_journal-name">Transition Metal Chemistry</span><span> <strong>2018,</strong> <em>43 </em>
                                    (1)
                                     , 65-72. <a href="https://doi.org/10.1007/s11243-017-0194-0" title="DOI URL">https://doi.org/10.1007/s11243-017-0194-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11243-017-0194-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11243-017-0194-0%26sid%3Dliteratum%253Aachs%26jtitle%3DTransition%2520Metal%2520Chemistry%26atitle%3DTransition%252Bmetal%252Bcomplexes%252Bof%252Ba%252Bhydrazone%252Bderived%252Bfrom%252Bhydralazine%252Bhydrochloride%252Band%252B3%25252C5-di-tert-butylsalicylaldehyde%26aulast%3DPatil%26aufirst%3DSunil%2BM.%26date%3D2018%26date%3D2017%26volume%3D43%26issue%3D1%26spage%3D65%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Phil R.  Kym</span>, <span class="hlFld-ContribAuthor ">Xueqing  Wang</span>, <span class="hlFld-ContribAuthor ">Mathieu  Pizzonero</span>, <span class="hlFld-ContribAuthor ">Steven E.  Van der Plas</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in the Discovery and Development of Small-Molecule Modulators of CFTR. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 235-276. <a href="https://doi.org/10.1016/bs.pmch.2018.01.001" title="DOI URL">https://doi.org/10.1016/bs.pmch.2018.01.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2018.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2018.01.001%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BProgress%252Bin%252Bthe%252BDiscovery%252Band%252BDevelopment%252Bof%252BSmall-Molecule%252BModulators%252Bof%252BCFTR%26aulast%3DKym%26aufirst%3DPhil%2BR.%26date%3D2018%26spage%3D235%26epage%3D276%26pub%3DElsevier%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han-I  Yeh</span>, <span class="hlFld-ContribAuthor ">Yoshiro  Sohma</span>, <span class="hlFld-ContribAuthor ">Katja  Conrath</span>, <span class="hlFld-ContribAuthor ">Tzyh-Chang  Hwang</span>. </span><span class="cited-content_cbyCitation_article-title">A common mechanism for CFTR potentiators. </span><span class="cited-content_cbyCitation_journal-name">Journal of General Physiology</span><span> <strong>2017,</strong> <em>149 </em>
                                    (12)
                                     , 1105-1118. <a href="https://doi.org/10.1085/jgp.201711886" title="DOI URL">https://doi.org/10.1085/jgp.201711886</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1085/jgp.201711886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1085%2Fjgp.201711886%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520General%2520Physiology%26atitle%3DA%252Bcommon%252Bmechanism%252Bfor%252BCFTR%252Bpotentiators%26aulast%3DYeh%26aufirst%3DHan-I%26date%3D2017%26date%3D2017%26volume%3D149%26issue%3D12%26spage%3D1105%26epage%3D1118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Zhang</span>, <span class="hlFld-ContribAuthor ">Guanyu  Han</span>, <span class="hlFld-ContribAuthor ">Luobin  Jiang</span>, <span class="hlFld-ContribAuthor ">Yao  Shen</span>, <span class="hlFld-ContribAuthor ">Rui  Yang</span>, <span class="hlFld-ContribAuthor ">Yongjun  Mao</span>, <span class="hlFld-ContribAuthor ">Hang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An Efficient Synthesis of Ivacaftor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2017,</strong> <em>54 </em>
                                    (6)
                                     , 3169-3173. <a href="https://doi.org/10.1002/jhet.2931" title="DOI URL">https://doi.org/10.1002/jhet.2931</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2931%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DAn%252BEfficient%252BSynthesis%252Bof%252BIvacaftor%26aulast%3DZhang%26aufirst%3DRui%26date%3D2017%26date%3D2017%26volume%3D54%26issue%3D6%26spage%3D3169%26epage%3D3173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Glenn E.  Croston</span>. </span><span class="cited-content_cbyCitation_article-title">The utility of target-based discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2017,</strong> <em>12 </em>
                                    (5)
                                     , 427-429. <a href="https://doi.org/10.1080/17460441.2017.1308351" title="DOI URL">https://doi.org/10.1080/17460441.2017.1308351</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2017.1308351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2017.1308351%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DThe%252Butility%252Bof%252Btarget-based%252Bdiscovery%26aulast%3DCroston%26aufirst%3DGlenn%2BE.%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D5%26spage%3D427%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olga  Zegarra-Moran</span>, <span class="hlFld-ContribAuthor ">Luis J. V.  Galietta</span>. </span><span class="cited-content_cbyCitation_article-title">CFTR pharmacology. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2017,</strong> <em>74 </em>
                                    (1)
                                     , 117-128. <a href="https://doi.org/10.1007/s00018-016-2392-x" title="DOI URL">https://doi.org/10.1007/s00018-016-2392-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-016-2392-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-016-2392-x%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DCFTR%252Bpharmacology%26aulast%3DZegarra-Moran%26aufirst%3DOlga%26date%3D2017%26date%3D2016%26volume%3D74%26issue%3D1%26spage%3D117%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.C.  Silva</span>, <span class="hlFld-ContribAuthor ">A.  Cross</span>, <span class="hlFld-ContribAuthor ">N.J.  Brandon</span>, <span class="hlFld-ContribAuthor ">S.J.  Haggarty</span>. </span><span class="cited-content_cbyCitation_article-title">Human iPSC Models in Drug Discovery: Opportunities and Challenges. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 48-73. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12284-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12284-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12284-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12284-X%26sid%3Dliteratum%253Aachs%26atitle%3DHuman%252BiPSC%252BModels%252Bin%252BDrug%252BDiscovery%25253A%252BOpportunities%252Band%252BChallenges%26aulast%3DSilva%26aufirst%3DM.C.%26date%3D2017%26spage%3D48%26epage%3D73%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neil A.  Bradbury</span>. </span><span class="cited-content_cbyCitation_article-title">All Cells Have a Sex. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 269-290. <a href="https://doi.org/10.1016/B978-0-12-803506-1.00051-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-803506-1.00051-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803506-1.00051-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803506-1.00051-6%26sid%3Dliteratum%253Aachs%26atitle%3DAll%252BCells%252BHave%252Ba%252BSex%26aulast%3DBradbury%26aufirst%3DNeil%2BA.%26date%3D2017%26spage%3D269%26epage%3D290%26pub%3DElsevier%26atitle%3DPrinciples%252Bof%252BGender-Specific%252BMedicine%26date%3D2017%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael Glenn  O'Connor</span>, <span class="hlFld-ContribAuthor ">Adam  Seegmiller</span>. </span><span class="cited-content_cbyCitation_article-title">The effects of ivacaftor on CF fatty acid metabolism: An analysis from the GOAL study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cystic Fibrosis</span><span> <strong>2017,</strong> <em>16 </em>
                                    (1)
                                     , 132-138. <a href="https://doi.org/10.1016/j.jcf.2016.07.006" title="DOI URL">https://doi.org/10.1016/j.jcf.2016.07.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jcf.2016.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jcf.2016.07.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cystic%2520Fibrosis%26atitle%3DThe%252Beffects%252Bof%252Bivacaftor%252Bon%252BCF%252Bfatty%252Bacid%252Bmetabolism%25253A%252BAn%252Banalysis%252Bfrom%252Bthe%252BGOAL%252Bstudy%26aulast%3DO%2527Connor%26aufirst%3DMichael%2BGlenn%26date%3D2017%26volume%3D16%26issue%3D1%26spage%3D132%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathaniel H.  Park</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Senter</span>, <span class="hlFld-ContribAuthor ">Stephen L.  Buchwald</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid Synthesis of Aryl Fluorides in Continuous Flow through the Balz-Schiemann Reaction. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2016,</strong> <em>128 </em>
                                    (39)
                                     , 12086-12090. <a href="https://doi.org/10.1002/ange.201606601" title="DOI URL">https://doi.org/10.1002/ange.201606601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201606601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201606601%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DRapid%252BSynthesis%252Bof%252BAryl%252BFluorides%252Bin%252BContinuous%252BFlow%252Bthrough%252Bthe%252BBalz-Schiemann%252BReaction%26aulast%3DPark%26aufirst%3DNathaniel%2BH.%26date%3D2016%26date%3D2016%26volume%3D128%26issue%3D39%26spage%3D12086%26epage%3D12090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathaniel H.  Park</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Senter</span>, <span class="hlFld-ContribAuthor ">Stephen L.  Buchwald</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid Synthesis of Aryl Fluorides in Continuous Flow through the Balz-Schiemann Reaction. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2016,</strong> <em>55 </em>
                                    (39)
                                     , 11907-11911. <a href="https://doi.org/10.1002/anie.201606601" title="DOI URL">https://doi.org/10.1002/anie.201606601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201606601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201606601%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DRapid%252BSynthesis%252Bof%252BAryl%252BFluorides%252Bin%252BContinuous%252BFlow%252Bthrough%252Bthe%252BBalz-Schiemann%252BReaction%26aulast%3DPark%26aufirst%3DNathaniel%2BH.%26date%3D2016%26date%3D2016%26volume%3D55%26issue%3D39%26spage%3D11907%26epage%3D11911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen J.  Haggarty</span>, <span class="hlFld-ContribAuthor ">M. Catarina  Silva</span>, <span class="hlFld-ContribAuthor ">Alan  Cross</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Brandon</span>, <span class="hlFld-ContribAuthor ">Roy H.  Perlis</span>. </span><span class="cited-content_cbyCitation_article-title">Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Neuroscience</span><span> <strong>2016,</strong> <em>73 </em>, 104-115. <a href="https://doi.org/10.1016/j.mcn.2016.01.011" title="DOI URL">https://doi.org/10.1016/j.mcn.2016.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mcn.2016.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mcn.2016.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Neuroscience%26atitle%3DAdvancing%252Bdrug%252Bdiscovery%252Bfor%252Bneuropsychiatric%252Bdisorders%252Busing%252Bpatient-specific%252Bstem%252Bcell%252Bmodels%26aulast%3DHaggarty%26aufirst%3DStephen%2BJ.%26date%3D2016%26volume%3D73%26spage%3D104%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Chiba</span>, <span class="hlFld-ContribAuthor ">Gerhard F.  Ecker</span>, <span class="hlFld-ContribAuthor ">Fauzia  Nasim</span>, <span class="hlFld-ContribAuthor ">Yaprak  Dönmez-Cakil</span>. </span><span class="cited-content_cbyCitation_article-title">Interaction of ABC Transporters with Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 135-151. <a href="https://doi.org/10.1007/978-3-319-23476-2_7" title="DOI URL">https://doi.org/10.1007/978-3-319-23476-2_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-23476-2_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-23476-2_7%26sid%3Dliteratum%253Aachs%26atitle%3DInteraction%252Bof%252BABC%252BTransporters%252Bwith%252BDrugs%26aulast%3DChiba%26aufirst%3DPeter%26date%3D2016%26date%3D2015%26spage%3D135%26epage%3D151%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DABC%252BTransporters%252B-%252B40%252BYears%252Bon%26aulast%3DGeorge%26aufirst%3DAnthony%2BM.%26date%3D2016%26volume%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miguel  Paraja</span>, <span class="hlFld-ContribAuthor ">Carlos  Valdés</span>. </span><span class="cited-content_cbyCitation_article-title">Pd-catalyzed cascade reactions between o-iodo-N-alkenylanilines and tosylhydrazones: novel approaches to the synthesis of polysubstituted indoles and 1,4-dihydroquinolines. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2016,</strong> <em>52 </em>
                                    (37)
                                     , 6312-6315. <a href="https://doi.org/10.1039/C6CC01880G" title="DOI URL">https://doi.org/10.1039/C6CC01880G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6CC01880G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6CC01880G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DPd-catalyzed%252Bcascade%252Breactions%252Bbetween%252Bo-iodo-N-alkenylanilines%252Band%252Btosylhydrazones%25253A%252Bnovel%252Bapproaches%252Bto%252Bthe%252Bsynthesis%252Bof%252Bpolysubstituted%252Bindoles%252Band%252B1%25252C4-dihydroquinolines%26aulast%3DParaja%26aufirst%3DMiguel%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D37%26spage%3D6312%26epage%3D6315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cho K.  Lai</span>, <span class="hlFld-ContribAuthor ">Theresa V.  Song</span>, <span class="hlFld-ContribAuthor ">Jie Jack  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Ivacaftor (Kalydeco): A CFTR Potentiator for the Treatment of Cystic Fibrosis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 303-316. <a href="https://doi.org/10.1002/9781118819951.ch16" title="DOI URL">https://doi.org/10.1002/9781118819951.ch16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118819951.ch16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118819951.ch16%26sid%3Dliteratum%253Aachs%26atitle%3DIvacaftor%252B%252528Kalydeco%252529%25253A%252BA%252BCFTR%252BPotentiator%252Bfor%252Bthe%252BTreatment%252Bof%252BCystic%252BFibrosis%26aulast%3DLai%26aufirst%3DCho%2BK.%26date%3D2015%26date%3D2015%26spage%3D303%26epage%3D316%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DInnovative%252BDrug%252BSynthesis%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2015%26volume%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.  Vasudevan</span>, <span class="hlFld-ContribAuthor ">Gorakhnath R.  Jachak</span>, <span class="hlFld-ContribAuthor ">D. Srinivasa  Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Breaking and Making of Rings: A Method for the Preparation of 4-Quinolone-3-carb­oxylic Acid Amides and the Expensive Drug Ivacaftor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (34)
                                     , 7433-7437. <a href="https://doi.org/10.1002/ejoc.201501048" title="DOI URL">https://doi.org/10.1002/ejoc.201501048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201501048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201501048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DBreaking%252Band%252BMaking%252Bof%252BRings%25253A%252BA%252BMethod%252Bfor%252Bthe%252BPreparation%252Bof%252B4-Quinolone-3-carb%2525C2%2525ADoxylic%252BAcid%252BAmides%252Band%252Bthe%252BExpensive%252BDrug%252BIvacaftor%26aulast%3DVasudevan%26aufirst%3DN.%26date%3D2015%26date%3D2015%26volume%3D2015%26issue%3D34%26spage%3D7433%26epage%3D7437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naomi L.  Pollock</span>, <span class="hlFld-ContribAuthor ">Tracy L.  Rimington</span>, <span class="hlFld-ContribAuthor ">Robert C.  Ford</span>. </span><span class="cited-content_cbyCitation_article-title">Characterizing diverse orthologues of the cystic fibrosis transmembrane conductance regulator protein for structural studies. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Society Transactions</span><span> <strong>2015,</strong> <em>43 </em>
                                    (5)
                                     , 894-900. <a href="https://doi.org/10.1042/BST20150081" title="DOI URL">https://doi.org/10.1042/BST20150081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BST20150081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBST20150081%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Society%2520Transactions%26atitle%3DCharacterizing%252Bdiverse%252Borthologues%252Bof%252Bthe%252Bcystic%252Bfibrosis%252Btransmembrane%252Bconductance%252Bregulator%252Bprotein%252Bfor%252Bstructural%252Bstudies%26aulast%3DPollock%26aufirst%3DNaomi%25C2%25A0L.%26date%3D2015%26date%3D2015%26volume%3D43%26issue%3D5%26spage%3D894%26epage%3D900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0001.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of CFTR potentiators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0002.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed active tautomer of compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0003.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray structure of compound <b>16</b>. Anisotropic atomic displacement ellipsoids for the non-hydrogen atoms are shown at the 50% probability level. Hydrogen atoms are displayed with an arbitrarily small radius.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Quinolinone-4-oxo-3-sulfonamide <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ClSO<sub>3</sub>H, 125 °C, 100%; (b) 6-indolylamine, pyridine, DCE, Δ<i>T</i>, 3%.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Reverse Amide <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaOH, H<sub>2</sub>O, rt to 45 °C; (b) anthranilic acid, HCl, H<sub>2</sub>O, 96% over two steps; (c) AcONa anhydrous, Ac<sub>2</sub>O, 120 °C, 41%; (d) ammonium formate, Pd/C, THF, 70 °C, 99%; (e) 6-indolylcarboxylic acid, HATU, DIEA, DMF, rt, 21%.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Compound <b>36</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a><sup>,</sup><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) fuming HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4,</sub> 0 °C to rt, 95% ; (b) H<sub>2</sub>, Pd/C, MeOH, 51%; (c) HATU, DIEA, DMF, 62%.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of <b>49</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ag<sub>2</sub>SO<sub>4</sub>, Br<sub>2</sub>, 90% H<sub>2</sub>SO<sub>4</sub>, 98%; (b) Pd(PPh<sub>3</sub>)<sub>4</sub>, Zn(CN)<sub>2</sub>, DMF, 200 °C, 80%; (c) BH<sub>3</sub>, THF, 70 °C, 43%; (d) Boc<sub>2</sub>O, THF, 70 °C, 78%; (e) H<sub>2</sub>, Pd/C, AcOH, MeOH, 92%; (f) (i) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), DMF, TEA, HBTU; (ii) CH<sub>2</sub>Cl<sub>2</sub>, TFA, 53% over two steps.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of <b>40</b> and <b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 75% H<sub>2</sub>SO<sub>4</sub>, microwave, 200 °C, 90%; (b) (i) K<sub>2</sub>CO<sub>3</sub>, MeI, DMF, 71%; (ii) Pd/C, HCO<sub>2</sub>H, EtOH, 95%; (c) LAH, THF, 70 °C, 20%; (d) (i) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), HATU, Et<sub>3</sub>N, DMF, 60 °C, 80%; (ii) LiOH, MeOH, THF, microwave 140 °C, 66%; (e) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), HBTU, Et<sub>3</sub>N, DMF, 5%.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of <b>42</b> and <b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, 64%; (b) (i) NaNO<sub>2</sub>, H<sub>2</sub>SO<sub>4</sub>–H<sub>2</sub>O, 62%; (ii) NH<sub>4</sub>CO<sub>2</sub>H, Pd–C, 87%; (c) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), HBTU, Et<sub>3</sub>N, DMF, 47% (<b>45</b>), 33% (<b>42</b>); (d) (i) NaNO<sub>2</sub>, HCl, Na<sub>2</sub>SO<sub>3</sub>, CuSO<sub>4</sub>, H<sub>2</sub>O, 17%; (ii) NH<sub>4</sub>OH, diethyl ether, 34% ; (iii) SnCl<sub>2</sub>, EtOH, 100%.</p></p></figure><figure data-id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Preparation of <b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaNO<sub>2</sub>, HPF<sub>6,</sub> 12%; (b) NaBH<sub>4,</sub> NiCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 75%; (c) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), HATU, Et<sub>3</sub>N, THF, 21%.</p></p></figure><figure data-id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Preparation of <b>46</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <sup><i>t</i></sup>BuOH, H<sub>2</sub>SO<sub>4</sub>, AlCl<sub>3,</sub> 42%; (b) CH<sub>3</sub>CO<sub>2</sub>Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2,</sub> 59%; (c) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4,</sub> 55%; (d) piperidine, CH<sub>2</sub>Cl<sub>2,</sub> 62%; (e) ammonium formate, Pd/C, EtOH, 83%; (f) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), HBTU, Et<sub>3</sub>N, DMF, 23%.</p></p></figure><figure data-id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Preparation of <b>47</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, CH<sub>3</sub>CN, 68%; (b) CH<sub>3</sub>CO<sub>2</sub>Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 72%; (c) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4,</sub> 83%; (d) KOH, MeOH, 96%; (e) BnBr, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 94%; (f) ClCF<sub>2</sub>CO<sub>2</sub>Me, KF, KBr, CuI, DMF, 67%; (g) ammonium formate, Pd/C, EtOH, 52%; (h) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), HBTU, Et<sub>3</sub>N, DMF, 8%.</p></p></figure><figure data-id="sch10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/medium/jm-2014-012808_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0013.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Preparation of <b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012808/20141205/images/large/jm-2014-012808_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012808&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>3</sub>CO<sub>2</sub>Cl, Et<sub>3</sub>N, DMAP, CH<sub>2</sub>Cl<sub>2,</sub> quant; (b) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>; (c) KOH, MeOH, 29% over two steps for the preparation of <b>91</b>; (d) ammonium formate, Pd/C, EtOH, quant; (e) 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (<b>49</b>), HBTU, Et<sub>3</sub>N, DMF, 71%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i119">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65327" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65327" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 42 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>Cystic Fibrosis Foundation: <a href="http://www.cff.org/" class="extLink">http://www.cff.org/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cystic+Fibrosis+Foundation%3A+http%3A%2F%2Fwww.cff.org%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Welsh, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. E.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1016%2F0092-8674%2893%2990353-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=7686820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADyaK3sXkvFant70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1993&pages=1251-1254&author=M.+J.+Welshauthor=A.+E.+Smith&title=Molecular+mechanisms+of+CFTR+chloride+channel+dysfunction+in+cystic+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis</span></div><div class="casAuthors">Welsh, Michael J.; Smith, Alan E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1251-4</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">A review with 24 refs. on mol. mechanisms by which cystic fibrosis-assocd. mutations cause a loss of CFTR chloride channel function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbYfixTm46m7Vg90H21EOLACvtfcHk0lj556asqTqW0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvFant70%253D&md5=a04cd81e1e4e5060cd4c94e66af7598d</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2893%2990353-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252893%252990353-R%26sid%3Dliteratum%253Aachs%26aulast%3DWelsh%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DA.%2BE.%26atitle%3DMolecular%2520mechanisms%2520of%2520CFTR%2520chloride%2520channel%2520dysfunction%2520in%2520cystic%2520fibrosis%26jtitle%3DCell%26date%3D1993%26volume%3D73%26spage%3D1251%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rowe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorscher, E. J.</span><span> </span><span class="NLM_article-title">Cystic Fibrosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">1992</span><span class="NLM_x">–</span> <span class="NLM_lpage">2001</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1056%2FNEJMra043184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=15888700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFyrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1992-2001&author=S.+M.+Roweauthor=S.+Millerauthor=E.+J.+Sorscher&title=Cystic+Fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Cystic fibrosis</span></div><div class="casAuthors">Rowe, Steven M.; Miller, Stacey; Sorscher, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1992-2001</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  Important advances have improved our understanding of the role of the CFTR protein in the progression of suppurative pulmonary failure in cystic fibrosis.  These discoveries are ushering in a new era of translational research that incorporates specific therapeutic targets and new cellular pathways.  Progress in research on cystic fibrosis will continue to rely on an improved understanding of CFTR function and its relationship to mucociliary clearance, airway secretion, and other ion channels.  Clin. advances directed at the correction of CFTR function predict an optimistic future for patients with cystic fibrosis and their families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKiiafli4tp7Vg90H21EOLACvtfcHk0lj556asqTqW0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFyrtLY%253D&md5=e6bc05b49d7b177d43dd7592ad63f0fb</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1056%2FNEJMra043184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra043184%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DS.%2BM.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DSorscher%26aufirst%3DE.%2BJ.%26atitle%3DCystic%2520Fibrosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1992%26epage%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">O’Sullivan, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. D.</span><span> </span><span class="NLM_article-title">Cystic fibrosis</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">1891</span><span class="NLM_x">–</span> <span class="NLM_lpage">1904</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2009&pages=1891-1904&author=B.+P.+O%E2%80%99Sullivanauthor=S.+D.+Freedman&title=Cystic+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DB.%2BP.%26aulast%3DFreedman%26aufirst%3DS.%2BD.%26atitle%3DCystic%2520fibrosis%26jtitle%3DLancet%26date%3D2009%26volume%3D373%26spage%3D1891%26epage%3D1904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Boyle, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBoeck, K.</span><span> </span><span class="NLM_article-title">A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect</span> <span class="citation_source-journal">Lancet Respir. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1016%2FS2213-2600%2812%2970057-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=158-163&author=M.+P.+Boyleauthor=K.+DeBoeck&title=A+new+era+in+the+treatment+of+cystic+fibrosis%3A+correction+of+the+underlying+CFTR+defect"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1016%2FS2213-2600%2812%2970057-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS2213-2600%252812%252970057-7%26sid%3Dliteratum%253Aachs%26aulast%3DBoyle%26aufirst%3DM.%2BP.%26aulast%3DDeBoeck%26aufirst%3DK.%26atitle%3DA%2520new%2520era%2520in%2520the%2520treatment%2520of%2520cystic%2520fibrosis%253A%2520correction%2520of%2520the%2520underlying%2520CFTR%2520defect%26jtitle%3DLancet%2520Respir.%2520Med.%26date%3D2013%26volume%3D12%26spage%3D158%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Rowe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clancy, J. P.</span><span> </span><span class="NLM_article-title">Advances in cystic fibrosis therapies</span> <span class="citation_source-journal">Curr. Opin. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">604</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1097%2FMOP.0b013e3280109b90" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=17099358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A280%3ADC%252BD28nmt1Cktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=604-613&author=S.+M.+Roweauthor=J.+P.+Clancy&title=Advances+in+cystic+fibrosis+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in cystic fibrosis therapies</span></div><div class="casAuthors">Rowe Steven M; Clancy John P</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in pediatrics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">604-13</span>
        ISSN:<span class="NLM_cas:issn">1040-8703</span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Over the past four decades, outcomes for patients with cystic fibrosis have improved dramatically.  Major contributors to this improvement are a better understanding of disease pathogenesis and the systematic conduct of clinical trials evaluating new therapies designed to address these defects.  This review describes recent developments in cystic fibrosis pulmonary therapies intended to treat various facets of the disease, including several treatments currently in development.  RECENT FINDINGS:  The mainstays of therapy for cystic fibrosis, such as nutritional support and mechanical mucus clearance, are now supplemented with aggressive antibiotic regimens intended to suppress or eradicate bacterial colonization, anti-inflammatory agents, and new approaches that improve mucociliary clearance.  Therapies in development address the underlying ion transport defect found in cystic fibrosis airways and also include small-molecule agents that restore function to the mutant cystic fibrosis transmembrane conductance regulator.  SUMMARY:  Recent advances in therapies for cystic fibrosis offer the promise of improved outcomes and longer lives for patients with cystic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDX7KjsEQJ0nwOGIfWJ7-GfW6udTcc2eaHzwK691_pcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nmt1Cktw%253D%253D&md5=a46bb8048fca7651d5f8ece637031e81</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2FMOP.0b013e3280109b90&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMOP.0b013e3280109b90%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DS.%2BM.%26aulast%3DClancy%26aufirst%3DJ.%2BP.%26atitle%3DAdvances%2520in%2520cystic%2520fibrosis%2520therapies%26jtitle%3DCurr.%2520Opin.%2520Pediatr.%26date%3D2006%26volume%3D18%26spage%3D604%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Van Goor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P. D. J.</span><span> </span><span class="NLM_article-title">Pharmacological rescue of mutant CFTR function for the treatment of cystic fibrosis</span> <span class="citation_source-journal">Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1007%2F7355_2008_022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=91-120&author=F.+Van+Goorauthor=S.+Hadidaauthor=P.+D.+J.+Grootenhuis&title=Pharmacological+rescue+of+mutant+CFTR+function+for+the+treatment+of+cystic+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2F7355_2008_022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F7355_2008_022%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DHadida%26aufirst%3DS.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%2BJ.%26atitle%3DPharmacological%2520rescue%2520of%2520mutant%2520CFTR%2520function%2520for%2520the%2520treatment%2520of%2520cystic%2520fibrosis%26jtitle%3DTop.%2520Med.%2520Chem.%26date%3D2008%26volume%3D3%26spage%3D91%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hadida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P. D. J.</span><span> </span><span class="NLM_article-title">CFTR modulators for the treatment of cystic fibrosis</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=157-173&author=S.+Hadidaauthor=F.+Van+Goorauthor=P.+D.+J.+Grootenhuis&title=CFTR+modulators+for+the+treatment+of+cystic+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHadida%26aufirst%3DS.%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%2BJ.%26atitle%3DCFTR%2520modulators%2520for%2520the%2520treatment%2520of%2520cystic%2520fibrosis%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D157%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pedemonte, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zegarra-Moran, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galietta, L. J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkman, A. S.</span><span> </span><span class="NLM_article-title">Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">2564</span><span class="NLM_x">–</span> <span class="NLM_lpage">2571</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1172%2FJCI24898" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=16127463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVSjs7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=2564-2571&author=N.+Pedemonteauthor=G.+L.+Lukacsauthor=K.+Duauthor=E.+Caciauthor=O.+Zegarra-Moranauthor=L.+J.+V.+Galiettaauthor=A.+S.+Verkman&title=Small-molecule+correctors+of+defective+DeltaF508-CFTR+cellular+processing+identified+by+high-throughput+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening</span></div><div class="casAuthors">Pedemonte, Nicoletta; Lukacs, Gergely L.; Du, Kai; Caci, Emanuela; Zegarra-Moran, Olga; Galietta, Luis J. V.; Verkman, A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2564-2571</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">The most common cause of cystic fibrosis (CF) is deletion of phenylalanine 508 (ΔF508) in the CF transmembrane conductance regulator (CFTR) chloride channel.  The ΔF508 mutation produces defects in folding, stability, and channel gating.  To identify small-mol. correctors of defective cellular processing, the authors assayed iodide flux in ΔF508-CFTR-transfected epithelial cells using a fluorescent halide indicator.  Screening of 150,000 chem. diverse compds. and more than 1500 analogs of active compds. yielded several classes of ΔF508-CFTR correctors (aminoarylthiazoles, quinazolinylaminopyrimidinones, and bisaminomethylbithiazoles) with micromolar potency that produced greater apical membrane chloride current than did low-temp. rescue.  Correction was seen within 3-6 h and persisted for more than 12 h after washout.  Functional correction was correlated with plasma membrane expression of complex-glycosylated ΔF508-CFTR protein.  Biochem. studies suggested a mechanism of action involving improved ΔF508-CFTR folding at the ER and stability at the cell surface.  The bisaminomethylbithiazoles cor. ΔF508-CFTR in ΔF508/ΔF508 human bronchial epithelia but did not correct a different temp.-sensitive CFTR mutant (P574H-CFTR) or a dopamine receptor mutant.  Small-mol. correctors may be useful in the treatment of CF caused by the ΔF508 mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0JvKffZOaLbVg90H21EOLACvtfcHk0ljdgeZOYLbnIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVSjs7%252FN&md5=514c68e675dd7a127e7fbe763cd9c4e8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1172%2FJCI24898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI24898%26sid%3Dliteratum%253Aachs%26aulast%3DPedemonte%26aufirst%3DN.%26aulast%3DLukacs%26aufirst%3DG.%2BL.%26aulast%3DDu%26aufirst%3DK.%26aulast%3DCaci%26aufirst%3DE.%26aulast%3DZegarra-Moran%26aufirst%3DO.%26aulast%3DGalietta%26aufirst%3DL.%2BJ.%2BV.%26aulast%3DVerkman%26aufirst%3DA.%2BS.%26atitle%3DSmall-molecule%2520correctors%2520of%2520defective%2520DeltaF508-CFTR%2520cellular%2520processing%2520identified%2520by%2520high-throughput%2520screening%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D2564%26epage%3D2571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naren, A. P.</span><span> </span><span class="NLM_article-title">Recent advance and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.4155%2Ffmc.12.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlGkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=329-345&author=W.+Zhangauthor=N.+Fujiiauthor=A.+P.+Naren&title=Recent+advance+and+new+perspectives+in+targeting+CFTR+for+therapy+of+cystic+fibrosis+and+enterotoxin-induced+secretory+diarrheas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas</span></div><div class="casAuthors">Zhang, Weiqiang; Fujii, Naoaki; Naren, Anjaparavanda P.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-345</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated chloride channel localized primarily at the apical surfaces of epithelial cells lining airway, gut, and exocrine glands, where it is responsible for transepithelial salt and water transport.  Several human diseases are assocd. with an altered channel function of CFTR.  Cystic fibrosis (CF) is caused by the loss or dysfunction of CFTR-channel activity resulting from the mutations on the gene; whereas enterotoxin-induced secretory diarrheas are caused by the hyperactivation of CFTR channel function.  CFTR is a validated target for drug development to treat these diseases.  Significant progress was made in developing CFTR modulator therapy by high-throughput screening followed by hit-to-lead optimization.  Several oral administrated investigational drugs are currently being evaluated in clin. trials for CF.  Also importantly, new ideas and methodologies are emerging.  Targeting CFTR-contg. macromol. complexes is one such novel approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFOzCPzfAWhLVg90H21EOLACvtfcHk0ljdgeZOYLbnIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlGkt7k%253D&md5=e30c647656b9e188a2cbfbc3b9e51c27</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.1%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DNaren%26aufirst%3DA.%2BP.%26atitle%3DRecent%2520advance%2520and%2520new%2520perspectives%2520in%2520targeting%2520CFTR%2520for%2520therapy%2520of%2520cystic%2520fibrosis%2520and%2520enterotoxin-induced%2520secretory%2520diarrheas%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D329%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Merk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz</span><span> </span><span class="NLM_article-title">Repairing mutated proteins—development of small molecules targeting defects in the cystic fibrosis transmembrane conductance regulator</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=691-708&author=D.+Merkauthor=+Schubert-Zsilavecz&title=Repairing+mutated+proteins%E2%80%94development+of+small+molecules+targeting+defects+in+the+cystic+fibrosis+transmembrane+conductance+regulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMerk%26aufirst%3DD.%26aulast%3DSchubert-Zsilavecz%26atitle%3DRepairing%2520mutated%2520proteins%25E2%2580%2594development%2520of%2520small%2520molecules%2520targeting%2520defects%2520in%2520the%2520cystic%2520fibrosis%2520transmembrane%2520conductance%2520regulator%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26spage%3D691%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Van Goor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straley, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazlewood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchenco, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negulescu, P.</span><span> </span><span class="NLM_article-title">Rescue of ΔF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules</span> <span class="citation_source-journal">Am. J. Physiol.: Lung Cell. Mol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">L1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">L1130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2006&pages=L1117-L1130&author=F.+Van+Goorauthor=K.+S.+Straleyauthor=D.+Caoauthor=J.+Gonzalezauthor=S.+Hadidaauthor=A.+Hazlewoodauthor=J.+Joubranauthor=T.+Knappauthor=M.+Millerauthor=T.+Neubergerauthor=E.+Olsonauthor=V.+Panchencoauthor=J.+Raderauthor=A.+Singhauthor=J.+H.+Stackauthor=R.+Tungauthor=P.+D.+J.+Grootenhuisauthor=P.+Negulescu&title=Rescue+of+%CE%94F508-CFTR+trafficking+and+gating+in+human+cystic+fibrosis+airway+primary+cultures+by+small+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DHadida%26aufirst%3DS.%26aulast%3DHazlewood%26aufirst%3DA.%26aulast%3DJoubran%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DNeuberger%26aufirst%3DT.%26aulast%3DOlson%26aufirst%3DE.%26aulast%3DPanchenco%26aufirst%3DV.%26aulast%3DRader%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DStack%26aufirst%3DJ.%2BH.%26aulast%3DTung%26aufirst%3DR.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%2BJ.%26aulast%3DNegulescu%26aufirst%3DP.%26atitle%3DRescue%2520of%2520%25CE%2594F508-CFTR%2520trafficking%2520and%2520gating%2520in%2520human%2520cystic%2520fibrosis%2520airway%2520primary%2520cultures%2520by%2520small%2520molecules%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Lung%2520Cell.%2520Mol.%2520Physiol.%26date%3D2006%26volume%3D290%26spage%3DL1117%26epage%3DL1130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Zegarra-Moran, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteverde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galietta, L. J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, O.</span><span> </span><span class="NLM_article-title">functional analysis of mutations in the putative binding site for cystic fibrosis transmembrane conductance regulator potentiators: interaction between activation and inhibition</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">9098</span><span class="NLM_x">–</span> <span class="NLM_lpage">9104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=9098-9104&author=O.+Zegarra-Moranauthor=M.+Monteverdeauthor=L.+J.+V.+Galiettaauthor=O.+Moran&title=functional+analysis+of+mutations+in+the+putative+binding+site+for+cystic+fibrosis+transmembrane+conductance+regulator+potentiators%3A+interaction+between+activation+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZegarra-Moran%26aufirst%3DO.%26aulast%3DMonteverde%26aufirst%3DM.%26aulast%3DGalietta%26aufirst%3DL.%2BJ.%2BV.%26aulast%3DMoran%26aufirst%3DO.%26atitle%3Dfunctional%2520analysis%2520of%2520mutations%2520in%2520the%2520putative%2520binding%2520site%2520for%2520cystic%2520fibrosis%2520transmembrane%2520conductance%2520regulator%2520potentiators%253A%2520interaction%2520between%2520activation%2520and%2520inhibition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D9098%26epage%3D9104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Pedemonte, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonawane, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zegarra-Moran, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suen, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicus, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willenbring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantz, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurth, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galietta, L. J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkman, A. S.</span><span> </span><span class="NLM_article-title">Phenylglycine and sulfonamide correctors of defective ΔF508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1797</span><span class="NLM_x">–</span> <span class="NLM_lpage">1807</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=1797-1807&author=N.+Pedemonteauthor=N.+D.+Sonawaneauthor=A.+Taddeiauthor=J.+Huauthor=O.+Zegarra-Moranauthor=Y.+T.+Suenauthor=L.+I.+Robinsauthor=C.+W.+Dicusauthor=D.+Willenbringauthor=M.+H.+Nantzauthor=M.+J.+Kurthauthor=L.+J.+V.+Galiettaauthor=A.+S.+Verkman&title=Phenylglycine+and+sulfonamide+correctors+of+defective+%CE%94F508+and+G551D+cystic+fibrosis+transmembrane+conductance+regulator+chloride-channel+gating"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPedemonte%26aufirst%3DN.%26aulast%3DSonawane%26aufirst%3DN.%2BD.%26aulast%3DTaddei%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DZegarra-Moran%26aufirst%3DO.%26aulast%3DSuen%26aufirst%3DY.%2BT.%26aulast%3DRobins%26aufirst%3DL.%2BI.%26aulast%3DDicus%26aufirst%3DC.%2BW.%26aulast%3DWillenbring%26aufirst%3DD.%26aulast%3DNantz%26aufirst%3DM.%2BH.%26aulast%3DKurth%26aufirst%3DM.%2BJ.%26aulast%3DGalietta%26aufirst%3DL.%2BJ.%2BV.%26aulast%3DVerkman%26aufirst%3DA.%2BS.%26atitle%3DPhenylglycine%2520and%2520sulfonamide%2520correctors%2520of%2520defective%2520%25CE%2594F508%2520and%2520G551D%2520cystic%2520fibrosis%2520transmembrane%2520conductance%2520regulator%2520chloride-channel%2520gating%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D67%26spage%3D1797%26epage%3D1807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Van Goor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazlewood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCartney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arumugam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frizzell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashlock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negulescu, P.</span><span> </span><span class="NLM_article-title">Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">18825</span><span class="NLM_x">–</span> <span class="NLM_lpage">18830</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1073%2Fpnas.0904709106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=19846789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKmsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=18825-18830&author=F.+Van+Goorauthor=S.+Hadidaauthor=P.+D.+J.+Grootenhuisauthor=B.+Burtonauthor=D.+Caoauthor=T.+Neubergerauthor=A.+Turnbullauthor=A.+Singhauthor=J.+Joubranauthor=A.+Hazlewoodauthor=J.+Zhouauthor=J.+McCartneyauthor=V.+Arumugamauthor=C.+Deckerauthor=J.+Yangauthor=C.+Youngauthor=E.+R.+Olsonauthor=J.+Wineauthor=R.+A.+Frizzellauthor=M.+Ashlockauthor=P.+Negulescu&title=Rescue+of+CF+airway+epithelial+cell+function+in+vitro+by+a+CFTR+potentiator%2C+VX-770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770</span></div><div class="casAuthors">Van Goor, Fredrick; Hadida, Sabine; Grootenhuis, Peter D. J.; Burton, Bill; Cao, Dong; Neuberger, Tim; Turnbull, Amanda; Singh, Ashvani; Joubran, John; Hazlewood, Anna; Zhou, Jinglan; McCartney, Jason; Arumugam, Vijayalaksmi; Decker, Caroline; Yang, Jennifer; Young, Chris; Olson, Eric R.; Wine, Jeffrey J.; Frizzell, Raymond A.; Ashlock, Melissa; Negulescu, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">18825-18830, S18825/1-S18825/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cystic fibrosis (CF) is a fatal genetic disease caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR), a protein kinase A (PKA)-activated epithelial anion channel involved in salt and fluid transport in multiple organs, including the lung.  Most CF mutations either reduce the no. of CFTR channels at the cell surface (e.g., synthesis or processing mutations) or impair channel function (e.g., gating or conductance mutations) or both.  There are currently no approved therapies that target CFTR.  Here we describe the in vitro pharmacol. of VX-770, an orally bioavailable CFTR potentiator in clin. development for the treatment of CF.  In recombinant cells VX-770 increased CFTR channel open probability (Po) in both the F508del processing mutation and the G551D gating mutation.  VX-770 also increased Cl- secretion in cultured human CF bronchial epithelia (HBE) carrying the G551D gating mutation on one allele and the F508del processing mutation on the other allele by ≈ 10-fold, to ≈ 50% of that obsd. in HBE isolated from individuals without CF.  Furthermore, VX-770 reduced excessive Na+ and fluid absorption to prevent dehydration of the apical surface and increased cilia, beating in these epithelial cultures.  These results support the hypothesis that pharmacol. agents that restore or increase CFTR function can rescue epithelial cell function in human CF airway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo89BTNOARZ5bVg90H21EOLACvtfcHk0ljPGWLxRD3xsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKmsLrI&md5=786c6c860d90115c29863a706f0e1248</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0904709106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0904709106%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DHadida%26aufirst%3DS.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%2BJ.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DNeuberger%26aufirst%3DT.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DJoubran%26aufirst%3DJ.%26aulast%3DHazlewood%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DMcCartney%26aufirst%3DJ.%26aulast%3DArumugam%26aufirst%3DV.%26aulast%3DDecker%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DOlson%26aufirst%3DE.%2BR.%26aulast%3DWine%26aufirst%3DJ.%26aulast%3DFrizzell%26aufirst%3DR.%2BA.%26aulast%3DAshlock%26aufirst%3DM.%26aulast%3DNegulescu%26aufirst%3DP.%26atitle%3DRescue%2520of%2520CF%2520airway%2520epithelial%2520cell%2520function%2520in%2520vitro%2520by%2520a%2520CFTR%2520potentiator%252C%2520VX-770%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D18825%26epage%3D18830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Accurso, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clancy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunitz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durie, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagel, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornick, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konstan, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donalson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilewski, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubenstein, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uluer, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aitken, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer-Hamblett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ordoñez, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashlock, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey, B. W.</span><span> </span><span class="NLM_article-title">Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1991</span><span class="NLM_x">–</span> <span class="NLM_lpage">2003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1056%2FNEJMoa0909825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=21083385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVykt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1991-2003&author=F.+J.+Accursoauthor=S.+M.+Roweauthor=J.+P.+Clancyauthor=M.+P.+Boyleauthor=J.+M.+Dunitzauthor=P.+R.+Durieauthor=S.+D.+Sagelauthor=D.+B.+Hornickauthor=M.+W.+Konstanauthor=S.+H.+Donalsonauthor=R.+B.+Mossauthor=J.+M.+Pilewskiauthor=R.+C.+Rubensteinauthor=A.+Z.+Uluerauthor=M.+L.+Aitkenauthor=S.+D.+Freedmanauthor=M.+R.+Lynnauthor=N.+Mayer-Hamblettauthor=Q.+Dongauthor=J.+Zhaauthor=A.+J.+Stoneauthor=E.+R.+Olsonauthor=C.+L.+Ordo%C3%B1ezauthor=P.+W.+Campbellauthor=M.+A.+Ashlockauthor=B.+W.+Ramsey&title=Effect+of+VX-770+in+persons+with+cystic+fibrosis+and+the+G551D-CFTR+mutation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation</span></div><div class="casAuthors">Accurso, Frank J.; Rowe, Steven M.; Clancy, J. P.; Boyle, Michael P.; Dunitz, Jordan M.; Durie, Peter R.; Sagel, Scott D.; Hornick, Douglas B.; Konstan, Michael W.; Donaldson, Scott H.; Moss, Richard B.; Pilewski, Joseph M.; Rubenstein, Ronald C.; Uluer, Ahmet Z.; Aitken, Moira L.; Freedman, Steven D.; Rose, Lynn M.; Mayer-Hamblett, Nicole; Dong, Qunming; Zha, Jiuhong; Stone, Annej.; Olson, Eric R.; Ordonez, Claudia L.; Campbell, Preston W.; Ashlock, Melissa A.; Ramsey, Bonnie W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1991-2003</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND A new approach in the treatment of cystic fibrosis involves improving the function of mutant cystic fibrosis transmembrane conductance regulator (CFTR).  VX-770, a CFTR potentiator, has been shown to increase the activity of wild-type and defective cell-surface CFTR in vitro.  METHODS We randomly assigned 39 adults with cystic fibrosis and at least one G551D-CFTR allele to receive oral VX-770 every 12 h at a dose of 25, 75, or 150 mg or placebo for 14 days (in part 1 of the study) or VX-770 every 12 h at a dose of 150 or 250 mg or placebo for 28 days (in part 2 of the study).  RESULTS At day 28, in the group of subjects who received 150 mg of VX-770, the median change in the nasal p.d. (in response to the administration of a chloride-free isoproterenol soln.) from baseline was -3.5 mV (range, -8.3 to 0.5; P = 0.02 for the within-subject comparison, P = 0.13 vs. placebo), and the median change in the level of sweat chloride was -59.5 mmol per L (range, -66.0 to -19.0; P = 0.008 within-subject, P = 0.02 vs. placebo).  The median change from baseline in the percent of predicted forced expiratory vol. in 1 s was 8.7% (range, 2.3 to 31.3; P = 0.008 for the within-subject comparison, P = 0.56 vs. placebo).  None of the subjects withdrew from the study.  Six severe adverse events occurred in two subjects (diffuse macular rash in one subject and five incidents of elevated blood and urine glucose levels in one subject with diabetes).  All severe adverse events resolved without the discontinuation of VX-770.  CONCLUSIONS This study to evaluate the safety and adverse-event profile of VX-770 showed that VX-770 was assocd. with within-subject improvements in CFTR and lung function.  These findings provide support for further studies of pharmacol. potentiation of CFTR as a means to treat cystic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiAWkJr_XSVrVg90H21EOLACvtfcHk0lgFcJKMcm3xQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVykt7jO&md5=35cd4c36f7676daec0f318e74abd25fa</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0909825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0909825%26sid%3Dliteratum%253Aachs%26aulast%3DAccurso%26aufirst%3DF.%2BJ.%26aulast%3DRowe%26aufirst%3DS.%2BM.%26aulast%3DClancy%26aufirst%3DJ.%2BP.%26aulast%3DBoyle%26aufirst%3DM.%2BP.%26aulast%3DDunitz%26aufirst%3DJ.%2BM.%26aulast%3DDurie%26aufirst%3DP.%2BR.%26aulast%3DSagel%26aufirst%3DS.%2BD.%26aulast%3DHornick%26aufirst%3DD.%2BB.%26aulast%3DKonstan%26aufirst%3DM.%2BW.%26aulast%3DDonalson%26aufirst%3DS.%2BH.%26aulast%3DMoss%26aufirst%3DR.%2BB.%26aulast%3DPilewski%26aufirst%3DJ.%2BM.%26aulast%3DRubenstein%26aufirst%3DR.%2BC.%26aulast%3DUluer%26aufirst%3DA.%2BZ.%26aulast%3DAitken%26aufirst%3DM.%2BL.%26aulast%3DFreedman%26aufirst%3DS.%2BD.%26aulast%3DLynn%26aufirst%3DM.%2BR.%26aulast%3DMayer-Hamblett%26aufirst%3DN.%26aulast%3DDong%26aufirst%3DQ.%26aulast%3DZha%26aufirst%3DJ.%26aulast%3DStone%26aufirst%3DA.%2BJ.%26aulast%3DOlson%26aufirst%3DE.%2BR.%26aulast%3DOrdo%25C3%25B1ez%26aufirst%3DC.%2BL.%26aulast%3DCampbell%26aufirst%3DP.%2BW.%26aulast%3DAshlock%26aufirst%3DM.%2BA.%26aulast%3DRamsey%26aufirst%3DB.%2BW.%26atitle%3DEffect%2520of%2520VX-770%2520in%2520persons%2520with%2520cystic%2520fibrosis%2520and%2520the%2520G551D-CFTR%2520mutation%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D1991%26epage%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ramsey, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElvaney, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tullis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dřevı́nek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKone, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainwright, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konstan, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratjen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sermet-Gaudelus, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ordoñez, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elborn, J. S.</span><span> </span><span class="NLM_article-title">A CFTR potentiator in patients with cystic fibrosis and the G551D mutation</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">1663</span><span class="NLM_x">–</span> <span class="NLM_lpage">1672</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1056%2FNEJMoa1105185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=22047557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWqtbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2011&pages=1663-1672&author=B.+W.+Ramseyauthor=J.+Daviesauthor=N.+G.+McElvaneyauthor=E.+Tullisauthor=S.+C.+Bellauthor=P.+D%C5%99ev%C4%B1%CC%81nekauthor=M.+Grieseauthor=E.+F.+McKoneauthor=C.+E.+Wainwrightauthor=M.+W.+Konstanauthor=R.+Mossauthor=F.+Ratjenauthor=I.+Sermet-Gaudelusauthor=S.+M.+Roweauthor=Q.+Dongauthor=S.+Rodriguezauthor=K.+Yenauthor=C.+L.+Ordo%C3%B1ezauthor=J.+S.+Elborn&title=A+CFTR+potentiator+in+patients+with+cystic+fibrosis+and+the+G551D+mutation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A CFTR potentiator in patients with cystic fibrosis and the G551D mutation</span></div><div class="casAuthors">Ramsey, Bonnie W.; Davis, Jane; McElvaney, Gerard; Tullis, Elizabeth; Bell, Scott C.; Dievinek, Pavel; Griese, Matthias; McKone, Edward F.; Wainwright, Claire E.; Konstan, Michael W.; Moss, Richard; Ratjen, Felix; Sermet-Gaudelus, Isabelle; Rowe, Steven M.; Dong, Qunming; Rodriguez, Sally; Yen, Karl; Ordonez, Claudia; Elborn, J. Stuart</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1663-1672</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Increasing the activity of defective cystic fibrosis transmembrane conductance regulator (CFTR) protein is a potential treatment for cystic fibrosis.  METHODS: We conducted a randomized, double-blind, placebo-controlled trial to evaluate ivacaftor (VX-770), a CFTR potentiator, in subjects 12 years of age or older with cystic fibrosis and at least one G551D-CFTR mutation.  Subjects were randomly assigned to receive 150 mg of ivacaftor every 12 h (84 subjects, of whom 83 received at least one dose) or placebo (83, of whom 78 received at least one dose) for 48 wk.  The primary end point was the estd. mean change from baseline through week 24 in the percent of predicted forced expiratory vol. in 1 s (FEV1).  RESULTS: The change from baseline through week 24 in the percent of predicted FEV1 was greater by 10.6 percentage points in the ivacaftor group than in the placebo group (P < 0.001).  Effects on pulmonary function were noted by 2 wk, and a significant treatment effect was maintained through week 48.  Subjects receiving ivacaftor were 55% less likely to have a pulmonary exacerbation than were patients receiving placebo, through week 48 (P < 0.001).  In addn., through week 48, subjects in the ivacaftor group scored 8.6 points higher than did subjects in the placebo group on the respiratory-symptoms domain of the Cystic Fibrosis Questionnaire-revised instrument (a 100-point scale, with higher nos. indicating a lower effect of symptoms on the patient's quality of life) (P < 0.001).  By 48 wk, patients treated with ivacaftor had gained, on av., 2.7 kg more wt. than had patients receiving placebo (P < 0.001).  The change from baseline through week 48 in the concn. of sweat chloride, a measure of CFTR activity, with ivacaftor as compared with placebo was -48.1 mmol per L (P < 0.001).  The incidence of adverse events was similar with ivacaftor and placebo, with a lower proportion of serious adverse events with ivacaftor than with placebo (24% vs. 42%).  CONCLUSIONS: Ivacaftor was assocd. with improvements in lung function at 2 wk that were sustained through 48 wk.  Substantial improvements were also obsd. in the risk of pulmonary exacerbations, patient-reported respiratory symptoms, wt., and concn. of sweat chloride.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-6U5nty7i_rVg90H21EOLACvtfcHk0lgFcJKMcm3xQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWqtbbE&md5=c9f4abffc063d6269677eb32dc9a83e8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1105185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1105185%26sid%3Dliteratum%253Aachs%26aulast%3DRamsey%26aufirst%3DB.%2BW.%26aulast%3DDavies%26aufirst%3DJ.%26aulast%3DMcElvaney%26aufirst%3DN.%2BG.%26aulast%3DTullis%26aufirst%3DE.%26aulast%3DBell%26aufirst%3DS.%2BC.%26aulast%3DD%25C5%2599ev%25C4%25B1%25CC%2581nek%26aufirst%3DP.%26aulast%3DGriese%26aufirst%3DM.%26aulast%3DMcKone%26aufirst%3DE.%2BF.%26aulast%3DWainwright%26aufirst%3DC.%2BE.%26aulast%3DKonstan%26aufirst%3DM.%2BW.%26aulast%3DMoss%26aufirst%3DR.%26aulast%3DRatjen%26aufirst%3DF.%26aulast%3DSermet-Gaudelus%26aufirst%3DI.%26aulast%3DRowe%26aufirst%3DS.%2BM.%26aulast%3DDong%26aufirst%3DQ.%26aulast%3DRodriguez%26aufirst%3DS.%26aulast%3DYen%26aufirst%3DK.%26aulast%3DOrdo%25C3%25B1ez%26aufirst%3DC.%2BL.%26aulast%3DElborn%26aufirst%3DJ.%2BS.%26atitle%3DA%2520CFTR%2520potentiator%2520in%2520patients%2520with%2520cystic%2520fibrosis%2520and%2520the%2520G551D%2520mutation%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D365%26spage%3D1663%26epage%3D1672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span>U.S. Food and Drug Administration: <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="1c586e697b6f5c5a585d">[email protected]</a>, FDA Approved Drug Products. <a href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203188s007lbl.pdf" class="extLink">http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203188s007lbl.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=U.S.+Food+and+Drug+Administration%3A+Drugs%40FDA%2C+FDA+Approved+Drug+Products.+http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2014%2F203188s007lbl.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first">When compound <b>1</b> is drawn as the quinolin-4-ol, the cLogP is calculated to be 5.2, more than 2 log units higher than that of the corresponding quinolin-4(1<i>H</i>)-one. Experimental log <i>P</i> values were determined for compounds <b>16</b> and <b>45</b>. Experimental determinations were closer to the quinolin-4-ol value than the corresponding quinolin-4(1<i>H</i>)-one value. See the table below.</p><p class="last"><div class="NLM_array"><table class="array-table"><tbody><tr>compdcLogP,cLogP,exptl log P</tr><tr> quinolin-4-olquinolin-4(1H)-one </tr><tr>164.61.63.2</tr><tr>455.62.64.8</tr></tbody></table></div></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">Compounds showing less that 50% activity at 30 μM were not tested in a dose–response format; their activity is expressed as a percent response at that concentration.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span>For additional information on the GABA<sub>A</sub> binding assay at Ricerca Biosciences, see <a href="http://www.ricerca.com" class="extLink">www.ricerca.com</a>. Percent activity at 10 μM was also measured for compounds <b>36</b> (47%), <b>45</b> (52%), and <b>48</b> (18%).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+additional+information+on+the+GABAA+binding+assay+at+Ricerca+Biosciences%2C+see+www.ricerca.com.+Percent+activity+at+10+%CE%BCM+was+also+measured+for+compounds+36+%2847%25%29%2C+45+%2852%25%29%2C+and+48+%2818%25%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">Measured thermodynamic solubility of compound <b>16</b>: water, not detectable; ethanol, 1.2 mg/mL; miglyol 810, 0.057 mg/mL)</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span> Torsional potentials were evaluated using internally developed software that utilizes the Szybki Toolkit from OpenEye Scientific Software [OpenEye Scientific Software, Santa Fe, NM; <a href="http://www.eyesopen.com/products/applications/szybki.html" class="extLink">http://www.eyesopen.com/products/applications/szybki.html</a>]. Potentials were evaluated by restraining the torsion angle in question at 5° increments and energy minimizing the remainder of the molecule using the MMFF force field as reported by the following:</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Torsional+potentials+were+evaluated+using+internally+developed+software+that+utilizes+the+Szybki+Toolkit+from+OpenEye+Scientific+Software+%5BOpenEye+Scientific+Software%2C+Santa+Fe%2C+NM%3B+http%3A%2F%2Fwww.eyesopen.com%2Fproducts%2Fapplications%2Fszybki.html%5D.+Potentials+were+evaluated+by+restraining+the+torsion+angle+in+question+at+5%C2%B0+increments+and+energy+minimizing+the+remainder+of+the+molecule+using+the+MMFF+force+field+as+reported+by+the+following%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b1"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span> </span><span class="NLM_article-title">Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b1&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b1&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1996&pages=490-519&author=T.+A.+Halgren&title=Merck+molecular+force+field.+I.+Basis%2C+form%2C+scope%2C+parameterization%2C+and+performance+of+MMFF94"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19b1R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5 & 6</span>),
    <span class="NLM_cas:pages">490-519</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">This article introduces MMFF94, the initial published version of the Merck mol. force field (MMFF).  It describes the objectives set for MMFF, the form it takes, and the range of systems to which it applies.  This study also outlines the methodol. employed in parameterizing MMFF94 and summarizes its performance in reproducing computational and exptl. data.  Though similar to MM3 in some respects, MMFF94 differs in ways intended to facilitate application to condensed-phase processes in mol.-dynamics simulations.  Indeed, MMFF94 seeks to achieve MM3-like accuracy for small mols. in a combined "org./protein" force field that is equally applicable to proteins and other systems of biol. significance.  A second distinguishing feature is that the core protion of MMFF94 has primarily been derived from high-quality computational data-ca. 500 mol. structures optimized at the HF/6-31G* level, 475 structures optimized at the MP2/6-31G* level, 380 MP2/6-31* structures evaluated at a defined approxn. to the MP4SDQ/TZP level, and 1450 structures partly derived from MP2/6-31G* geometries and evaluated at the MP2/TZP level.  A third distinguishing feature is that MMFF94 has been parameterized for a wide variety of chem. systems of interest to org. and combinations of functional groups for which little, if any, useful exptl. data are available.  The methodol. used in parameterizing MMFF94 represents a fourth distinguishing feature.  Rather than using the common "functional group" approach, nearly all MMFF parameters have been detd. in a mutually consistent fashion from the full set of available computational data.  MMFF94 reproduces the computational data used in its parameterization very well.  In addn., MMFF94 reproduces exptl. bond lengths (0.014 Å root mean square [rms]), bond angles (1.2° rms), vibrational frequencies (61 cm-1 rms), conformational energies (0.38 kcal/mol rms), and rotational barriers (0.39 kcal/mol rms) very nearly as well as does MM3 for comparable systems.  MMFF94 also describes intermol. interactions in hydrogen-bonded systems in a way that closely parallels that given by the highly regarded OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAzCYfKnN83rVg90H21EOLACvtfcHk0lg_HDiQja9t-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D&md5=56fb073477b4f49d1dfbd786fc56a480</span></div><a href="/servlet/linkout?suffix=cit19b1&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%2528199604%252917%253A5%252F6%253C490%253A%253AAID-JCC1%253E3.0.CO%253B2-P%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26atitle%3DMerck%2520molecular%2520force%2520field.%2520I.%2520Basis%252C%2520form%252C%2520scope%252C%2520parameterization%252C%2520and%2520performance%2520of%2520MMFF94%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1996%26volume%3D17%26spage%3D490%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-ref19_3"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span> </span><span class="NLM_article-title">MMFF VI. MMFF94s option for energy minimization studies</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/ref19_3&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1002%2F%28SICI%291096-987X%28199905%2920%3A7%3C720%3A%3AAID-JCC7%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/ref19_3&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVSlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=720-729&author=T.+A.+Halgren&title=MMFF+VI.+MMFF94s+option+for+energy+minimization+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref19_3R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">MMFF VI. MMFF94s option for energy minimization studies</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">720-729</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">This article describes the derivation of MMFF94s, which is the "s" (static) variant of MMFF94.  MMFF94s incorporates altered out of plane bending parameters that yield planar (or nearly planar) energy-minimized geometries at unstrained delocalized trigonal nitrogen centers.  Some exptl. and most theor. structures show appreciable puckering at nitrogen in isolated structures.  However, condensed-phase effects or even strong intermol. hydrogen bonding tends to reduce, but need not eliminate, such puckering; in contravention to results reported on the lower level Hartree-Fock surface, we show in the correlated LMP2/6-31G** calcns. for the Watson-Crick guanine-cytosine base pair that one of the hydrogen-bonded NH2 groups remains appreciably puckered.  The resultant MMFF94s geometries emulate the "time-averaged" structures typically obsd. in crystallog. and most other exptl. structure detns.  MMFF94s also employs modified torsion parameters for interactions that involve such centers, but is identical to MMFF94 for other systems.  Isolated instances are found in which MMFF94s fails to locate a (probably shallow) local min. found on the MMFF94 and ref. MP2/6-31G* surfaces.  In general, however, MMFF94s describes conformation energies for delocalized trigonal nitrogen systems nearly as well as MMFF94 does.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr9BF4aVDzDLVg90H21EOLACvtfcHk0lg_HDiQja9t-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVSlsrc%253D&md5=bd4da8a3fed88ecf5cc27bcb0b0a3679</span></div><a href="/servlet/linkout?suffix=ref19_3&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%28199905%2920%3A7%3C720%3A%3AAID-JCC7%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%2528199905%252920%253A7%253C720%253A%253AAID-JCC7%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26atitle%3DMMFF%2520VI.%2520MMFF94s%2520option%2520for%2520energy%2520minimization%2520studies%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1999%26volume%3D20%26spage%3D720%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">The energy difference between the superimposed conformation of <b>18</b> and the solid state conformation of <b>10</b> exceeded 10 kcal/mol and can explain the reduction of activity of sulfonamide linker.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Patani, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVoie, E. J.</span><span> </span><span class="NLM_article-title">Bioisosterism: a rational approach in drug design</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3147</span><span class="NLM_x">–</span> <span class="NLM_lpage">3176</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr950066q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1996&pages=3147-3176&author=G.+A.+Pataniauthor=E.+J.+LaVoie&title=Bioisosterism%3A+a+rational+approach+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosterism: A rational approach in drug design</span></div><div class="casAuthors">Patani, George A.; LaVoie, Edmond J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3147-3176</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with 191 refs., on bioisosteres that incorporates sufficient detail to enable the reader to understand the concepts being delineated.  Classical bioisosteres, such as monovalent atoms and groups, divalent isosteres, trivalent atoms and groups, tetra substituted atoms, and ring equiv., and non-classical bioisosteres, such as cyclic vs. non-cyclic non-classical bioisosteric replacements and non-classical bioisosteric replacements of functional groups, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrADeNoRGbU9LVg90H21EOLACvtfcHk0lggi-Ucz5lI5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D&md5=4b3ec55087feabc53e0490ebd5a3ddcd</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fcr950066q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr950066q%26sid%3Dliteratum%253Aachs%26aulast%3DPatani%26aufirst%3DG.%2BA.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26atitle%3DBioisosterism%253A%2520a%2520rational%2520approach%2520in%2520drug%2520design%26jtitle%3DChem.%2520Rev.%26date%3D1996%26volume%3D96%26spage%3D3147%26epage%3D3176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Asselin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humber, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, G.</span><span> </span><span class="NLM_article-title">Drug design via pharmacophore identification. Dopaminergic activity of 3<i>H</i>-benz[<i>e</i>]indol-8-amines and their mode of interaction with the dopamine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">654</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00155a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=648-654&author=A.+A.+Asselinauthor=L.+G.+Humberauthor=K.+Voithauthor=G.+Metcalf&title=Drug+design+via+pharmacophore+identification.+Dopaminergic+activity+of+3H-benz%5Be%5Dindol-8-amines+and+their+mode+of+interaction+with+the+dopamine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm00155a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00155a011%26sid%3Dliteratum%253Aachs%26aulast%3DAsselin%26aufirst%3DA.%2BA.%26aulast%3DHumber%26aufirst%3DL.%2BG.%26aulast%3DVoith%26aufirst%3DK.%26aulast%3DMetcalf%26aufirst%3DG.%26atitle%3DDrug%2520design%2520via%2520pharmacophore%2520identification.%2520Dopaminergic%2520activity%2520of%25203H-benz%255Be%255Dindol-8-amines%2520and%2520their%2520mode%2520of%2520interaction%2520with%2520the%2520dopamine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D648%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Asselin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humber, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosilla, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojdan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaslip, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimele, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, C.</span><span> </span><span class="NLM_article-title">Indole-phenol bioisosterism. Synthesis and antihypertensive activity of pyrrolo analog of labetalol</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00156a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=1009-1015&author=A.+A.+Asselinauthor=L.+G.+Humberauthor=D.+Crosillaauthor=G.+Oshiroauthor=A.+Wojdanauthor=D.+Grimesauthor=R.+J.+Heaslipauthor=T.+J.+Rimeleauthor=C.+Shaw&title=Indole-phenol+bioisosterism.+Synthesis+and+antihypertensive+activity+of+pyrrolo+analog+of+labetalol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fjm00156a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00156a019%26sid%3Dliteratum%253Aachs%26aulast%3DAsselin%26aufirst%3DA.%2BA.%26aulast%3DHumber%26aufirst%3DL.%2BG.%26aulast%3DCrosilla%26aufirst%3DD.%26aulast%3DOshiro%26aufirst%3DG.%26aulast%3DWojdan%26aufirst%3DA.%26aulast%3DGrimes%26aufirst%3DD.%26aulast%3DHeaslip%26aufirst%3DR.%2BJ.%26aulast%3DRimele%26aufirst%3DT.%2BJ.%26aulast%3DShaw%26aufirst%3DC.%26atitle%3DIndole-phenol%2520bioisosterism.%2520Synthesis%2520and%2520antihypertensive%2520activity%2520of%2520pyrrolo%2520analog%2520of%2520labetalol%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D1009%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="note"><p class="first last">Measured thermodynamic solubility of compound <b>38</b>: water, not detectable; ethanol, 5.7 mg/mL; miglyol 810, 15.2 mg/mL.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urrutia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seepersaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goor, F.</span><span> </span><span class="NLM_article-title">Ivacaftor potentiation of multiple CFTR channels with gating mutations</span> <span class="citation_source-journal">J. Cystic Fibrosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1016%2Fj.jcf.2011.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=22293084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1ektbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=237-245&author=H.+Yuauthor=B.+Burtonauthor=C.-J.+Huangauthor=J.+Worleyauthor=D.+Caoauthor=J.+P.+Johnsonauthor=A.+Urrutiaauthor=J.+Joubranauthor=S.+Seepersaudauthor=K.+Susskyauthor=B.+J.+Hoffmanauthor=F.+Van+Goor&title=Ivacaftor+potentiation+of+multiple+CFTR+channels+with+gating+mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Ivacaftor potentiation of multiple CFTR channels with gating mutations</span></div><div class="casAuthors">Yu, Haihui; Burton, Bill; Huang, Chien-Jung; Worley, Jennings; Cao, Dong; Johnson, James P., Jr.; Urrutia, Art; Joubran, John; Seepersaud, Sheila; Sussky, Katherine; Hoffman, Beth J.; Van Goor, Fredrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cystic Fibrosis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-245</span>CODEN:
                <span class="NLM_cas:coden">JCFOAC</span>;
        ISSN:<span class="NLM_cas:issn">1569-1993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background: The investigational CFTR potentiator ivacaftor (VX-770) increased CFTR channel activity and improved lung function in subjects with CF who have the G551D CFTR gating mutation.  The aim of this in vitro study was to det. whether ivacaftor potentiates mutant CFTR with gating defects caused by other CFTR gating mutations.  Methods: The effects of ivacaftor on CFTR channel open probability and chloride transport were tested in electrophysiol. studies using Fischer rat thyroid (FRT) cells expressing different CFTR gating mutations.  Results: Ivacaftor potentiated multiple mutant CFTR forms with defects in CFTR channel gating.  These included the G551D, G178R, S549N, S549R, G551S, G970R, G1244E, S1251N, S1255P and G1349D CFTR gating mutations.  Conclusion: These in vitro data suggest that ivacaftor has a similar effect on all CFTR forms with gating defects and support investigation of the potential clin. benefit of ivacaftor in CF patients who have CFTR gating mutations beyond G551D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTZOkxP_soI7Vg90H21EOLACvtfcHk0lggi-Ucz5lI5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1ektbc%253D&md5=b03927bc525b3b2ac2cfece02c8b67f6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jcf.2011.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jcf.2011.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DC.-J.%26aulast%3DWorley%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DUrrutia%26aufirst%3DA.%26aulast%3DJoubran%26aufirst%3DJ.%26aulast%3DSeepersaud%26aufirst%3DS.%26aulast%3DSussky%26aufirst%3DK.%26aulast%3DHoffman%26aufirst%3DB.%2BJ.%26aulast%3DVan%2BGoor%26aufirst%3DF.%26atitle%3DIvacaftor%2520potentiation%2520of%2520multiple%2520CFTR%2520channels%2520with%2520gating%2520mutations%26jtitle%3DJ.%2520Cystic%2520Fibrosis%26date%3D2012%26volume%3D11%26spage%3D237%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Van Goor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, B. J.</span><span> </span><span class="NLM_article-title">Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function</span> <span class="citation_source-journal">J. Cystic Fibrosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1016%2Fj.jcf.2013.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=23891399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A280%3ADC%252BC3sfksFKqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=29-36&author=F.+Van+Goorauthor=H.+Yuauthor=B.+Nurtonauthor=B.+J.+Hoffman&title=Effect+of+ivacaftor+on+CFTR+forms+with+missense+mutations+associated+with+defects+in+protein+processing+or+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function</span></div><div class="casAuthors">Van Goor Fredrick; Yu Haihui; Burton Bill; Hoffman Beth J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-36</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Ivacaftor (KALYDECO®, VX-770) is a CFTR potentiator that increased CFTR channel activity and improved lung function in patients age 6 years and older with CF who have the G551D-CFTR gating mutation.  The aim of this in vitro study was to evaluate the effect of ivacaftor on mutant CFTR protein forms with defects in protein processing and/or channel function.  METHODS:  The effect of ivacaftor on CFTR function was tested in electrophysiological studies using a panel of Fischer rat thyroid (FRT) cells expressing 54 missense CFTR mutations that cause defects in the amount or function of CFTR at the cell surface.  RESULTS:  Ivacaftor potentiated multiple mutant CFTR protein forms that produce functional CFTR at the cell surface.  These included mutant CFTR forms with mild defects in CFTR processing or mild defects in CFTR channel conductance.  CONCLUSIONS:  These in vitro data indicated that ivacaftor is a broad acting CFTR potentiator and could be used to help stratify patients with CF who have different CFTR genotypes for studies investigating the potential clinical benefit of ivacaftor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEKnRMau2Mr5dYoSR9eyvsfW6udTcc2eao9g0S5PwoM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfksFKqtQ%253D%253D&md5=e707cbc6ade54f57820ffc358f6d79db</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.jcf.2013.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jcf.2013.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DNurton%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DB.%2BJ.%26atitle%3DEffect%2520of%2520ivacaftor%2520on%2520CFTR%2520forms%2520with%2520missense%2520mutations%2520associated%2520with%2520defects%2520in%2520protein%2520processing%2520or%2520function%26jtitle%3DJ.%2520Cystic%2520Fibrosis%26date%3D2014%26volume%3D13%26spage%3D29%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pellowska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span> </span><span class="NLM_article-title">Advances in personalized medicine—medicinal chemistry and pharmacology of vemurafenib and ivacaftor</span> <span class="citation_source-journal">Pharmazie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=484-491&author=M.+Pellowskaauthor=D.+Merkauthor=M.+Schubert-Zsilavecz&title=Advances+in+personalized+medicine%E2%80%94medicinal+chemistry+and+pharmacology+of+vemurafenib+and+ivacaftor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPellowska%26aufirst%3DM.%26aulast%3DMerk%26aufirst%3DD.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26atitle%3DAdvances%2520in%2520personalized%2520medicine%25E2%2580%2594medicinal%2520chemistry%2520and%2520pharmacology%2520of%2520vemurafenib%2520and%2520ivacaftor%26jtitle%3DPharmazie%26date%3D2013%26volume%3D68%26spage%3D484%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Milla, C. E.</span><span> </span><span class="NLM_article-title">Cystic fibrosis in the era of genomic medicine</span> <span class="citation_source-journal">Curr. Opin. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1097%2FMOP.0b013e328360dbf5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=23652683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlaiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2013&pages=323-328&author=C.+E.+Milla&title=Cystic+fibrosis+in+the+era+of+genomic+medicine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Cystic fibrosis in the era of genomic medicine</span></div><div class="casAuthors">Milla, Carlos E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pediatrics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-328</span>CODEN:
                <span class="NLM_cas:coden">COPEE9</span>;
        ISSN:<span class="NLM_cas:issn">1040-8703</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: The field of cystic fibrosis (CF) is changing dramatically as the scientific knowledge accumulated since the cloning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is being translated into effective therapies to correct the basic defect and provide better disease models and in-depth understanding of the basic mechanisms of disease.  Recent findings: This review focuses on three main aspects of the recent advances in the field: understanding the lung disease pathophysiol. (in particular, the early events that condition its onset), better definition of the complex microbiol. of the CF airway, and therapeutic developments.  Although the most recently developed therapies, whether approved or under study, do not constitute a definitive cure, the benefit to patients is already becoming clearly apparent.  Summary: As the field continues to change rapidly and new therapies are being identified, CF has become a paradigm for the application of concepts such as translational medicine, genomic medicine, and personalized care, with measurable clin. benefit for the patients affected by this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnw4RR6-jtb7Vg90H21EOLACvtfcHk0lih-1rXnnSGzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlaiu7g%253D&md5=3c5712c30c3c932d47dba34350026e6e</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1097%2FMOP.0b013e328360dbf5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMOP.0b013e328360dbf5%26sid%3Dliteratum%253Aachs%26aulast%3DMilla%26aufirst%3DC.%2BE.%26atitle%3DCystic%2520fibrosis%2520in%2520the%2520era%2520of%2520genomic%2520medicine%26jtitle%3DCurr.%2520Opin.%2520Pediatr.%26date%3D2013%26volume%3D25%26spage%3D323%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Rommens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannuzzi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerem, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drumm, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melmer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozmahel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zsiga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riordan, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, L.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F. S.</span><span> </span><span class="NLM_article-title">Identification of the cystic fibrosis gene: chromosome walking and jumping</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">245</span><span class="NLM_x">, </span> <span class="NLM_fpage">1059</span><span class="NLM_x">–</span> <span class="NLM_lpage">1065</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1126%2Fscience.2772657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5012808&amp;key=2772657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADyaL1MXls1yms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1989&pages=1059-1065&author=J.+M.+Rommensauthor=M.+C.+Iannuzziauthor=B.+Keremauthor=M.+L.+Drummauthor=G.+Melmerauthor=M.+Deanauthor=R.+Rozmahelauthor=J.+L.+Coleauthor=D.+Kennedyauthor=N.+Hidakaauthor=M.+Zsigaauthor=M.+Buchwaldauthor=J.+R.+Riordanauthor=L.-C.+Tsuiauthor=F.+S.+Collins&title=Identification+of+the+cystic+fibrosis+gene%3A+chromosome+walking+and+jumping"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the cystic fibrosis gene:  chromosome walking and jumping</span></div><div class="casAuthors">Rommens, Johanna M.; Iannuzzi, Michael C.; Kerem, Bat Sheva; Drumm, Mitchell L.; Melmer, Georg; Dean, Michael; Rozmahel, Richard; Cole, Jeffery L.; Kennedy, Dara; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue">4922</span>),
    <span class="NLM_cas:pages">1059-65</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">An understanding of the basic defect in the inherited disorder cystic fibrosis requires cloning in the cystic fibrosis gene and definition of its protein product.  In the absence of direct functional information, chromosomal map position is a guide for locating the gene.  Chromosome walking and jumping and cDNA hybridization were used to isolate DNA sequences, encompassing more than 500,000 base pairs, from the cystic fibrosis region on the long arm of human chromosome 7.  Several transcribed sequences and conserved segments were identified in this cloned region.  One of these corresponds to the cystic fibrosis gene and spans approx. 250,000 base pairs of genomic DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYv4p8ba0LILVg90H21EOLACvtfcHk0lhvoWNQ2FPR_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXls1yms7c%253D&md5=fe61f569e3324cd0a55037ce8d8b8207</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscience.2772657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2772657%26sid%3Dliteratum%253Aachs%26aulast%3DRommens%26aufirst%3DJ.%2BM.%26aulast%3DIannuzzi%26aufirst%3DM.%2BC.%26aulast%3DKerem%26aufirst%3DB.%26aulast%3DDrumm%26aufirst%3DM.%2BL.%26aulast%3DMelmer%26aufirst%3DG.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DRozmahel%26aufirst%3DR.%26aulast%3DCole%26aufirst%3DJ.%2BL.%26aulast%3DKennedy%26aufirst%3DD.%26aulast%3DHidaka%26aufirst%3DN.%26aulast%3DZsiga%26aufirst%3DM.%26aulast%3DBuchwald%26aufirst%3DM.%26aulast%3DRiordan%26aufirst%3DJ.%2BR.%26aulast%3DTsui%26aufirst%3DL.-C.%26aulast%3DCollins%26aufirst%3DF.%2BS.%26atitle%3DIdentification%2520of%2520the%2520cystic%2520fibrosis%2520gene%253A%2520chromosome%2520walking%2520and%2520jumping%26jtitle%3DScience%26date%3D1989%26volume%3D245%26spage%3D1059%26epage%3D1065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Koga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irikura, T.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1358</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00186a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1980&pages=1358-1363&author=H.+Kogaauthor=A.+Itohauthor=S.+Murayamaauthor=S.+Suzueauthor=T.+Irikura&title=Structure%E2%80%93activity+relationships+of+antibacterial+6%2C7-+and+7%2C8-disubstituted+1-alkyl-1%2C4-dihydro-4-oxoquinoline-3-carboxylic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1021%2Fjm00186a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00186a014%26sid%3Dliteratum%253Aachs%26aulast%3DKoga%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DA.%26aulast%3DMurayama%26aufirst%3DS.%26aulast%3DSuzue%26aufirst%3DS.%26aulast%3DIrikura%26aufirst%3DT.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520antibacterial%25206%252C7-%2520and%25207%252C8-disubstituted%25201-alkyl-1%252C4-dihydro-4-oxoquinoline-3-carboxylic%2520acids%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1980%26volume%3D23%26spage%3D1358%26epage%3D1363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shah, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coats, E. A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and correlation analysis of 7-substituted 4-hydroxyquinoline-3-carboxylic acids as inhibitors of cellular respiration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00218a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1977&pages=1001-1006&author=K.+J.+Shahauthor=E.+A.+Coats&title=Design%2C+synthesis%2C+and+correlation+analysis+of+7-substituted+4-hydroxyquinoline-3-carboxylic+acids+as+inhibitors+of+cellular+respiration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1021%2Fjm00218a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00218a003%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DK.%2BJ.%26aulast%3DCoats%26aufirst%3DE.%2BA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520correlation%2520analysis%2520of%25207-substituted%25204-hydroxyquinoline-3-carboxylic%2520acids%2520as%2520inhibitors%2520of%2520cellular%2520respiration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1977%26volume%3D20%26spage%3D1001%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Davies, R. V.; Fraser, J.; Nichol, K. J.</span> EP 206616A2,<span class="NLM_x"> </span><span class="NLM_year">1986</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Davies%2C+R.+V.%3B+Fraser%2C+J.%3B+Nichol%2C+K.+J.+EP+206616A2%2C+1986."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DR.%2BV.%26date%3D1986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Coppola, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardtmann, G. E.</span><span> </span><span class="NLM_article-title">The chemistry of 2<i>H</i>-3,1-benzoxazine-2,4(1<i>H</i>)-dione (isatoic anhydride). 7. Reactions with anions of active methylenes to form quinolines</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1610</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=1605-1610&author=G.+M.+Coppolaauthor=G.+E.+Hardtmann&title=The+chemistry+of+2H-3%2C1-benzoxazine-2%2C4%281H%29-dione+%28isatoic+anhydride%29.+7.+Reactions+with+anions+of+active+methylenes+to+form+quinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DHardtmann%26aufirst%3DG.%2BE.%26atitle%3DThe%2520chemistry%2520of%25202H-3%252C1-benzoxazine-2%252C4%25281H%2529-dione%2520%2528isatoic%2520anhydride%2529.%25207.%2520Reactions%2520with%2520anions%2520of%2520active%2520methylenes%2520to%2520form%2520quinolines%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1979%26volume%3D16%26spage%3D1605%26epage%3D1610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabio, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuck, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, R. T.</span><span> </span><span class="NLM_article-title">Pyrido[3,4-<i>e</i>]-1,2,4-triazines and related heterocycles as potential antifungal agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2474</span><span class="NLM_x">–</span> <span class="NLM_lpage">2485</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00131a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=2474-2485&author=M.+F.+Reichauthor=P.+F.+Fabioauthor=V.+J.+Leeauthor=N.+A.+Kuckauthor=R.+T.+Testa&title=Pyrido%5B3%2C4-e%5D-1%2C2%2C4-triazines+and+related+heterocycles+as+potential+antifungal+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm00131a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00131a010%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DFabio%26aufirst%3DP.%2BF.%26aulast%3DLee%26aufirst%3DV.%2BJ.%26aulast%3DKuck%26aufirst%3DN.%2BA.%26aulast%3DTesta%26aufirst%3DR.%2BT.%26atitle%3DPyrido%255B3%252C4-e%255D-1%252C2%252C4-triazines%2520and%2520related%2520heterocycles%2520as%2520potential%2520antifungal%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D2474%26epage%3D2485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Murphy, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridd, J. H.</span><span> </span><span class="NLM_article-title">The rearrangement of aromatic nitro compounds. Part I. The reactions of nitroanilines in aqueous sulphuric acid</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans 2</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1767</span><span class="NLM_x">–</span> <span class="NLM_lpage">1772</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1039%2Fp29870001767" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1987&pages=1767-1772&author=J.+T.+Murphyauthor=J.+H.+Ridd&title=The+rearrangement+of+aromatic+nitro+compounds.+Part+I.+The+reactions+of+nitroanilines+in+aqueous+sulphuric+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2Fp29870001767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp29870001767%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DJ.%2BT.%26aulast%3DRidd%26aufirst%3DJ.%2BH.%26atitle%3DThe%2520rearrangement%2520of%2520aromatic%2520nitro%2520compounds.%2520Part%2520I.%2520The%2520reactions%2520of%2520nitroanilines%2520in%2520aqueous%2520sulphuric%2520acid%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans%25202%26date%3D1987%26volume%3D12%26spage%3D1767%26epage%3D1772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Derbyshire, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, W. A.</span><span> </span><span class="NLM_article-title">108. The Significance of bromine cation in aromatic substitution. Part II. Preparative applicability</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1950&pages=573-577&author=D.+H.+Derbyshireauthor=W.+A.+Waters&title=108.+The+Significance+of+bromine+cation+in+aromatic+substitution.+Part+II.+Preparative+applicability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDerbyshire%26aufirst%3DD.%2BH.%26aulast%3DWaters%26aufirst%3DW.%2BA.%26atitle%3D108.%2520The%2520Significance%2520of%2520bromine%2520cation%2520in%2520aromatic%2520substitution.%2520Part%2520II.%2520Preparative%2520applicability%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1950%26spage%3D573%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Tschaen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmond, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pipik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeven, T. R.</span><span> </span><span class="NLM_article-title">An improved procedure for aromatic cyanation</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">887</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1080%2F00397919408011310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADyaK2cXktVyrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=887-890&issue=6&author=D.+M.+Tschaenauthor=R.+Desmondauthor=A.+O.+Kingauthor=M.+C.+Fortinauthor=B.+Pipikauthor=S.+Kingauthor=T.+R.+Verhoeven&title=An+improved+procedure+for+aromatic+cyanation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">An improved procedure for aromatic cyanation</span></div><div class="casAuthors">Tschaen, D. M.; Desmond, R.; King, A. O.; Fortin, M. C.; Pipik, B.; King, S.; Verhoeven, T. R.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">887-90</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">An effective method for conversion of aryl bromides to aryl cyanides is described.  The procedure involves treatment of the aryl halide with zinc cyanide in the presence of a catalytic amt. of Pd(PPh3)4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkwjVF7zhEyrVg90H21EOLACvtfcHk0ljQe9oolzjh1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktVyrsb8%253D&md5=f56e0d59d6ff886e3d549832dce904f3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1080%2F00397919408011310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919408011310%26sid%3Dliteratum%253Aachs%26aulast%3DTschaen%26aufirst%3DD.%2BM.%26aulast%3DDesmond%26aufirst%3DR.%26aulast%3DKing%26aufirst%3DA.%2BO.%26aulast%3DFortin%26aufirst%3DM.%2BC.%26aulast%3DPipik%26aufirst%3DB.%26aulast%3DKing%26aufirst%3DS.%26aulast%3DVerhoeven%26aufirst%3DT.%2BR.%26atitle%3DAn%2520improved%2520procedure%2520for%2520aromatic%2520cyanation%26jtitle%3DSynth.%2520Commun.%26date%3D1994%26volume%3D24%26issue%3D6%26spage%3D887%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kovendi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kircz, M.</span><span> </span><span class="NLM_article-title">Synthesis of halo-, amino-, sulfonyl-, and aminosulfonyl(nitro)(ethyl)benzenes</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1896</span><span class="NLM_x">–</span> <span class="NLM_lpage">1901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1964&pages=1896-1901&author=A.+Kovendiauthor=M.+Kircz&title=Synthesis+of+halo-%2C+amino-%2C+sulfonyl-%2C+and+aminosulfonyl%28nitro%29%28ethyl%29benzenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKovendi%26aufirst%3DA.%26aulast%3DKircz%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520halo-%252C%2520amino-%252C%2520sulfonyl-%252C%2520and%2520aminosulfonyl%2528nitro%2529%2528ethyl%2529benzenes%26jtitle%3DChem.%2520Ber.%26date%3D1964%26volume%3D97%26spage%3D1896%26epage%3D1901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Capon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claudon, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornubert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivant, G.</span><span> </span><span class="NLM_article-title">Cyclane stereochemistry. XLI. 2,4-, 3,4-, and 3,5-Dimethylcyclohexanones</span> <span class="citation_source-journal">Bull. Soc. Chim. Fr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1958&pages=847-853&author=D.+Caponauthor=M.+M.+Claudonauthor=R.+Cornubertauthor=H.+Lemoineauthor=G.+Vivant&title=Cyclane+stereochemistry.+XLI.+2%2C4-%2C+3%2C4-%2C+and+3%2C5-Dimethylcyclohexanones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCapon%26aufirst%3DD.%26aulast%3DClaudon%26aufirst%3DM.%2BM.%26aulast%3DCornubert%26aufirst%3DR.%26aulast%3DLemoine%26aufirst%3DH.%26aulast%3DVivant%26aufirst%3DG.%26atitle%3DCyclane%2520stereochemistry.%2520XLI.%25202%252C4-%252C%25203%252C4-%252C%2520and%25203%252C5-Dimethylcyclohexanones%26jtitle%3DBull.%2520Soc.%2520Chim.%2520Fr.%26date%3D1958%26spage%3D847%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Oya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coenen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">New PET imaging agent for the serotonin transporter: [<sup>18</sup>F]ACF (2-[(2-amino-4-chloro-5-fluorophenyl)thio]-<i>N</i>,<i>N</i>-dimethyl-benzenemethanamine)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4716</span><span class="NLM_x">–</span> <span class="NLM_lpage">4723</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020167y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4716-4723&author=S.+Oyaauthor=S.+R.+Choiauthor=H.+Coenenauthor=H.+F.+Kung&title=New+PET+imaging+agent+for+the+serotonin+transporter%3A+%5B18F%5DACF+%282-%5B%282-amino-4-chloro-5-fluorophenyl%29thio%5D-N%2CN-dimethyl-benzenemethanamine%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm020167y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020167y%26sid%3Dliteratum%253Aachs%26aulast%3DOya%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DS.%2BR.%26aulast%3DCoenen%26aufirst%3DH.%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DNew%2520PET%2520imaging%2520agent%2520for%2520the%2520serotonin%2520transporter%253A%2520%255B18F%255DACF%2520%25282-%255B%25282-amino-4-chloro-5-fluorophenyl%2529thio%255D-N%252CN-dimethyl-benzenemethanamine%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4716%26epage%3D4723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Charpentier, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardon, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eustache, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shroot, B.</span><span> </span><span class="NLM_article-title">Synthesis, structure–affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4993</span><span class="NLM_x">–</span> <span class="NLM_lpage">5006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=4993-5006&author=B.+O.+Charpentierauthor=J.-M.+Bernardonauthor=J.+Eustacheauthor=C.+Milloisauthor=B.+Martinauthor=S.+Michelauthor=B.+Shroot&title=Synthesis%2C+structure%E2%80%93affinity+relationships%2C+and+biological+activities+of+ligands+binding+to+retinoic+acid+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharpentier%26aufirst%3DB.%2BO.%26aulast%3DBernardon%26aufirst%3DJ.-M.%26aulast%3DEustache%26aufirst%3DJ.%26aulast%3DMillois%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DB.%26aulast%3DMichel%26aufirst%3DS.%26aulast%3DShroot%26aufirst%3DB.%26atitle%3DSynthesis%252C%2520structure%25E2%2580%2593affinity%2520relationships%252C%2520and%2520biological%2520activities%2520of%2520ligands%2520binding%2520to%2520retinoic%2520acid%2520receptor%2520subtypes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D38%26spage%3D4993%26epage%3D5006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Hennequin, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, E. S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, J.-J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curwen, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrew, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert-van der Brempt, C.</span><span> </span><span class="NLM_article-title">Design and structure–activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5369</span><span class="NLM_x">–</span> <span class="NLM_lpage">5389</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990345w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5369-5389&author=L.+F.+Hennequinauthor=A.+P.+Thomasauthor=C.+Johnstoneauthor=E.+S.+E.+Stokesauthor=P.+A.+Pleauthor=J.-J.+M.+Lohmannauthor=D.+J.+Ogilvieauthor=M.+Dukesauthor=S.+R.+Wedgeauthor=J.+O.+Curwenauthor=J.+Kendrewauthor=C.+Lambert-van+der+Brempt&title=Design+and+structure%E2%80%93activity+relationship+of+a+new+class+of+potent+VEGF+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm990345w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990345w%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26aulast%3DThomas%26aufirst%3DA.%2BP.%26aulast%3DJohnstone%26aufirst%3DC.%26aulast%3DStokes%26aufirst%3DE.%2BS.%2BE.%26aulast%3DPle%26aufirst%3DP.%2BA.%26aulast%3DLohmann%26aufirst%3DJ.-J.%2BM.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26aulast%3DDukes%26aufirst%3DM.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DCurwen%26aufirst%3DJ.%2BO.%26aulast%3DKendrew%26aufirst%3DJ.%26aulast%3DLambert-van%2Bder%2BBrempt%26aufirst%3DC.%26atitle%3DDesign%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520a%2520new%2520class%2520of%2520potent%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5369%26epage%3D5389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Su, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span> </span><span class="NLM_article-title">Synthesis of functionalized long-chain perfluoroalkanes from methyl halodifluoroacetates: a process of difluorocarbene insertion into copper–carbon bonds</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">1–2</span><span class="NLM_x">) </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm5012808&amp;key=10.1016%2FS0022-1139%2800%2980465-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm5012808&amp;key=1%3ACAS%3A528%3ADyaK2cXhvFWjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1993&pages=11-14&issue=1%E2%80%932&author=D.+Suauthor=J.+Duanauthor=A.+Yuauthor=Q.+Chen&title=Synthesis+of+functionalized+long-chain+perfluoroalkanes+from+methyl+halodifluoroacetates%3A+a+process+of+difluorocarbene+insertion+into+copper%E2%80%93carbon+bonds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of functionalized long-chain perfluoroalkanes from methyl halodifluoroacetates: a process of difluorocarbene insertion into copper-carbon bonds</span></div><div class="casAuthors">Su, Debao; Duan, Jianxing; Yu, Anjuan; Chen, Qingyun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">11-14</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    </div><div class="casAbstract">Treatment of XCF2CO2Me (X = Cl, Br) with org. halides RX (PhI, PhBr, 1-iodonaphthalene, PhCH2Br, allyl bromide) in the presence of KF and catalytic amts. of CuI at 80-120° for 3-8 h in DMF gave long-chain perfluoroalkylated compds. R(CF2)nCF3, which are considered to be formed by the insertions of CF2: into carbon-copper bonds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1owjFliboYrVg90H21EOLACvtfcHk0ljY0eGPej1WKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhvFWjt7g%253D&md5=4d5f698958e699b1b9802d930b556900</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0022-1139%2800%2980465-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-1139%252800%252980465-0%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DD.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DQ.%26atitle%3DSynthesis%2520of%2520functionalized%2520long-chain%2520perfluoroalkanes%2520from%2520methyl%2520halodifluoroacetates%253A%2520a%2520process%2520of%2520difluorocarbene%2520insertion%2520into%2520copper%25E2%2580%2593carbon%2520bonds%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D1993%26volume%3D65%26issue%3D1%25E2%2580%25932%26spage%3D11%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Hansch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helmkamp, G.</span><span> </span><span class="NLM_article-title">Catalytic synthesis of heterocycles. VI. Dehydrocyclization of <i>o</i>-alkylbenzenes to indoles</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1951</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">3080</span><span class="NLM_x">–</span> <span class="NLM_lpage">3082</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01151a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1951&pages=3080-3082&author=C.+Hanschauthor=G.+Helmkamp&title=Catalytic+synthesis+of+heterocycles.+VI.+Dehydrocyclization+of+o-alkylbenzenes+to+indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fja01151a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01151a031%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26aulast%3DHelmkamp%26aufirst%3DG.%26atitle%3DCatalytic%2520synthesis%2520of%2520heterocycles.%2520VI.%2520Dehydrocyclization%2520of%2520o-alkylbenzenes%2520to%2520indoles%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1951%26volume%3D73%26spage%3D3080%26epage%3D3082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Barlett, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallbillich, G. E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wingrove, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenton, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, B. D.</span><span> </span><span class="NLM_article-title">Cycloaddition. V. 2-Alkylbutadienes and 1,1-dichloro-2,2-difluoroethylene. The effect of diene conformation on mode of cycloaddition</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">2049</span><span class="NLM_x">–</span> <span class="NLM_lpage">2056</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1968&pages=2049-2056&author=P.+D.+Barlettauthor=G.+E.+H.+Wallbillichauthor=A.+S.+Wingroveauthor=J.+S.+Swentonauthor=L.+K.+Montgomeryauthor=B.+D.+Kramer&title=Cycloaddition.+V.+2-Alkylbutadienes+and+1%2C1-dichloro-2%2C2-difluoroethylene.+The+effect+of+diene+conformation+on+mode+of+cycloaddition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarlett%26aufirst%3DP.%2BD.%26aulast%3DWallbillich%26aufirst%3DG.%2BE.%2BH.%26aulast%3DWingrove%26aufirst%3DA.%2BS.%26aulast%3DSwenton%26aufirst%3DJ.%2BS.%26aulast%3DMontgomery%26aufirst%3DL.%2BK.%26aulast%3DKramer%26aufirst%3DB.%2BD.%26atitle%3DCycloaddition.%2520V.%25202-Alkylbutadienes%2520and%25201%252C1-dichloro-2%252C2-difluoroethylene.%2520The%2520effect%2520of%2520diene%2520conformation%2520on%2520mode%2520of%2520cycloaddition%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1968%26volume%3D90%26spage%3D2049%26epage%3D2056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Carpenter, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easter, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, T. F.</span><span> </span><span class="NLM_article-title">Nitro musks. Isomers, homologs, and analogs of musk ambrette</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1951</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01144a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1951&pages=586-617&author=M.+S.+Carpenterauthor=W.+M.+Easterauthor=T.+F.+Wood&title=Nitro+musks.+Isomers%2C+homologs%2C+and+analogs+of+musk+ambrette"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1021%2Fjo01144a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01144a011%26sid%3Dliteratum%253Aachs%26aulast%3DCarpenter%26aufirst%3DM.%2BS.%26aulast%3DEaster%26aufirst%3DW.%2BM.%26aulast%3DWood%26aufirst%3DT.%2BF.%26atitle%3DNitro%2520musks.%2520Isomers%252C%2520homologs%252C%2520and%2520analogs%2520of%2520musk%2520ambrette%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1951%26volume%3D16%26spage%3D586%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Galietta, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lantero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazzolo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacco, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zegarra-Moran, O.</span><span> </span><span class="NLM_article-title">An improved method to obtain highly differenciated monolayers of human bronchial epithelial cells</span> <span class="citation_source-journal">In Vitro Cell. Dev. Biol.: Anim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">478</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1998&pages=478-481&author=L.+J.+Galiettaauthor=S.+Lanteroauthor=A.+Gazzoloauthor=O.+Saccoauthor=L.+Romanoauthor=G.+A.+Rossiauthor=O.+Zegarra-Moran&title=An+improved+method+to+obtain+highly+differenciated+monolayers+of+human+bronchial+epithelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalietta%26aufirst%3DL.%2BJ.%26aulast%3DLantero%26aufirst%3DS.%26aulast%3DGazzolo%26aufirst%3DA.%26aulast%3DSacco%26aufirst%3DO.%26aulast%3DRomano%26aufirst%3DL.%26aulast%3DRossi%26aufirst%3DG.%2BA.%26aulast%3DZegarra-Moran%26aufirst%3DO.%26atitle%3DAn%2520improved%2520method%2520to%2520obtain%2520highly%2520differenciated%2520monolayers%2520of%2520human%2520bronchial%2520epithelial%2520cells%26jtitle%3DIn%2520Vitro%2520Cell.%2520Dev.%2520Biol.%253A%2520Anim.%26date%3D1998%26volume%3D34%26spage%3D478%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i115"><a href="/doi/suppl/10.1021/jm5012808">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82052"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures for compounds <b>27</b>–<b>30</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5012808/suppl_file/jm5012808_si_001.pdf">jm5012808_si_001.pdf (34.4 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5012808&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-23%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm5012808%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5012808" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679998cb684d3dc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
